Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

BACK TO DOWNLOADS INDEX

---

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0350195	[act15]: acbA(Y72A)	acbA	decreased lipid binding
DBS0350657	[csaA]: csaA	csaA	aberrant aggregation | increased calcium-independent cell-cell adhesion
DBS0350059	mcln-	mcln	aberrant cellular response to fluid shear stress | increased growth rate | aberrant post-lysosomal vacuole exocytosis
DBS0351382	myoB-/ [act15]: GFP: myoB(1-921,1057-1111)	myoB	abolished protein localization to actin wave
DBS0350826	pinA-	pinA	decreased growth rate | decreased mound size | decreased sporulation
DBS0235412	1C7	gp130	decreased cell-substrate adhesion | delayed development | increased growth rate
DBS0238601	5NT-	5nt	delayed development of tipped mound | increased number of mound tips | increased number of early culminant tips
DBS0351520	AK1334	DDB_G0271574 | nip7	decreased response to Gram-negative bacterium
DBS0235584	CF45-1-	cf45-1	increased mound size | increased glucose level | decreased mound size | decreased cell motility | increased cell-cell adhesion
DBS0235585	CF50-	cf50-1 | cf50-2	decreased response to Gram-negative bacterium | decreased response to Gram-positive bacterium | increased mound size | increased cell-cell adhesion | increased prespore gene expression | increased protein level | decreased protein secretion
DBS0235594	CHE10	cbpC	decreased slug migration | precocious aggregation | decreased mound size | decreased fruiting body size | delayed culmination
DBS0235595	CHI2	cbpC	increased slug migration
DBS0235596	ChLim-	ChLim	increased growth rate | increased phagocytosis
DBS0351197	D2B-	D2B	aberrant chemotaxis to cAMP
DBS0235659	DD3-3-	DD3-3	decreased gene expression | precocious aggregation
DBS0236049	DDB_G0268012-	DDB_G0268012	wild type
DBS0236046	DDB_G0268158-	DDB_G0268158	wild type
DBS0236039	DDB_G0268678-	DDB_G0268678	wild type
DG1007	DDB_G0269232-	DDB_G0269232	abolished culmination
DBS0236025	DDB_G0270366-	DDB_G0270366	wild type
DBS0236026	DDB_G0270368-	DDB_G0270368	wild type
DBS0236036	DDB_G0270744-	DDB_G0270744	wild type
DBS0351081	DDB_G0272538-	DDB_G0272538	delayed aggregation | increased cell-substrate adhesion
LAS29	DDB_G0273201-	DDB_G0273201	decreased socially cooperative development
LAS8	DDB_G0273809-	zplC-1 | zplC-2	decreased socially cooperative development
LAS43	DDB_G0274429-	DDB_G0274429	decreased socially cooperative development
DBS0351079	DDB_G0274679-	DDB_G0274679	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0236043	DDB_G0276221-	fam21	wild type
DBS0236042	DDB_G0276689-	DDB_G0276689	wild type
DBS0236041	DDB_G0277179-	DDB_G0277179	wild type
LAS26	DDB_G0277239-	DDB_G0277239	decreased socially cooperative development
DBS0236045	DDB_G0277575-	DDB_G0277575	wild type
DBS0236044	DDB_G0278315-	DDB_G0278315	wild type
LAS34	DDB_G0278585-	DDB_G0278585	decreased socially cooperative development
DBS0236038	DDB_G0279005-	cnot11	wild type
DBS0236032	DDB_G0279163-	DDB_G0279163	wild type
DBS0236033	DDB_G0279163-	DDB_G0279163	wild type
LAS70	DDB_G0279405-	DDB_G0279405	decreased socially cooperative development
DBS0236028	DDB_G0279609-	DDB_G0279609	wild type
DBS0236029	DDB_G0279609-	DDB_G0279609	wild type
LAS103	DDB_G0280089-	DDB_G0280089	decreased socially cooperative development
LAS54	DDB_G0280299-	DDB_G0280299	decreased socially cooperative development
DBS0236035	DDB_G0280481-	DDB_G0280481	wild type
DBS0351082	DDB_G0281485-	DDB_G0281485	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0351080	DDB_G0281497-	DDB_G0281497	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0236019	DDB_G0281735-	DDB_G0281735	wild type
DBS0236020	DDB_G0281735-	DDB_G0281735	wild type
DBS0351620	DDB_G0281735-/ DDB_G0281737-	DDB_G0281735 | DDB_G0281737	decreased response to Gram-negative bacterium | aberrant vegetative growth
LAS92	DDB_G0283373-	DDB_G0283373	decreased socially cooperative development
LAS106	DDB_G0283595-	DDB_G0283595	decreased socially cooperative development
DBS0351085	DDB_G0284955-	DDB_G0284955	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
LAS3	DDB_G0287153-	DDB_G0287153	decreased socially cooperative development
LAS10	DDB_G0288547-	DDB_G0288547	decreased socially cooperative development
LAS9	DDB_G0289789-	DDB_G0289789	decreased socially cooperative development
DBS0236027	DDB_G0290225-	DDB_G0290225	wild type
DBS0351086	DDB_G0290519-	DDB_G0290519	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
LAS7	DDB_G0290685-	DDB_G0290685	decreased socially cooperative development
DG1003	DDB_G0291992-	DDB_G0291992	aberrant late culminant morphology
LAS39	DDB_G0292148-	DDB_G0292148	decreased socially cooperative development
DBS0236037	DDB_G0292186-	DDB_G0292186	wild type
DBS0350073	DDB_G0293074-	DDB_G0293074	decreased spore germination | delayed aggregation
DBS0351083	DDB_G0293098-	DDB_G0293098	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0236023	DDB_G0293116-	DDB_G0293116	wild type
DBS0236024	DDB_G0293116-	DDB_G0293116	wild type
DBS0350516	DDB_G0293356-	DDB_G0293356	decreased defense response to Gram-negative bacterium
DBS0236030	DDB_G0293762-	DDB_G0293762	wild type
DG1039	DG1039-	DDB_G0284037	aberrant fruiting body morphogenesis
DG1040	DG1040-	DDB_G0276029	aberrant fruiting body morphogenesis
DG1041	DG1041-	DDB_G0269126	aberrant fruiting body morphogenesis
DG1054	DG1054-	DDB_G0277719	aberrant fruiting body morphogenesis
DG1060	DG1060-	DDB_G0281953	aberrant fruiting body morphogenesis
DG1062	DG1062-	cdl1A	aberrant fruiting body morphogenesis
DG1074	DG1074-	DDB_G0272108	aberrant fruiting body morphogenesis
DG1080	DG1080-	DDB_G0281559	aberrant fruiting body morphogenesis
DG1091	DG1091-	DG1091	decreased fruiting body size
DG1098	DG1098-	DG1098	decreased fruiting body size
DG1104	DG1104-	DDB_G0283535	abolished aggregation
DG1106	DG1106-	keaA	abolished aggregation
DG1110	DG1110-	DDB_G0269128	aberrant fruiting body morphogenesis
DG1112	DG1112-	DG1112	decreased stalk width
DG1113	DG1113-	DG1113	increased stalk length
DG1122	DG1122-	DG1122	aberrant fruiting body morphogenesis
DG1124	DG1124-	DG1124	development arrests at loose mound stage
DG2033	DG2033-	DG2033	development arrests at mound stage
DG2044	DG2044-	DG2044	development arrests at loose mound stage
DBS0266700	Dd5P1-	Dd5P1	increased chemotaxis to cAMP | decreased phagocytosis
DBS0266705	Dd5P1-/ Dd5P2-	Dd5P1 | Dd5P2	increased chemotaxis to cAMP
DBS0266704	Dd5P1-/ Dd5P3-	Dd5P1 | Dd5P3	increased chemotaxis to cAMP
DBS0235660	Dd5P2-	Dd5P2	increased chemotaxis to cAMP | increased actin filament polymerization
DBS0266703	Dd5P2-/ Dd5P3-	Dd5P2 | Dd5P3	wild type
DBS0266702	Dd5P3-	Dd5P3	wild type
DBS0266692	Dd5P4-	Dd5P4	increased protein localization | increased protein phosphorylation | increased contractile vacuole size | decreased defense response to Gram-negative bacterium | increased number of mound tips | aberrant contractile vacuole discharge | decreased growth rate | decreased phagocytosis | decreased engulfment during phagocytosis | aberrant endosome morphology | aberrant vacuole organization | decreased protein localization | increased cell motility | increased activation of GTPase activity
DBS0266693	Dd5P4-/ [act15]: Dd5P4	Dd5P4	wild type
DBS0266719	Dd5P4-/ [act15]: Dd5P4: GFP	Dd5P4	wild type
DBS0266695	Dd5P4-/ [act15]: GAP5P4	Dd5P4	increased number of mound tips | decreased growth rate
DBS0351414	Dd5P4-/ [act15]: GFP: Dd5P4(D319G)	Dd5P4	increased contractile vacuole size | aberrant contractile vacuole discharge | aberrant protein localization to contractile vacuole
DBS0266720	Dd5P4-/ [act15]: Hs-OCRL	Dd5P4	decreased phagocytosis
DBS0266721	Dd5P4-/ [act15]: Hs-OCRL(D422A)	Dd5P4	decreased phagocytosis
DBS0266694	Dd5P4-/ [act15]: cat5P4	Dd5P4	increased number of mound tips | decreased growth rate
DBS0351050	DidioMp27-	DidioMp27	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant phototaxis
DBS0351049	DidioMp36-	DidioMp36	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant phototaxis
CW0391	FLAG-VwkA	vwkA	increased myosin II assembly | decreased growth rate | aberrant cytokinesis | development arrests at mound stage | aberrant hypotonic response | increased protein level
DBS0236015	GEG04K11 (tmcB- in KAX3)	tmcB	decreased macrocyst size | aberrant macrocyst formation
DBS0236017	GEG10K23 (tmcC- in KAX3)	tmcC	aberrant macrocyst formation
CW0368	GFP-VwkA	vwkA	decreased growth rate | aberrant cytokinesis
DBS0266872	GFP: pcna	pcna	wild type
DBS0350102	GFP: pcp	pcp	aberrant contractile vacuole morphology | aberrant hypotonic response
DBS0302615	GFP: phgA(1-274: 283-438)/ phgA-	phgA	aberrant hypotonic response
DBS0302614	GFP: phgA/ phgA-	phgA	wild type
DBS0236084	GP138A-/ GP138B-/ GP138C-/ GP138D-	cfrA | cfrB | cfrC | cfrD	decreased gene expression
DBS0236085	GP138C-	cfrC	wild type
DBS0236128	HB3	H3b	abolished stream development | abolished response to cAMP
DL118	HL216/ HL261	gnt2	decreased migratory slug size | decreased calcium-independent cell-cell adhesion | decreased fruiting body size
HL220	HL220	gnt2	abolished gene expression | aberrant spore coat morphology | decreased calcium-independent cell-cell adhesion
HL241	HL241	alg9	aberrant protein modification
HL260	HL260	gnt2	decreased calcium-independent cell-cell adhesion
HMW404	HMW404	manA	abolished gene expression | abolished catalytic activity | abolished aggregation
DBS0350714	HMW437	manA	wild type | abolished catalytic activity
AP1	HSPC300-	hspc300	aberrant cytokinesis
AP2	HSPC300-	hspc300	decreased actin filament polymerization | decreased cell motility | decreased vegetative cell size | decreased phototaxis | decreased pseudopodium size
DBS0351312	HSPC300-/ [act15]: abpB(129-295)	abpB | hspc300	aberrant cellular process
HTY506	HTY506	pkaR	aberrant spore morphology | precocious sporulation | aberrant fruiting body morphogenesis | decreased actin phosphorylation | precocious development | decreased cAMP level | decreased sporulation
HTY507	HTY507	rdeA	precocious aggregation | decreased mound size | increased cAMP level | aberrant fruiting body morphogenesis
DBS0236426	I6KA-	I6KA	aberrant cellular homeostasis | aberrant inositol phosphate metabolic process | increased growth rate
DBS0236444	JH.D	cbfA	abolished gene expression | aberrant cellular metabolic process | decreased gene expression | increased gene expression | decreased growth rate | increased pinocytosis | increased vegetative cell size | decreased fruiting body size | decreased stalk width | abolished aggregation | increased phagocytosis
DBS0236532	M2	manA	abolished vegetative growth
DBS0236535	M31	modA	decreased catalytic activity | decreased secretion of lysosomal enzymes
DBS0236840	R7	nosA	development arrests at mound stage
DBS0266873	RFP: pcna	pcna	wild type
DBS0236917	SA219	dscA-1 | dscA-2 | dscC-1 | dscC-2 | dscD-1 | dscD-2 | dscE	abolished gene expression
SA31	SA31	dscA-1 | dscA-2 | dscC-1 | dscC-2 | dscD-1 | dscD-2 | dscE	abolished gene expression | abolished stream development | aberrant microtubule cytoskeleton organization | decreased establishment of cell polarity
DBS0264065	V00262	dagA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264066	V00347	DDB_G0281917	abolished culmination
DBS0264073	V10108	DDB_G0292162	abolished stream development | abolished slug migration | aberrant vegetative growth | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264075	V10113	yakA	abolished stream development | abolished slug migration | aberrant vegetative growth | abolished oscillatory cAMP signaling | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264078	V10116	tipB	aberrant aggregation | abolished slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264079	V10117	DDB_G0285083	aberrant slug migration | abolished culmination
DBS0264081	V10119	DDB_G0292194	wild type
DBS0264083	V10121	zntC	wild type
DBS0264087	V10125	DDB_G0293302	aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264088	V10126	tipC	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264089	V10127	DG1037	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264098	V10136	DDB_G0293590	wild type | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264099	V10137	yelA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264100	V10138	tipC	wild type
DBS0264106	V10144	comH	aberrant aggregation | abolished slug migration | abolished culmination
DBS0264108	V10146	yakA	abolished stream development | abolished slug migration | aberrant vegetative growth | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264109	V10147	tipA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264112	V10150	swp1	wild type
DBS0264116	V10155	DDB_G0282093	abolished stream development | aberrant aggregation | abolished slug migration | aberrant culmination | aberrant slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264118	V10157	usp12	aberrant culmination | aberrant slug migration | aberrant stream morphology | abolished culmination
DBS0264125	V10164	comE	aberrant vegetative growth | aberrant culmination | aberrant slug migration | abolished culmination
DBS0264126	V10165	comD	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264128	V10167	DG1098	wild type | aberrant oscillatory cAMP signaling
DBS0264129	V10168	prsC	wild type | aberrant slug migration
DBS0264131	V10170	DDB_G0283015	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264135	V10174	DDB_G0288581	aberrant vegetative growth | aberrant culmination | aberrant slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264145	V10185	abcA5	wild type | aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264150	V10190	yelA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264151	V10191	sfbA	aberrant culmination | aberrant slug migration | abolished culmination
DBS0264152	V10192	tipD	aberrant aggregation | abolished slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264154	V10194	modA	aberrant culmination | aberrant slug migration
DBS0264155	V10195	migA	aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264157	V10197	yelA	abolished slug migration | aberrant culmination | aberrant slug migration
DBS0264158	V10198	splA	aberrant aggregation | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264159	V10199	DG1037	abolished slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264160	V10200	DDB_G0289377	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264161	V10201	rgaA	aberrant vegetative growth | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264163	V10203	modA	wild type | aberrant vegetative growth | aberrant culmination
DBS0264164	V10204	DG1124	aberrant aggregation | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264166	V10206	wimA	wild type
DBS0264169	V10209	dcsA	abolished culmination
DBS0264170	V10210	mkpA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264171	V10211	migA	aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264172	V10212	tipC	aberrant aggregation | abolished slug migration | aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264173	V10213	DG1098	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264175	V10215	cbfB	wild type
DBS0264176	V10216	DDB_G0292884	wild type | aberrant vegetative growth
DBS0264180	V10220	potA	wild type
DBS0264181	V10221	tipD	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264182	V10222	ctaA	wild type
DBS0264183	V10223	erkA	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264184	V10224	DG1091	aberrant oscillatory cAMP signaling
DBS0264185	V10225	acrA	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264186	V10226	ggtA	aberrant vegetative growth | aberrant culmination | aberrant slug migration | abolished aggregation | abolished culmination
DBS0264187	V10227	piaA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264188	V10228	comG	aberrant aggregation | abolished slug migration | aberrant vegetative growth | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264189	V10229	dcsA	aberrant oscillatory cAMP signaling | abolished culmination
DBS0264190	V10230	ctrA	aberrant aggregation | aberrant culmination | aberrant slug migration
DBS0264193	V10233	piaA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264195	V10235	DDB_G0285985	wild type
DBS0264196	V10236	DDB_G0270872_ps	aberrant stream morphology
DBS0264197	V10237	DDB_G0278621	wild type
DBS0264198	V10238	DDB_G0269128	aberrant culmination | aberrant slug migration
DBS0264199	V10239	kif12	wild type | aberrant culmination
DBS0264201	V10241	lvsB	aberrant culmination
DBS0264202	V10242	tagB	aberrant aggregation | abolished slug migration | abolished culmination
DBS0264204	V10244	gbfA	aberrant culmination | aberrant slug migration
DBS0264205	V10245	gefA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264206	V10246	dicB	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264207	V10247	yelA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264212	V10252	tagB	aberrant aggregation | abolished slug migration | abolished culmination
DBS0264216	V10256	DDB_G0293302	abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264218	V10258	rdeA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264220	V10260	gacT	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264224	V10264	DDB_G0282787_RTE	aberrant aggregation | wild type | abolished slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264225	V10265	lvsD	aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264227	V10267	DDB_G0292260_RTE	aberrant aggregation | aberrant stream morphology
DBS0264228	V10268	dhkA	aberrant culmination | aberrant slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264229	V10269	helC	wild type | aberrant culmination | aberrant slug migration | abolished culmination
DBS0264230	V10270	mekA	aberrant vegetative growth | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264231	V10271	lvsB	abolished stream development | abolished slug migration | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264232	V10272	modA	abolished stream development | abolished slug migration | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264233	V10273	DDB_G0283535	wild type | aberrant vegetative growth
DBS0264234	V10274	DG1113	aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264235	V10275	DG1122	abolished stream development | wild type | abolished slug migration | aberrant vegetative growth | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264236	V10276	DDB_G0270654	wild type
DBS0264237	V10277	lvsE	aberrant oscillatory cAMP signaling
DBS0264238	V10278	modA	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264240	V10280	mekA	aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264241	V10281	DDB_G0268266	aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264242	V10282	phdA	abolished slug migration | aberrant culmination | aberrant stream morphology
DBS0264245	V10285	scaA	abolished stream development | abolished slug migration | aberrant vegetative growth | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264246	V10286	amdA	wild type | aberrant culmination
DBS0264247	V10287	helC	wild type | aberrant culmination | aberrant slug migration
DBS0264251	V10300	DDB_G0278333	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264269	V10322	roco5	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264272	V10326	DG1113	wild type | aberrant oscillatory cAMP signaling
DBS0264275	V10330	DDB_G0282121	wild type
DBS0264278	V10342	DDB_G0279727	wild type
DBS0264281	V10356	DDB_G0275747	aberrant slug migration
DBS0264283	V10363	msh5	wild type
DBS0264284	V10367	DDB_G0282463	aberrant vegetative growth | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264287	V10431	kcnma1	wild type | aberrant culmination | aberrant slug migration
DBS0264288	V10432	DDB_G0291103	wild type
DBS0264290	V10435	gefL	abolished slug migration | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264292	V10438	DDB_G0275671	wild type
DBS0264295	V10442	pks3	wild type
DBS0264297	V10445	DDB_G0290835	aberrant slug migration
DBS0264303	V10460	abcC9	aberrant slug migration
DBS0264316	V10483	yod1	aberrant aggregation | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264318	V10490	gefV	aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264319	V10492	med23	aberrant culmination | aberrant oscillatory cAMP signaling
DBS0264320	V10495	DDB_G0269128	wild type | aberrant culmination | aberrant slug migration
DBS0264324	V10514	adprt3	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264326	V10519	DDB_G0290575	wild type
DBS0264330	V10529	cyp508B1	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264331	V10530	DDB_G0270344	wild type | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264334	V10534	DDB_G0291812	wild type | aberrant culmination
DBS0264335	V10535	DDB_G0277165	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264337	V10537	gbpC	abolished stream development | wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264347	V10567	dagA	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264349	V10570	DDB_G0281115	wild type | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0264356	V10588	dhkC	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264373	V10633	gtaG	abolished slug migration | aberrant culmination | aberrant slug migration | abolished culmination
DBS0264377	V10642	fscD	wild type
DBS0264384	V10670	taf2	wild type
DBS0264390	V10682	clcD	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264425	V11033	nfaA	aberrant aggregation | wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264432	V11040	DDB_G0274177	abolished stream development | abolished slug migration | abolished oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0264438	V11047	DDB_G0269296	wild type
DBS0264439	V11048	xrcc4	wild type
DBS0264444	V11053	dscA-1 | dscA-2	wild type | aberrant vegetative growth
DBS0264446	V11055	ku80	aberrant vegetative growth | aberrant culmination
DBS0264464	V11075	cinC	wild type | aberrant culmination
DBS0264480	V11092	cnrO	wild type
DBS0264489	V11105	DDB_G0270350_ps	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264512	V11128	DDB_G0278945	aberrant vegetative growth | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264575	V30069	DDB_G0284619	aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264607	V30110	alg9	wild type | aberrant vegetative growth | aberrant oscillatory cAMP signaling
DBS0264630	V30133	DDB_G0272953	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264634	V30137	DDB_G0289529	wild type
DBS0264662	V30165	alg9	wild type | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264668	V30171	DDB_G0285261	wild type | aberrant vegetative growth | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264677	V30180	gpaF	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264684	V30188	DDB_G0287723	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264687	V30191	DDB_G0288219	wild type | aberrant vegetative growth
DBS0264700	V30213	act9	wild type | aberrant culmination
DBS0264715	V30229	dhx35	wild type | aberrant oscillatory cAMP signaling
DBS0264716	V30230	regA	aberrant aggregation | abolished slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished culmination
DBS0264731	V30245	DDB_G0279461	wild type | aberrant culmination
DBS0264749	V30264	DDB_G0273651	wild type
DBS0264752	V30267	DDB_G0283759	wild type
DBS0264756	V30271	ncapGa	wild type
DBS0264763	V30278	tnlA	wild type
DBS0264765	V30280	ppt1	wild type
DBS0264768	V30283	DDB_G0270872_ps	wild type
DBS0264770	V30285	DDB_G0293762	wild type | aberrant vegetative growth
DBS0264773	V30288	DDB_G0293300	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264777	V30292	glpD	wild type
DBS0264781	V30296	DDB_G0270212	wild type
DBS0264785	V30303	pakE	aberrant oscillatory cAMP signaling
DBS0264823	V30341	frmB	wild type | aberrant culmination | aberrant stream morphology
DBS0264832	V30350	DDB_G0284059	wild type
DBS0264835	V30353	DDB_G0282471	wild type
DBS0264853	V30371	abpC	aberrant aggregation | abolished slug migration | aberrant culmination | abolished culmination
DBS0264905	V30427	DDB_G0291926	aberrant culmination | aberrant slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264910	V30432	malA	wild type
DBS0264922	V30446	DDB_G0269430	wild type
DBS0264924	V30448	DDB_G0269680	wild type | aberrant oscillatory cAMP signaling
DBS0264941	V30466	dtfA	wild type | aberrant oscillatory cAMP signaling
DBS0264992	V30522	DDB_G0288007	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0264994	V30524	prmt5	aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0265002	V30532	lvsA	wild type | abolished slug migration | aberrant oscillatory cAMP signaling | abolished aggregation | abolished culmination
DBS0265017	V30547	DDB_G0279105	wild type | aberrant vegetative growth | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265029	V30561	DDB_G0277355	wild type | aberrant culmination
DBS0265045	V30578	DDB_G0277165	aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0265049	V30582	DDB_G0291722	wild type
DBS0265064	V30604	DDB_G0279461	abolished slug migration | aberrant culmination | aberrant slug migration | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265066	V30606	adkB	wild type
DBS0265099	V30642	tipC	aberrant aggregation | abolished slug migration | aberrant oscillatory cAMP signaling | abolished culmination
DBS0265126	V30673	dicB	aberrant aggregation | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0265140	V30688	DDB_G0279727	wild type | aberrant culmination
DBS0265170	V30724	cnrK	wild type
DBS0265206	V30766	rhgA	wild type
DBS0265226	V30789	itpa	wild type
DBS0265231	V30794	tpsA	wild type
DBS0265247	V30814	adprt1B	wild type
DBS0265279	V30846	DDB_G0286091	wild type
DBS0265286	V30853	DDB_G0292058	wild type
DBS0265296	V30863	DDB_G0269128	wild type
DBS0265302	V30869	DDB_G0292454	wild type | aberrant vegetative growth
DBS0265303	V30870	gxcJJ	wild type | aberrant oscillatory cAMP signaling
DBS0265309	V30876	DDB_G0268248	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265311	V30879	exoc2	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265319	V30887	adcC	wild type
DBS0265339	V30912	DDB_G0283821	wild type | aberrant oscillatory cAMP signaling
DBS0265348	V30921	snpC	wild type | aberrant culmination
DBS0265422	V30995	DDB_G0282959	wild type
DBS0265466	V31043	DDB_G0275917	aberrant aggregation | wild type | aberrant vegetative growth | aberrant slug migration | abolished culmination
DBS0265497	V31075	DDB_G0282985	wild type | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling | abolished aggregation
DBS0265520	V31102	DDB_G0287865	wild type
DBS0265529	V31111	vps13E	wild type | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265539	V31121	DDB_G0270912	wild type | aberrant vegetative growth | aberrant oscillatory cAMP signaling
DBS0265567	V31151	DDB_G0275539	wild type | aberrant vegetative growth | abolished culmination
DBS0265573	V31157	act9	wild type
DBS0265588	V31173	ggtA	aberrant vegetative growth | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265662	V31255	psiN	wild type | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265688	V31281	DDB_G0286417	wild type | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0265701	V31294	DDB_G0268424	wild type
DBS0265873	V31480	DDB_G0284177	aberrant culmination
DBS0265890	V31501	DDB_G0282985	wild type | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0265908	V31523	tmem184C	wild type | aberrant culmination
DBS0265911	V31528	DDB_G0279945	aberrant culmination
DBS0265938	V31568	rsc12	aberrant culmination
DBS0265947	V31583	DDB_G0282943	wild type
DBS0265992	V31640	DDB_G0274343	wild type
DBS0266000	V31649	DDB_G0290383	wild type | aberrant culmination
DBS0266021	V31670	DDB_G0281269	wild type
DBS0266022	V31671	dhkA	aberrant culmination | aberrant slug migration
DBS0266036	V31685	tipC	aberrant aggregation | wild type | abolished slug migration | aberrant culmination | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0266084	V31738	dcsA	wild type | aberrant culmination | abolished culmination
DBS0266088	V31742	dstA	aberrant culmination | aberrant slug migration | abolished culmination
DBS0266089	V31743	DDB_G0273459	aberrant aggregation | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0266098	V31752	oplah	wild type | aberrant oscillatory cAMP signaling
DBS0266149	V31807	gpt1	wild type | aberrant vegetative growth | abolished vegetative growth
DBS0266153	V31811	gpt1	wild type | aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0266190	V31853	chlA	aberrant aggregation | aberrant culmination | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0266195	V31858	DDB_G0286341	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0266246	V31916	psiF	wild type | aberrant vegetative growth | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0266249	V31919	DDB_G0276251	aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0266253	V31923	DDB_G0268314	wild type | aberrant culmination
DBS0266258	V31928	DDB_G0268314	wild type
DBS0266271	V31941	manA	aberrant aggregation | aberrant culmination | aberrant stream morphology | aberrant slug migration | aberrant oscillatory cAMP signaling
DBS0266299	V31970	DDB_G0280581	wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0266309	V31982	DDB_G0286341	abolished stream development | wild type | aberrant stream morphology | aberrant oscillatory cAMP signaling
DBS0266316	V31989	DDB_G0270342	abolished stream development | wild type | abolished slug migration | aberrant culmination | aberrant oscillatory cAMP signaling
DBS0237041	VatMpr	vatM	increased protein localization to cytoplasm | decreased phagocytosis | decreased growth rate | aberrant regulation of intracellular pH
DBS0237044	VatMpr/ [act15]: vatM	vatM	wild type
DBS0237042	VatMpr/ [act15]: vatM: GFP	vatM	decreased growth rate
DBS0237236	[AS]: [tet]: trrA	trrA	decreased growth rate | delayed development | abolished aggregation
DBS0350570	[AS]PARP	DDB_G0286613 | DDB_G0289141 | adprt1A | adprt1B | adprt2 | adprt3 | adprt4 | pARTf | pARTg	decreased cell death | aberrant positive regulation of mitochondrial membrane potential
DBS0350559	[AS]act15: adprt1A	adprt1A	development arrests at loose mound stage | decreased gene expression | decreased ATP level | increased mitochondrial fission
DBS0351092	[AS]aif	aif	aberrant cellular homeostasis | aberrant regulation of mitochondrial membrane potential | aberrant mitochondrion morphology | decreased ATP level | increased gene expression | decreased gene expression | decreased growth rate | aberrant cell cycle | increased necrotic cell death | delayed development | aberrant response to oxidative stress | aberrant cell morphology | increased mitochondrial fission | aberrant mitochondrion organization
DBS0304456	[AS]alrA/ gcsA-	alrA | gcsA	aberrant cellular metabolic process | increased gene expression | decreased growth rate | mitotic G1 phase arrest
DBS0237273	[AS]calA	calA	abolished cytokinesis
DBS0350897	[AS]carA	carA-1 | carA-2	abolished aggregation
DBS0237222	[AS]cf60	cf60	increased mound size | decreased number of mounds
DBS0237228	[AS]cfrA/ [AS]cfrB	cfrA | cfrB	decreased sexual fusion
DBS0237223	[AS]chcA	chcA	decreased pinocytosis | delayed hypotonic response | decreased number of vacuoles | decreased vegetative cell size | aberrant vacuole organization | abolished aggregation
DBS0237224	[AS]cmfA	cmfA	abolished aggregation
DBS0236982	[AS]csbA/ csbB	csbA | csbB	decreased cell-cell adhesion
DBS0237225	[AS]cupB	cupB	abolished aggregation
DBS0350979	[AS]deeJ	deeJ	decreased pinocytosis | decreased phagocytosis | aberrant fruiting body morphogenesis
DBS0237226	[AS]dia1	dia1	decreased gene expression | precocious aggregation
DBS0351176	[AS]dscA	dscA-1 | dscA-2	abolished stream development
DBS0238235	[AS]dutA	dutA	wild type
DBS0350560	[AS]ecmB: adprt1A	adprt1A	development arrests at slug stage
DBS0350676	[AS]erkA	erkA	aberrant vegetative growth
DBS0237229	[AS]gpaA	gpaA	wild type
DBS0351057	[AS]gshB	gshB	increased slug migration
HPF414	[AS]hspA	hspA	decreased growth rate | aberrant fruiting body morphogenesis | decreased defense response to bacterium
DBS0351041	[AS]hspA/ [AS]ndkC-1	hspA | ndkC-1 | ndkC-2	wild type
DBS0238749	[AS]hspA/ snfA	hspA | snfA	wild type
DBS0252819	[AS]hssA	hssA	wild type
DBS0351171	[AS]htrA	htrA	decreased growth rate | aberrant fruiting body morphogenesis
DBS0237230	[AS]ino1	ino1	abolished vegetative growth
DBS0304425	[AS]mppA1	mppA1	delayed development
DBS0304424	[AS]mppB	mppB	increased gene expression
DBS0236725	[AS]patA	patA	decreased growth rate
DBS0237504	[AS]pikE	pikE	aberrant stalk morphogenesis | decreased growth rate
DBS0237231	[AS]ppiA	ppiA	increased stalk length
DBS0237232	[AS]proA	proA	wild type
DBS0350355	[AS]proA-/ proB-/ lmpA-	lmpA | proA | proB	abolished sporulation | wild type
DBS0351311	[AS]proA/ abpB(129-295)	abpB | proA	aberrant cellular process
DBS0236827	[AS]proA/ proB-	proA | proB	decreased exocytosis | decreased pinocytosis | aberrant exocytosis | increased actin filament polymerization | development arrests at slug stage | aberrant cytokinesis | decreased cell motility | abolished vegetative growth | decreased secretion of lysosomal enzymes | increased phagocytosis
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA | proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA | proB	wild type
DBS0238035	[AS]proA/ proB-/ [unk]: FLAG: proC	proA | proB | proC	wild type
DBS0350334	[AS]proA/ proB-/ scrA-	proA | proB | scrA	decreased exocytosis | decreased pinocytosis | decreased secretion of lysosomal enzymes
DBS0350117	[AS]ptcB	ptcB	decreased growth rate
DBS0236851	[AS]rapA	rapA	decreased pinocytosis | aberrant osmosensory signaling pathway | decreased phagocytosis | abolished vegetative growth | increased actin phosphorylation | aberrant hyperosmotic response
DBS0351303	[AS]rheb	rheb	decreased growth rate | increased macropinocytosis | increased phagocytosis
DBS0350574	[AS]rps4	rps4	decreased spore germination | aberrant actin cytoskeleton organization | aberrant vegetative growth | decreased mound size | decreased spore size | aberrant fruiting body morphogenesis | decreased sporulation
DBS0236904	[AS]rps4	mrps4	delayed aggregation | aberrant fruiting body morphogenesis
DBS0237234	[AS]smlA	smlA	decreased fruiting body size
DBS0238748	[AS]snfA	snfA	decreased number of mitochondria | decreased ATP level | increased growth rate | decreased fruiting body size | aberrant mitochondrion organization
DBS0304498	[AS]sslA1	sslA1	decreased fruiting body size
DBS0237235	[AS]tcp1	tcp1	decreased growth rate | development arrests at mound stage | aberrant fruiting body morphogenesis
DBS0351302	[AS]tpp1	tpp1	aberrant cellular process | decreased growth rate | aberrant sorocarp development | increased macropinocytosis | increased phagocytosis
DBS0351218	[AS]twm1	twm1	decreased growth rate
DBS0350649	[AS]vatB	vatB	delayed aggregation | aberrant slug migration | aberrant response to chemical
DBS0306101	[AS]vatP	vatP	decreased calcium ion import | decreased growth rate
DBS0306102	[AS]vatP	vatP	decreased calcium ion import | decreased growth rate | delayed development
DBS0237276	[OE]: GFP: gxcA	gxcA	abolished aggregation
DBS0237279	[OE]: HA: rab21(Q66L)	rab21	increased phagocytosis | aberrant cytoskeleton organization
DBS0237280	[OE]: HA: rab21(T21N)	rab21	decreased phagocytosis | aberrant actin filament organization
DBS0237274	[OE]: chlim	ChLim	increased actin filament polymerization | decreased phagocytosis | decreased growth rate
DBS0350519	[OE]: egeA	egeA	decreased protein level | abolished aggregation
DBS0237275	[OE]: gbfA	gbfA	precocious prespore gene expression
JH182	[OE]: gpaD	gpaD	aberrant fruiting body morphogenesis | decreased sporulation
JH258	[OE]: gpaE	gpaE	precocious prestalk gene expression | precocious prespore gene expression | precocious development of tipped mound
DBS0348921	[OE]: ipkA1	ipkA1	aberrant inositol phosphate metabolic process | decreased response to lithium | aberrant gene expression
DBS0348922	[OE]: itpk1	itpk1	aberrant inositol phosphate metabolic process | decreased response to lithium | aberrant gene expression
DBS0237281	[OE]: limF	limF	increased actin filament polymerization | increased phagocytosis
DBS0237282	[OE]: pakC	pakC	decreased cell motility
DBS0236962	[OE]: pdiA	pdiA	delayed aggregation
DBS0237015	[OE]: pdiA	pdiA	aberrant development of tipped mound | abolished culmination | abolished slug development
DBS0237283	[OE]: rasB(G12T)	rasB	aberrant cytokinesis
DBS0302685	[OE]: sgcA(1-2000)(N1106A): GFP/ gca-/ sgcA-	gcA | sgcA	decreased chemotaxis rate
DBS0302683	[OE]: sgcA(878-2843)(N1106A): GFP/ gca-/ sgcA-	gcA | sgcA	decreased chemotaxis rate
DBS0302681	[OE]: sgcA(878-2843): GFP/ sgcA-	gcA | sgcA	aberrant chemotaxis to cAMP | decreased chemotaxis rate
DBS0302682	[OE]: sgcA(N1106A): GFP/ gca-/ sgcA-	gcA | sgcA	increased lateral pseudopodium formation | aberrant chemotaxis to cAMP | aberrant stream morphology | decreased chemotaxis rate
DBS0302684	[OE]: sgcA: GFP/ gca-/ sgcA-	gcA | sgcA	increased lateral pseudopodium formation | decreased chemotaxis rate
DBS0237284	[OE]GFP: gxcA(1-750: 764-1217)	gxcA	development arrests at loose mound stage
DBS0237285	[OE]GFP: gxcA(1-750: 764-984)	gxcA	development arrests at loose mound stage
DBS0266621	[OE]mipp1	mipp1	aberrant inositol phosphate metabolic process | aberrant gene expression | increased response to lithium
DBS0237299	[RNAi]DDB_G0270366	DDB_G0270366	wild type
DBS0237300	[RNAi]DDB_G0270368	DDB_G0270368	wild type
DBS0237301	[RNAi]DDB_G0271700	DDB_G0271700	wild type
DBS0237304	[RNAi]DDB_G0273449	DDB_G0273449 | DDB_G0273577	wild type
DBS0237303	[RNAi]DDB_G0279609	DDB_G0279609	wild type
DBS0237306	[RNAi]DDB_G0290063	DDB_G0290063	wild type
DBS0237302	[RNAi]DDB_G0290225	DDB_G0290225	wild type
DBS0237298	[RNAi]DDB_G0293116	DDB_G0293116	wild type
DBS0237305	[RNAi]DDB_G0293762	DDB_G0293762	wild type
DBS0237294	[RNAi]DidioMp05	DidioMp05	wild type
DBS0350172	[RNAi]allC	allC	development arrests at loose mound stage | decreased protein level | decreased gene expression | decreased vegetative cell size | increased growth rate
DBS0350070	[RNAi]canA	canA	aberrant sorus morphology | aberrant response to cation stress | increased defense response to Gram-negative bacterium | decreased fruiting body size | decreased stalk length
DBS0350727	[RNAi]cepE	cepE	increased number of centrosomes | aberrant cell separation during cytokinesis | aberrant mitotic sister chromatid segregation
DBS0235409	[RNAi]cnbA	cnbA	aberrant sorus morphology | decreased gene expression | aberrant response to cation stress | increased defense response to Gram-negative bacterium | aberrant stalk cell differentiation | decreased stalk length
DBS0349787	[RNAi]ctnnA	ctnnA	abolished epithelium-like organization | abolished stalk development | aberrant protein secretion | abolished establishment of cell polarity | aberrant Golgi localization | aberrant centrosome localization | abolished culmination | aberrant protein localization
DBS0349923	[RNAi]ctnnA/ [act15]: GFP-mhcA	ctnnA	aberrant stalk morphogenesis | decreased epithelium-like organization | aberrant protein localization
DBS0237537	[RNAi]enlA	enlA	decreased substrate adhesion-dependent cell spreading | decreased cell-substrate adhesion | aberrant cytokinesis
DBS0237295	[RNAi]fimA	fimA	wild type
DBS0349944	[RNAi]fttB	fttB	increased number of mound tips | aberrant cytokinesis | decreased growth rate | delayed development | decreased chemotaxis to cAMP | aberrant cytoskeleton organization
DBS0237308	[RNAi]gmsA	gmsA	decreased sexual fusion
DBS0237309	[RNAi]gsr	gsr	precocious culmination | decreased cell migration to prestalk region | precocious gene expression
DBS0252820	[RNAi]hssA	hssA	wild type
DBS0237307	[RNAi]kctd9	kctd9	wild type
DBS0350940	[RNAi]kif6	kif6	aberrant mitotic spindle organization
DBS0237310	[RNAi]lipA	lipA	wild type
DBS0349871	[RNAi]lkb1	lkb1	abolished prespore cell differentiation | delayed aggregation | aberrant slug development | aberrant sorocarp development | aberrant response to osmotic stress | aberrant response to oxidative stress | aberrant regulation of protein kinase activity | increased prestalk cell differentiation | decreased sporulation
DBS0350643	[RNAi]nse1	nse1	aberrant response to UV | aberrant stream morphology | decreased fruiting body size
DBS0350644	[RNAi]nse4	nse4	decreased gene expression | aberrant response to UV | aberrant stream morphology | decreased fruiting body size
DBS0237296	[RNAi]pks16	pks16	wild type
DBS0237297	[RNAi]psiM	psiM	wild type
DBS0237311	[RNAi]racF2	racF2	abolished vegetative growth
DBS0237312	[RNAi]rasZ	rasZ	wild type
DBS0350488	[RNAi]rmd1	rmd1	aberrant cell separation during cytokinesis
DBS0238734	[RNAi]sdhA	sdhA	abolished aggregation | decreased phototaxis
DBS0351295	[RNAi]sir2D	sir2D	decreased gene expression | delayed development
DBS0351599	[RNAi]srtA	srtA	increased pre-miRNA processing
DBS0304564	[RNAi]sun1	sun1	aberrant nucleus morphology | increased vegetative cell size
DBS0349929	[RNAi]tacA	tacA	aberrant response to cation stress | increased gene expression | delayed development | aberrant fruiting body morphogenesis
DBS0350046	[RNAi]tacc	tacc	aberrant response to abiotic stimulus | decreased protein level | decreased size of astral microtubules
YLD53	[RNAi]thg1	thg1	decreased growth rate
DBS0350794	[RNAi]tlp3	tlp3	decreased growth rate
DBS0350795	[RNAi]tlp4	tlp4	decreased growth rate
DBS0237313	[RNAi]tmcB	tmcB	aberrant macrocyst formation
DBS0237314	[RNAi]tmcC	tmcC	aberrant macrocyst formation
DBS0237315	[RNAi]trap1	trap1	decreased gene expression | delayed development
DBS0237818	[RNAi]wipA	wipA	decreased actin filament polymerization at leading edge | delayed pseudopodium formation | decreased chemotaxis to cAMP | decreased filopodium formation
DBS0350924	[TRE-Pmin]: 6xHis: GFP: dhcA(1384-4725(K1975T))	dhcA	aberrant molecular function
DBS0350052	[TRE-Pmin]: arfA(Q71L): GFP	arfA	aberrant filopodium formation | aberrant cytokinesis
DBS0350053	[TRE-Pmin]: arfA(T31N): GFP	arfA	wild type | increased defense response to Gram-negative bacterium
DBS0351202	[act15]: 6xHis: amd1: eYFP	amd1	decreased gene expression | increased gene expression | aberrant vegetative growth | aberrant fruiting body morphogenesis | delayed development | mitotic G1 phase arrest
DBS0351167	[act15]: 6xHis: ei24: eYFP	ei24	aberrant aggregation | increased chemotaxis to cAMP | aberrant cell cycle | increased cAMP level | increased sporulation
DBS0350674	[act15]: 6xHis: erkA	erkA	aberrant slug development
DBS0351253	[act15]: 6xHis: sesn: eYFP	sesn	aberrant aggregation | decreased protein level | increased gene expression | decreased growth rate | aberrant response to oxidative stress
DBS0349845	[act15]: 7xHis: myoK: Ty1	myoK	aberrant cortical actin cytoskeleton organization | aberrant engulfment during phagocytosis | aberrant cell morphology
DBS0237100	[act15]: CFP: racC(G15V)	racC	increased actin filament polymerization
DBS0237101	[act15]: CFP: racC(T20N)	racC	decreased actin filament polymerization | aberrant cytokinesis | abolished positive chemotaxis
DBS0350908	[act15]: DD: GFP: rab8A(N128I)	rab8A	increased contractile vacuole size | increased number of contractile vacuoles | abolished protein localization to contractile vacuole
DBS0350909	[act15]: DD: GFP: rab8A(Q74L)	rab8A	aberrant contractile vacuole localization | increased number of contractile vacuoles | decreased contractile vacuole size
DBS0266512	[act15]: DDB_G0272656	sigN4	wild type
DBS0350566	[act15]: FLAG: Rab14(Q67L)	rab14	increased lysosome size | increased post-lysosomal vacuole size | aberrant phagosome maturation | increased endosomal vesicle fusion
DBS0350049	[act15]: FLAG: cycC	cycC	precocious development of tipped mound
DBS0350321	[act15]: FLAG: hbx4	hbx4	aberrant aggregation | abolished gene expression | abolished slug migration | decreased growth rate | aberrant cytokinesis
DBS0350322	[act15]: FLAG: hbx4/ [act15]: cadA	cadA | hbx4	wild type
DBS0350325	[act15]: FLAG: hbx4/ [ecmAO]: lacZ	hbx4	decreased spore germination | increased prestalk gene expression | abolished prespore gene expression | increased prestalk cell differentiation
DBS0351294	[act15]: FLAG: mybB	mybB	increased gene expression | precocious development
DBS0238107	[act15]: FLAG: ppp4C	ppp4c	wild type
DBS0238108	[act15]: FLAG: ppp4C(H113Q)	ppp4c	development arrests at mound stage | delayed development
DBS0351488	[act15]: FLAG: rasC(Q62L)	rasC	abolished protein localization to plasma membrane | increased actin filament polymerization | decreased chemotaxis to cAMP
DBS0351292	[act15]: FLAG: sir2A	sir2A	delayed development
DBS0351293	[act15]: FLAG: sir2C	sir2C	delayed development
DBS0351291	[act15]: FLAG: sir2D	sir2D	increased gene expression | precocious development
DBS0237110	[act15]: GFP(S65T)-racG	racG	increased filopodium formation | decreased actin filament polymerization | decreased cell motility | increased phagocytosis
DBS0304572	[act15]: GFP: abpD(1441-1736)	abpD	abolished protein localization to nuclear envelope
DBS0304571	[act15]: GFP: abpD(1441-1738)	abpD	abolished protein localization to nuclear envelope
DBS0304573	[act15]: GFP: abpD(1441-1738,1737P/ A)	abpD	abolished protein localization to nuclear envelope
DBS0237114	[act15]: GFP: abpE(413-481)	abpE-1 | abpE-2	increased lateral pseudopodium formation
DBS0237116	[act15]: GFP: act15	act15	abolished cytokinesis | decreased cell motility | aberrant cell morphology
DBS0351483	[act15]: GFP: aqpB(1-208,219-294)	aqpB	decreased hypotonic response
DBS0351097	[act15]: GFP: cbpG	cbpG	increased cell-substrate adhesion | increased vegetative cell size | decreased chemotaxis to cAMP | abolished aggregation
DBS0350593	[act15]: GFP: cepL	cepL	decreased growth rate | decreased phagocytosis | increased vegetative cell size | increased cell-substrate adhesion | aberrant centrosome localization | decreased establishment of cell polarity
DBS0350594	[act15]: GFP: cepL(1-1114)	cepL	increased number of centrosomes | decreased growth rate | aberrant vegetative growth | increased fruiting body size | decreased phagocytosis | increased cell-substrate adhesion | decreased chemotaxis rate | aberrant phototaxis
DBS0350595	[act15]: GFP: cepL(1-763)	cepL	increased number of centrosomes | decreased growth rate | aberrant vegetative growth | increased fruiting body size | decreased phagocytosis | increased cell-substrate adhesion | decreased chemotaxis rate | aberrant phototaxis
DBS0350596	[act15]: GFP: cepL(763-1114)	cepL	development arrests at loose mound stage | abolished establishment of cell polarity | delayed aggregation | decreased vegetative cell size | increased cell-substrate adhesion | decreased chemotaxis rate | increased growth rate | aberrant phototaxis | delayed gene expression
DBS0350460	[act15]: GFP: docD	docD	increased actin filament polymerization | increased cell motility | increased pseudopodium formation
DBS0350288	[act15]: GFP: forF(1-1087)	forF	decreased pinocytosis | decreased phagocytosis | decreased growth rate
DBS0235662	[act15]: GFP: forH(1-425)	forH	abolished protein localization to pseudopodium
DBS0350984	[act15]: GFP: frmB	frmB	decreased spore size | aberrant stalk development
DBS0304973	[act15]: GFP: gefQ(173-651,818-1298)	gefQ	increased guanyl-nucleotide exchange factor activity
DBS0304971	[act15]: GFP: gefQ(683-833)	gefQ	decreased guanyl-nucleotide exchange factor activity
DBS0304972	[act15]: GFP: gefQ(910-1298)	gefQ	aberrant cytokinesis | aberrant phototaxis
DBS0351254	[act15]: GFP: gflB	gflB	decreased substrate adhesion-dependent cell spreading | decreased actin filament polymerization | increased cell motility
DBS0350422	[act15]: GFP: gpbB	gpbB	aberrant vegetative growth | delayed development
DBS0350349	[act15]: GFP: gtaC(1-467: 497-587)	gtaC	abolished protein localization to nucleus
DBS0350351	[act15]: GFP: gtaC(229-587)	gtaC	abolished protein localization to cytoplasm
DBS0350359	[act15]: GFP: gtaC(281-467: 497-587)	gtaC	aberrant protein localization to cytoplasm
DBS0350352	[act15]: GFP: gtaC(281-587)	gtaC	abolished protein localization to cytoplasm
DBS0350360	[act15]: GFP: gtaC(346-467: 497-587)	gtaC	aberrant protein localization to cytoplasm | aberrant protein localization to nucleus
DBS0350353	[act15]: GFP: gtaC(346-587)	gtaC	abolished protein localization to cytoplasm
DBS0350350	[act15]: GFP: gtaC(K469,470,494,496A/ R468,471A)	gtaC	abolished protein localization to nucleus
DBS0236070	[act15]: GFP: hcpA	hcpA	decreased growth rate | aberrant mitotic anaphase
DBS0236071	[act15]: GFP: hcpB	hcpB	decreased growth rate
DBS0351562	[act15]: GFP: impA1	impa1	decreased response to lithium
DBS0237117	[act15]: GFP: krsA	krsA	decreased slug migration
DBS0237118	[act15]: GFP: limE	limE	aberrant cytokinesis
DBS0351530	[act15]: GFP: lis1	lis1	decreased phagocytosis | decreased chemotaxis to folate
DBS0349983	[act15]: GFP: lmnB	lmnB	aberrant chromatin assembly
DBS0350490	[act15]: GFP: mhcA(T1823D/ T1833D/ T2029D)/ AX3	mhcA	decreased growth rate | aberrant localization
DBS0237120	[act15]: GFP: nek2	nek2	aberrant nucleus morphology | increased number of microtubule organizing center
DBS0350852	[act15]: GFP: nkaP	nkaP	aberrant aggregation | decreased gene expression | increased gene expression | aberrant vegetative growth | increased chemotaxis rate
DBS0237121	[act15]: GFP: numA(1-117: 168-340)	numA	aberrant cytokinesis
DBS0350338	[act15]: GFP: pakA	pakA	increased phagocytosis
DBS0350337	[act15]: GFP: pakA(797-1197)	pakA	decreased phagocytosis | decreased cell motility
DBS0237122	[act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0237123	[act15]: GFP: phg2(1-245)	phg2	decreased phagocytosis
DBS0235442	[act15]: GFP: pldB	pldB	abolished aggregation
DBS0237702	[act15]: GFP: rac1A	rac1A	increased filopodium formation | increased membrane ruffling | increased macropinocytosis | increased growth rate | increased cell motility
DBS0351073	[act15]: GFP: rac1A(G12V)	rac1A	decreased growth rate | decreased phagocytosis | aberrant cytokinesis | decreased macropinocytosis | decreased cell motility | delayed development | aberrant actin filament organization | abolished filopodium formation
DBS0351075	[act15]: GFP: rac1A(T17N)	rac1A	aberrant filopodium formation
DBS0237703	[act15]: GFP: rac1B	rac1B	increased filopodium formation | increased membrane ruffling
DBS0237704	[act15]: GFP: rac1C	rac1C	increased filopodium formation | increased membrane ruffling | increased growth rate | increased cell motility
DBS0351074	[act15]: GFP: rac1C(G12V)	rac1C	decreased growth rate | decreased phagocytosis | aberrant cytokinesis | decreased macropinocytosis | decreased cell motility | delayed development | aberrant actin filament organization | abolished filopodium formation
DBS0351076	[act15]: GFP: rac1C(T17N)	rac1C	aberrant filopodium formation
DBS0237125	[act15]: GFP: racG(1-168): racH(164-200)	racG | racH	increased filopodium formation | decreased actin filament polymerization | decreased phagocytosis
DBS0237127	[act15]: GFP: racH	racH	decreased pinocytosis | wild type | decreased phagocytosis | decreased growth rate | aberrant cytokinesis | aberrant cell morphology
DBS0237128	[act15]: GFP: racH(1-163): racG(167-201)	racG | racH	decreased actin filament polymerization
DBS0237130	[act15]: GFP: racH(M13V)	racH	increased actin filament polymerization | aberrant cytokinesis | aberrant cell morphology
DBS0237132	[act15]: GFP: racH(T18N)	racH	aberrant cytokinesis | aberrant cell morphology
DBS0237133	[act15]: GFP: racH: gemA(630-658)	gemA | racH	delayed cytokinesis
DBS0238392	[act15]: GFP: rapA	rapA	increased cell-substrate adhesion
DBS0238393	[act15]: GFP: rapA(G12V)	rapA	increased cell-substrate adhesion
DBS0238394	[act15]: GFP: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0350112	[act15]: GFP: rheb(D60I)	rheb	increased phagocytosis
DBS0350111	[act15]: GFP: rheb(Q64L)	rheb	decreased phagocytosis
DBS0237134	[act15]: GFP: sbds	sbds	wild type
DBS0237135	[act15]: GFP: sbds	sbds	wild type
DBS0351177	[act15]: GFP: sey1	sey1	decreased defense response to Gram-negative bacterium | aberrant vacuole organization
DBS0351178	[act15]: GFP: sey1(K154A)	sey1	increased defense response to Gram-negative bacterium | aberrant catalytic activity | decreased protein localization | aberrant endoplasmic reticulum organization
DBS0350715	[act15]: GFP: src1(2-646)	src1	aberrant nuclear envelope morphology
DBS0304563	[act15]: GFP: sun1(283-905)	sun1	increased number of centrosomes | decreased protein localization to nuclear envelope | aberrant nuclear membrane organization | aberrant nucleus morphology | increased vegetative cell size | aberrant centrosome localization | aberrant mitotic sister chromatid segregation
DBS0350441	[act15]: GFP: talA/ mhcA-/ talA-	mhcA | talA	aberrant protein localization
DBS0350648	[act15]: HA: Rab14(N121I)	rab14	decreased pinocytosis | decreased hypotonic response | aberrant contractile vacuole morphology
DBS0350899	[act15]: HA: rab11(N126I)	rab11A	aberrant contractile vacuole organization | aberrant contractile vacuole morphology | increased phagocytosis
DBS0350812	[act15]: HA: rab7A(Q67L)	rab7A	increased exocytosis
DBS0350813	[act15]: HA: rab7A(T22N)	rab7A	decreased pinocytosis | increased secretion of lysosomal enzymes | decreased exocytosis | decreased phagocytosis | aberrant phagosome maturation | abolished macropinocytosis | abolished protein localization to phagocytic vesicle
DBS0238111	[act15]: HA: smkA	smkA	delayed development | decreased fruiting body size | decreased establishment of cell polarity | decreased chemotaxis to cAMP
DBS0350429	[act15]: RFP: abpE	abpE-1 | abpE-2	delayed aggregation
DBS0350867	[act15]: RFP: mtpn	mtpn	increased filopodium formation | decreased protein localization to cell cortex | aberrant actin filament organization | decreased pseudopodium size
DBS0351228	[act15]: T7: rasG(G12T)	rasG	increased protein phosphorylation | decreased growth rate | decreased phagocytosis | increased cell-substrate adhesion | decreased filopodium formation
DBS0351226	[act15]: YFP: iqgC	iqgC	decreased phagocytosis | decreased macropinocytosis
DBS0350986	[act15]: YFP: myoC(G395A)	myoC	decreased pinocytosis | aberrant mitotic spindle organization | decreased phagocytosis
DBS0237201	[act15]: YFP: myoE	myoE	decreased pinocytosis | increased phagocytosis
DBS0237817	[act15]: YFP: wipA	wipA	increased filopodium formation | increased actin filament polymerization at leading edge
DBS0237819	[act15]: YFP: wipA(K36A)	wipA	increased filopodium formation | increased actin filament polymerization at leading edge
DBS0237821	[act15]: YFP: wipA(K93A/ S95A)	wipA	increased filopodium formation | increased actin filament polymerization at leading edge
DBS0237227	[act15]: [AS]dia2	dia2	aberrant extracellular cAMP signaling pathway | abolished aggregation | decreased cAMP level
DBS0350673	[act15]: abpC: GFP	abpC	decreased cell motility
DBS0304574	[act15]: abpD	abpD	abolished protein localization to nuclear envelope
DBS0237096	[act15]: abpE	abpE-1 | abpE-2	aberrant aggregation | increased lateral pseudopodium formation | decreased cell motility | delayed development | decreased fruiting body size
DBS0349940	[act15]: acrA(1-731): YFP	acrA	aberrant spore coat morphology | decreased adenylate cyclase activity
DBS0350292	[act15]: act15(Y144W)	act15	aberrant binding
DBS0350800	[act15]: adprt1A	adprt1A	increased gene expression | decreased gene expression | decreased ATP level | delayed aggregation | aberrant cell cycle | decreased growth rate | aberrant response to oxidative stress | increased mitochondrial fission | decreased cAMP level
DBS0238086	[act15]: atg1	atg1	wild type
DBS0238091	[act15]: atg1(1-628)	atg1	wild type
DBS0238088	[act15]: atg1(K36A)	atg1	abolished macroautophagy | increased number of autophagosomes | aberrant cellular response to nitrogen starvation | abolished aggregation
DBS0238090	[act15]: atg1(K36A/ 1-628)	atg1	wild type
DBS0350008	[act15]: bzpN: GFP	bzpN	decreased growth rate | abolished negative regulation of vegetative growth
DBS0237097	[act15]: cak1: myc	cak1-1 | cak1-2	aberrant DNA repair
JK1	[act15]: carA	carA-1 | carA-2	delayed aggregation
DBS0252737	[act15]: carA(I104A)	carA-1 | carA-2	decreased cAMP binding
DBS0252732	[act15]: carA(I104C)	carA-1 | carA-2	decreased protein kinase activation
DBS0252740	[act15]: carA(I104D)	carA-1 | carA-2	increased cAMP binding | delayed aggregation | aberrant oscillatory cAMP signaling | decreased protein kinase activation
DBS0252744	[act15]: carA(I104E)	carA-1 | carA-2	increased cAMP binding | delayed aggregation | aberrant oscillatory cAMP signaling
DBS0252741	[act15]: carA(I104F)	carA-1 | carA-2	increased cAMP binding | decreased protein kinase activation
DBS0252738	[act15]: carA(I104G)	carA-1 | carA-2	increased cAMP binding | decreased protein kinase activation
DBS0252747	[act15]: carA(I104H)	carA-1 | carA-2	development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation
DBS0252749	[act15]: carA(I104K)	carA-1 | carA-2	increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation | abolished aggregation
DBS0252739	[act15]: carA(I104L)	carA-1 | carA-2	wild type
DBS0252742	[act15]: carA(I104M)	carA-1 | carA-2	increased cAMP binding
DBS0252746	[act15]: carA(I104N)	carA-1 | carA-2	development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation
DBS0252734	[act15]: carA(I104P)	carA-1 | carA-2	decreased protein kinase activation
DBS0252745	[act15]: carA(I104Q)	carA-1 | carA-2	development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation
DBS0252750	[act15]: carA(I104R)	carA-1 | carA-2	development arrests at loose mound stage | increased cAMP binding | abolished oscillatory cAMP signaling | decreased protein kinase activation
DBS0252743	[act15]: carA(I104S)	carA-1 | carA-2	increased cAMP binding | aberrant oscillatory cAMP signaling | decreased protein kinase activation
DBS0252735	[act15]: carA(I104T)	carA-1 | carA-2	increased cAMP binding | aberrant oscillatory cAMP signaling
DBS0252736	[act15]: carA(I104V)	carA-1 | carA-2	wild type
DBS0252733	[act15]: carA(I104W)	carA-1 | carA-2	increased cAMP binding
DBS0252748	[act15]: carA(I104Y)	carA-1 | carA-2	development arrests at loose mound stage | increased cAMP binding | aberrant oscillatory cAMP signaling | decreased protein kinase activation
DBS0351055	[act15]: catA	catA	decreased slug migration | decreased fruiting body size | decreased superoxide generation | decreased sporulation
DBS0351588	[act15]: cdcD(E219K): RFP	cdcD	abolished catalytic activity
DBS0350533	[act15]: cdcD(R154C): RFP	cdcD	decreased catalytic activity | aberrant protein modification | decreased phototaxis
DBS0350532	[act15]: cdcD: RFP	cdcD	decreased protein level | increased catalytic activity | decreased growth rate
DBS0237098	[act15]: cdk5(D144N)	cdk5	decreased pinocytosis | increased mound size | aberrant protein level | delayed aggregation | decreased phagocytosis | decreased growth rate | decreased sporulation | decreased protein secretion
DBS0237099	[act15]: cf60	cf60	increased number of mounds | aberrant mound size
DBS0302445	[act15]: cfaD	cfaD	decreased growth rate | aberrant fruiting body morphogenesis
DBS0350333	[act15]: cnrF: GFP	cnrF	aberrant regulation of GTPase activity
DBS0302658	[act15]: cnrN: myc/ smlA-	cnrN | smlA	decreased fruiting body size
DBS0237102	[act15]: cofA	cofA	increased actin bundle formation | increased membrane ruffling | increased cell motility
DBS0350583	[act15]: csaA	csaA	decreased cell-substrate adhesion | precocious aggregation | increased calcium-independent cell-cell adhesion
DBS0350684	[act15]: csaA(1-488): gppA(469-544)	csaA | gppA	aberrant protein localization to cell surface
DBS0350642	[act15]: cynA: GFP	cynA	aberrant cell motility | precocious aggregation | aberrant establishment or maintenance of cell polarity
DBS0349864	[act15]: cyrA: GFP	cyrA	increased chemotaxis to cAMP
DBS0237104	[act15]: dagA	dagA	wild type
DBS0350978	[act15]: deeJ	deeJ	increased pinocytosis | increased growth rate | increased phagocytosis
DBS0237105	[act15]: dgkA	dgkA	development arrests at loose mound stage | decreased chemotaxis rate | decreased myosin II assembly
DBS0350946	[act15]: dhcA(1384-4725)	dhcA	aberrant microtubule cytoskeleton organization
DBS0237106	[act15]: dhkC(394-661)	dhkC	development arrests at slug stage | increased slug migration
DBS0235716	[act15]: dhkK	dhkK	precocious aggregation | development arrests at mound stage
DBS0235705	[act15]: dhkK(D1125N)	dhkK	aberrant extracellular cAMP signaling pathway | delayed development
DBS0235707	[act15]: dhkK(H825Q)	dhkK	precocious development | decreased fruiting body size
DBS0235709	[act15]: dhkK(H825Q/ D1125N)	dhkK	aberrant slug migration | delayed culmination
DBS0237107	[act15]: dng1	dng1	aberrant extracellular cAMP signaling pathway | decreased growth rate | precocious aggregation
DBS0351565	[act15]: eIF6	eIF6	aberrant cellular process
DBS0350396	[act15]: eif2s1(S53A)	eif2s1	aberrant spore morphology | decreased spore germination | decreased protein level
DBS0350424	[act15]: eif2s1(S53A)/ [bzpR]: lacZ	eif2s1	abolished translation
DBS0237562	[act15]: enlA(92-497)	enlA	decreased cell-substrate adhesion
DBS0237108	[act15]: fbxA: FLAG	fbxA	decreased prespore cell differentiation
DBS0350365	[act15]: fip(1163-2038)	fip-1 | fip-2	aberrant prestalk O cell differentiation
DBS0237109	[act15]: fps	fps	increased resistance to alendronic acid
DBS0350012	[act15]: fps: GFP	fps	increased resistance to alendronic acid
DBS0235979	[act15]: fszA: GFP	fszA	aberrant mitochondrion morphology
DBS0351485	[act15]: fszB: GFP	fszB	decreased mitochondrial fusion | decreased mitochondrial fission
DBS0349956	[act15]: fttB(K49E): GFP	fttB	aberrant cytoskeleton organization
DBS0237601	[act15]: gbpD	gbpD	aberrant aggregation | decreased cell-cell adhesion | increased guanyl-nucleotide exchange factor activity | increased cell-substrate adhesion | decreased chemotaxis to cAMP | aberrant cell morphology | increased pseudopodium formation
DBS0351056	[act15]: gcsA	gcsA	increased catalytic activity | decreased slug migration | aberrant gene expression | decreased fruiting body size | decreased superoxide generation | decreased sporulation
DBS0237136	[act15]: gpaA	gpaA	increased stalk length | aberrant cytokinesis | aberrant fruiting body morphogenesis
DBS0351058	[act15]: gpaB	gpaB	aberrant aggregation | abolished sporulation | development arrests at mound stage | increased cAMP level | aberrant actin filament polymerization | decreased establishment of cell polarity | aberrant protein localization to plasma membrane | increased prestalk cell differentiation
DBS0350680	[act15]: gpaE	gpaE	abolished vegetative growth | decreased chemotaxis to folate
DBS0237145	[act15]: gpaG	gpaG	aberrant fruiting body morphogenesis
DBS0237146	[act15]: gpaH	gpaH	wild type
DBS0350971	[act15]: gpaH/ AX2	gpaH	aberrant cytokinesis | decreased growth rate | aberrant spore germination | aberrant sorocarp development | increased cell-substrate adhesion | increased cell-cell adhesion
DBS0237147	[act15]: gpaI(G38V): FLAG	gpaI	increased mound size | delayed aggregation | decreased number of mounds | aberrant fruiting body morphogenesis
DBS0237148	[act15]: gpaI(Q196L): FLAG	gpaI	increased oscillatory cAMP signaling | decreased protein localization to plasma membrane | increased mound size | aberrant activation of adenylate cyclase activity | increased chemotaxis to cAMP | increased lateral pseudopodium formation | delayed aggregation | decreased number of mounds | increased actin filament polymerization | aberrant adaptation of signaling pathway | aberrant fruiting body morphogenesis | decreased establishment of cell polarity | decreased cGMP biosynthesis
DBS0350079	[act15]: grlB	grlB	delayed aggregation
DBS0237149	[act15]: grxA	grxA	decreased prespore gene expression | delayed culmination
DBS0237151	[act15]: grxA(C21S)	grxA	wild type
DBS0237152	[act15]: grxA/ [act15]: lacZ	grxA	increased cell migration to prestalk region
DBS0351054	[act15]: gshB	gshB	aberrant aggregation | abolished sporulation | increased gene expression | development arrests at mound stage | increased cAMP level | aberrant actin filament polymerization | decreased establishment of cell polarity
DBS0351059	[act15]: gshB/ [AS]gpaB	gpaB | gshB	aberrant stream morphology | decreased establishment of cell polarity | decreased sporulation
DBS0237153	[act15]: gsr	gsr	increased cell migration to prestalk region | delayed culmination
DBS0350989	[act15]: gst4	gst4	increased fruiting body size
DBS0236152	[act15]: hcpA(1-161: 218-225): GFP	hcpA	decreased growth rate
DBS0236159	[act15]: hcpB(1-197: 237-244): GFP	hcpB	decreased growth rate
DBS0351607	[act15]: hsp101(K213A)	hsp101	decreased cellular thermotolerance
DBS0351608	[act15]: hsp101(K613A)	hsp101	decreased cellular thermotolerance
DBS0252821	[act15]: hssA	hssA	wild type
DBS0351173	[act15]: htrA(S300A)	htrA	decreased growth rate | aberrant fruiting body morphogenesis
DBS0351282	[act15]: htt: eYFP	htt	decreased gene expression | increased gene expression
DBS0350397	[act15]: ifkA(881-1514(K1258G,F1320L))	ifkA	decreased growth rate | increased protein level
DBS0350037	[act15]: mekA(299-360)	mekA	decreased mound size
DBS0350034	[act15]: mekA(K321A)	mekA	decreased mound size
DBS0350033	[act15]: mekA(S444A/ T448A)	mekA	decreased mound size
DBS0237203	[act15]: mhkB: FLAG	mhkB	aberrant cytokinesis | decreased myosin II assembly
DBS0350026	[act15]: mip1/ [act15]: mekA: FLAG	mekA | mip1-1 | mip1-2	aberrant protein localization to nucleus
DBS0237157	[act15]: mkkA	mkkA	development arrests at mound stage | delayed development
DBS0237158	[act15]: mkkA(K199A)	mkkA	precocious development | decreased sporulation
DBS0237159	[act15]: mkkA{deltaWD40}	mkkA	development arrests at mound stage | aberrant fruiting body morphogenesis | delayed development
DBS0350331	[act15]: mkpA: GFP: TAP	mkpA	increased resistance to cisplatin
DBS0350332	[act15]: mkpB(C294V)	mkpB-1 | mkpB-2	decreased migratory slug size | delayed prestalk gene expression | delayed prespore gene expression | aberrant sorocarp development | decreased resistance to cisplatin
DBS0350330	[act15]: mkpB: GFP: TAP	mkpB-1 | mkpB-2	increased resistance to cisplatin
DBS0237160	[act15]: mtaA(1-813)/ [dscB]tubA: GFP	cepJ	aberrant microtubule cytoskeleton organization
DBS0237162	[act15]: myc-cdk8	cdk8	increased number of tip-organizers | precocious development of tipped mound
DBS0350050	[act15]: myc: cdk8/ [act15]: FLAG: cycC	cdk8 | cycC	precocious development of tipped mound
DBS0266837	[act15]: myc: ptpC	ptpC	abolished protein localization to nucleus | aberrant hyperosmotic response | aberrant signal transduction
DBS0350417	[act15]: myc: ptpC	ptpC	aberrant protein phosphorylation
DBS0266839	[act15]: myc: ptpCΔ(C649S)	ptpC	aberrant protein localization to nucleus | increased protein tyrosine phosphorylation
DBS0266838	[act15]: myc: ptpC(C649S)	ptpC	aberrant protein localization to nucleus | increased protein tyrosine phosphorylation
DBS0238398	[act15]: myc: rapA	rapA	increased cell-substrate adhesion | decreased cell motility | aberrant cell morphology
DBS0238396	[act15]: myc: rapA(G12V)	rapA	increased protein localization to cell cortex | delayed aggregation | increased cell-substrate adhesion | decreased cell motility | increased protein kinase activation
DBS0238397	[act15]: myc: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0237167	[act15]: myc: rckA	rckA	delayed development
DBS0237163	[act15]: myc: rckA(C551A)	rckA	delayed slug development | decreased chemotaxis rate
DBS0237164	[act15]: myc: rckA(E510G)	rckA	delayed slug development | decreased chemotaxis rate
DBS0237165	[act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug development | decreased chemotaxis rate
DBS0237166	[act15]: myc: rckA(K867A)	rckA	precocious aggregation | delayed slug development | decreased chemotaxis rate
DBS0350132	[act15]: myc: splB	splB	increased protein localization to nucleus | increased protein tyrosine phosphorylation
DBS0351051	[act15]: myc: talA(2255-2492)/ puf118(677-1036)	puf118 | talA	aberrant chemotaxis to cAMP | abolished protein localization to leading edge
DBS0351359	[act15]: myoB	myoB	decreased pinocytosis | increased protein localization to cell cortex | delayed aggregation | decreased growth rate | decreased cell motility | delayed development | decreased fruiting body size | aberrant actin filament organization
DBS0351037	[act15]: myoE(1-1005)	myoE	abolished phosphatidylinositol binding
DBS0351036	[act15]: myoE(K859A/ K863A/ R868A/ R869A): GFP	myoE	abolished phosphatidylinositol binding | abolished protein localization to plasma membrane
DBS0349847	[act15]: myoK: Myc	myoK	decreased phagocytosis
DBS0237175	[act15]: myoM	myoM	aberrant stream morphology | delayed development | increased pseudopodium size
DBS0237178	[act15]: myoM-Mtail	myoM	decreased growth rate | aberrant hypotonic response | aberrant stream morphology | aberrant hyperosmotic response | delayed development | increased pseudopodium size
DBS0237179	[act15]: myr: rckA	rckA	delayed development | decreased chemotaxis rate
DBS0349860	[act15]: ndkC	ndkC-1 | ndkC-2	decreased exocytosis | decreased pinocytosis | decreased phagocytosis | decreased growth rate | increased growth rate
DBS0237180	[act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium | increased iron ion transport
DBS0350858	[act15]: odc	odc	aberrant cellular metabolic process | aberrant cell cycle
DBS0351201	[act15]: odc: eYFP	odc	decreased growth rate | delayed development
DBS0237182	[act15]: pakA	pakA	wild type
DBS0237183	[act15]: pakA(K394A)	pakA	development arrests at mound stage | delayed development
DBS0237184	[act15]: pakA[CA]	pakA	abolished aggregation
DBS0237185	[act15]: pakA[G+K]	pakA	wild type
DBS0349855	[act15]: pakB(1-337: 563-852)	pakB	decreased phagocytosis
DBS0350901	[act15]: pdeE: YFP	pdeE	development arrests at loose mound stage | decreased oscillatory cAMP signaling
DBS0351186	[act15]: phr2ab: GFP	phr2aB	aberrant cytokinesis | aberrant centrosome organization
DBS0349903	[act15]: pisA	pisA	aberrant development of tipped mound | decreased slug migration | delayed aggregation | decreased fruiting body size
DBS0349902	[act15]: pisA: GFP	pisA	decreased slug migration | increased gene expression | decreased gene expression | delayed aggregation | delayed development | decreased phototaxis
DBS0350693	[act15]: pkaC	pkaC	precocious development
DBS0237188	[act15]: pkaC(1-497)	pkaC	precocious development | decreased fruiting body size | decreased cAMP level
DBS0235418	[act15]: pkaR	pkaR	aberrant response to abiotic stimulus
DBS0237189	[act15]: pkaR(G135E/ G261A)	pkaR	decreased protein tyrosine phosphorylation | decreased protein kinase activity | abolished cAMP binding | abolished oscillatory cAMP signaling | abolished aggregation
DBS0350701	[act15]: pkaR(G135E/ G261A)/ AX3	pkaR	decreased gene expression | abolished oscillatory cAMP signaling
DBS0350609	[act15]: pkaR(S133T,G135E)	pkaR	decreased cAMP binding | decreased protein kinase activity | abolished oscillatory cAMP signaling | abolished aggregation
DBS0350920	[act15]: pkcA	pkcA	increased catalytic activity | abolished aggregation
DBS0235538	[act15]: pldB	pldB	increased catalytic activity | increased exocytosis | decreased actin filament polymerization | aberrant chemotaxis to cAMP | abolished aggregation | decreased sporulation
DBS0349874	[act15]: psaA: GFP	psaA	aberrant sporulation
DBS0351577	[act15]: psiA	psiA	decreased prespore gene expression | decreased stalk cell differentiation
DBS0351579	[act15]: psiA/ [cudA]: lacZ	psiA	aberrant prespore gene expression
DBS0351580	[act15]: psiA/ [ecmB]: lacZ	psiA	delayed prestalk gene expression
DBS0350751	[act15]: pten(16-515): GFP	pten	abolished catalytic activity
DBS0350750	[act15]: pten(186-515): GFP	pten	abolished catalytic activity
DBS0350752	[act15]: pten(C124S): GFP	pten	abolished catalytic activity
DBS0350753	[act15]: pten(G129E): GFP	pten	abolished catalytic activity
DBS0350318	[act15]: rab11A: RFP	rab11A	aberrant contractile vacuole organization | decreased contractile vacuole size | abolished hypotonic response
DBS0350951	[act15]: rac1B(Q61L)	rac1B	increased lateral pseudopodium formation | decreased chemotaxis to cAMP | aberrant actin filament organization
DBS0350952	[act15]: rac1B(T17N)	rac1B	abolished establishment of cell polarity | delayed aggregation | aberrant actin filament organization | abolished chemotaxis to cAMP
DBS0350469	[act15]: racE(G20V): GFP	racE	decreased actin filament polymerization | aberrant cytokinesis | decreased growth rate
DBS0350584	[act15]: rapA(G12V)	rapA	abolished protein localization to nucleus | increased protein localization to cell cortex | aberrant nucleus morphology | decreased growth rate | aberrant cytokinesis | increased cell-substrate adhesion | abolished protein localization to centrosome | increased number of microtubule organizing center
DBS0351497	[act15]: rasD(Q61L)	rasD	decreased protein kinase activation
DBS0351496	[act15]: rasD(S17N)	rasD	increased protein kinase activation
DBS0351212	[act15]: rasG(S17N)	rasG	aberrant activation of GTPase activity | decreased chemotaxis to cAMP
DBS0350262	[act15]: rbg3	rbg3	increased lysosome size | decreased growth rate | delayed development
DBS0237192	[act15]: rblA	rblA	delayed mitotic cell cycle
DBS0350671	[act15]: regA(126-316): myc	regA	precocious sporulation
DBS0349938	[act15]: rgaA	rgaA	decreased actin filament polymerization | aberrant cytokinesis | decreased cell motility
DBS0351529	[act15]: rgbA(751-1072,1080-1284,1517-1846)	rgbA	aberrant macropinocytosis | abolished protein localization to macropinosome
DBS0351528	[act15]: rgbA(751-1072,1121-1317,1505-1834)	rgbA	aberrant macropinocytosis | abolished protein localization to macropinosome
DBS0351304	[act15]: rheb	rheb	decreased phagocytosis | decreased macropinocytosis | increased growth rate
DBS0350294	[act15]: rheb: YFP	rheb	increased vegetative cell size
DBS0350890	[act15]: rnp1A	rnp1A	increased resistance to nocodazole
DBS0350575	[act15]: rps4	rps4	decreased spore germination | aberrant actin cytoskeleton organization | aberrant vegetative growth | decreased mound size | decreased spore size | aberrant fruiting body morphogenesis | decreased sporulation
DBS0236915	[act15]: rzpA	rzpA	increased prestalk gene expression | decreased prespore gene expression | delayed culmination
DBS0349793	[act15]: sadA(921-952)	sadA	decreased cell-substrate adhesion
SA604	[act15]: sgkA: FLAG	sgkA	aberrant response to abiotic stimulus | increased resistance to cisplatin | aberrant cytokinesis | increased resistance to carboplatin
DBS0304461	[act15]: sir2E	sir2E	increased growth rate
HPF437	[act15]: snfA(1-379): GFP	snfA	increased stalk width | increased ATP level | decreased growth rate | increased number of mitochondria | decreased defense response to bacterium | decreased phototaxis | decreased stalk length | aberrant mitochondrion organization
DBS0351040	[act15]: snfA(1-379): GFP/ [AS]ndkC-1	ndkC-1 | ndkC-2 | snfA	wild type
DBS0350976	[act15]: snfA: YFP	snfA	decreased growth rate | aberrant fruiting body morphogenesis
DBS0351053	[act15]: sod2	sod2	decreased slug migration | decreased fruiting body size | decreased superoxide generation | decreased sporulation
DBS0304457	[act15]: sodA/ gcsA-	gcsA | sodA	wild type
DBS0237194	[act15]: sodA: myc	sodA	aberrant response to abiotic stimulus | decreased gene expression | abolished aggregation
DBS0237195	[act15]: spkA: FLAG	spkA-1 | spkA-2	aberrant aggregation | decreased chemotaxis rate | aberrant actin filament organization | decreased establishment of cell polarity
AK1209	[act15]: tagA(1-890)	tagA	increased number of mound tips
DBS0350962	[act15]: tor(212-2380): YFP	tor	decreased growth rate | aberrant sorocarp development
DBS0237198	[act15]: torA	torA	abolished vegetative growth
DBS0350862	[act15]: tpt1: YFP	tpt1	decreased gene expression | decreased growth rate | decreased number of mounds | delayed development | aberrant fruiting body morphogenesis
DBS0237199	[act15]: trrA	trrA	aberrant aggregation | decreased growth rate | decreased phagocytosis | delayed culmination
DBS0351572	[act15]: vacA: GFP	vacA	decreased phagocytosis
DBS0351573	[act15]: vacB: GFP	vacB	decreased phagocytosis
DBS0351574	[act15]: vacC: GFP	vacC	decreased phagocytosis
DBS0237200	[act15]: vasP	vasP	increased filopodium formation | increased actin filament polymerization
DBS0351184	[act15]: washc5(N457D): GFP	washc5	aberrant cytokinesis
DBS0351183	[act15]: washc5: GFP	washc5	aberrant cytokinesis
DBS0350911	[act6]: GFP: cepA/ cepA(183-346)	cepA	increased number of centrosomes
DBS0237209	[act6]: GFP: cepJ	cepJ	decreased resistance to nocodazole | aberrant cytokinesis | decreased size of astral microtubules | decreased number of astral microtubules | increased number of microtubule organizing center
DBS0351235	[act6]: GFP: cepL	cepL	increased number of microtubule organizing center
DBS0351586	[act6]: GFP: gefQ(S431A)	gefQ	increased number of mound tips | delayed development
DBS0349984	[act6]: GFP: lmnB(1-712)	lmnB	aberrant cellular response to fluid shear stress | aberrant intermediate filament organization | abolished vegetative growth
DBS0351551	[act6]: GFP: lmnB(1-712)/ S122A	lmnB	aberrant intermediate filament bundle assembly
DBS0350497	[act6]: GFP: rab2A	rab2A	decreased pinocytosis | decreased phagocytosis | aberrant hypotonic response | increased growth rate
DBS0350498	[act6]: GFP: rab2A(N118I)	rab2A	aberrant cell-cell adhesion | aberrant hypotonic response | increased growth rate | precocious development
DBS0350499	[act6]: GFP: rab2A(Q64L)	rab2A	decreased autophagic cell death | aberrant cell-cell adhesion | aberrant sorocarp development | aberrant hypotonic response | increased growth rate | increased phagocytosis
DBS0306243	[act6]: GFP: sun1	sun1	increased number of centrosomes | aberrant nucleus morphology | aberrant mitotic sister chromatid segregation | aberrant centromere complex assembly | aberrant centrosome organization
DBS0306244	[act6]: GFP: sun1(1-722)	sun1	increased number of centrosomes | aberrant nucleus morphology | aberrant mitotic sister chromatid segregation | aberrant centromere complex assembly | aberrant centrosome organization
DBS0235563	[act6]: abpD(33-262)	abpB	decreased growth rate | delayed development
DBS0237204	[act6]: canA	canA	wild type
DBS0350685	[act6]: csaA	csaA	increased migratory slug size | increased calcium-independent cell-cell adhesion
DBS0237205	[act6]: dia1	dia1	delayed aggregation
DBS0236905	[act6]: mrps4	mrps4	precocious aggregation
DBS0235444	[act6]: myc: eppA(S250A)	eppA	decreased growth rate | delayed development | decreased cAMP level
DBS0235445	[act6]: myc: eppA(S325A)	eppA	decreased growth rate
DBS0266836	[act6]: ptpB	ptpB	delayed aggregation | decreased fruiting body size
DBS0237218	[act6]: ptpC	ptpC	increased mound size | decreased growth rate
DBS0237219	[act6]: ptpC(C649S)	ptpC	increased mound size | decreased growth rate
DBS0350807	[act6]: rabS(N137I): GFP	rabS	increased secretion of lysosomal enzymes | aberrant contractile vacuole organization | increased endocytic recycling
DBS0350806	[act6]: rabS: GFP	rabS	decreased cell-cell adhesion | increased secretion of lysosomal enzymes | increased cell death | increased pinocytosis | aberrant sorocarp development | aberrant hyperosmotic response | decreased chemotaxis to cAMP | increased growth rate | increased phagocytosis
DBS0350982	[act6]: rps6	rps6	aberrant cytokinesis | delayed development
DBS0304410	[act6]: srsA	srsA	increased migratory slug size | increased mound size | decreased gene expression | delayed aggregation | aberrant fruiting body morphogenesis | decreased sporulation
DBS0237220	[act6]: trap1	trap1	development arrests at loose mound stage | aberrant aggregation | abolished pinocytosis | increased gene expression | decreased gene expression | decreased growth rate
DBS0350695	[act6]: yakA	yakA	increased gene expression | abolished vegetative growth
DBS0350069	[act6]: zizB: GFP	zizB	aberrant cell separation during cytokinesis | increased filopodium formation
DBS0304460	[act]: alrA/ gcsA-	alrA | gcsA	wild type
DBS0349955	[ampA]: RFP: ampA	ampA	development arrests at mound stage
DBS0237221	[arkA]: arkA: myc2	arkA	aberrant aggregation
HM2191	[arpB]: arpB: GFP	arpB	decreased actin filament polymerization | decreased cell-substrate adhesion | decreased growth rate | decreased cell motility | decreased chemotaxis rate | increased bleb assembly
DBS0235407	[carA]: carA(1-317)	carA-1 | carA-2	delayed development
DBS0351495	[cotB]: FLAG: fbxD	fbxD	delayed culmination
HW358	[cotB]: fpaB: myc	fpaB-1 | fpaB-2	increased response to hypoxia
DBS0350705	[cotC]: pkaC	pkaC	aberrant sorocarp development | aberrant fruiting body morphogenesis | precocious development
DBS0350706	[cotC]: pkaC/ [spiA]: lacZ	pkaC | spiA	precocious gene expression
DBS0350048	[cycC]: cycC: TAP	cycC	decreased protein level
DBS0350942	[disc]: HA: rab14(N121I)	rab14	decreased endosomal vesicle fusion | decreased phagocytosis
DBS0350941	[disc]: HA: rab14(Q67L)	rab14	increased lysosome size | increased endosomal vesicle fusion | increased phagocytosis
DBS0351493	[dscA]: His: agtA	agtA	decreased sporulation
DBS0351492	[dscA]: His: agtA(D132A)	agtA	aberrant stalk morphogenesis | abolished sporulation
DBS0237238	[dscB]: GFP: rab8A	rab8A	wild type
DBS0237239	[dscB]: GFP: rab8A(N128I)	rab8A	increased mound size | increased cell-cell adhesion | decreased fruiting body size
DBS0237240	[dscB]: GFP: rab8A(Q74L)	rab8A	abolished aggregation | aberrant cytoskeleton organization
DBS0237241	[dscB]: GFP: rab8B	rab8B	increased mound size
DBS0237242	[dscB]: GFP: rab8B(Q74L)	rab8B	increased mound size
DBS0305081	[dscB]: GFP: vamp7A(L35A)	vamp7A	increased protein localization to plasma membrane
DBS0351106	[dscB]: HA: racC	racC	decreased exocytosis | decreased pinocytosis | decreased macropinocytosis | aberrant actin filament organization | increased phagocytosis
DBS0350903	[dscB]: HA: rapB(G12V)	racB	decreased exocytosis | decreased phagocytosis | aberrant cytokinesis | decreased growth rate | decreased macropinocytosis | aberrant actin filament organization | aberrant cell morphology
DBS0350433	[dscB]: abpB(E60K): GFP	abpB	abolished actin filament polymerization
DBS0350820	[dscB]: cafA	cafA	increased gene expression | precocious development
DBS0237237	[dscB]: cycB(106-436)	cycB	mitotic M phase arrest
DBS0350922	[dscB]: dicA(1-278)	dicA	increased cell death | abolished protein binding | aberrant microtubule cytoskeleton organization | aberrant Golgi localization | aberrant mitotic sister chromatid segregation | aberrant centrosome organization
DBS0350923	[dscB]: dicA(48-654)	dicA	aberrant microtubule cytoskeleton organization | aberrant Golgi localization | decreased protein binding | aberrant mitotic sister chromatid segregation | aberrant centrosome organization
DBS0237243	[dscB]: myc: rac1B	rac1B	increased rate of endocytosis | aberrant cytokinesis | decreased growth rate | delayed development
DBS0237244	[dscB]: myc: rac1B(G12V)	rac1B	decreased rate of endocytosis | decreased growth rate | abolished aggregation | aberrant cell morphology
DBS0237245	[dscB]: myc: rac1B(Q61L)	rac1B	decreased rate of endocytosis | decreased growth rate | abolished aggregation | aberrant cell morphology
DBS0237246	[dscB]: myc: rac1B(T17N)	rac1B	decreased rate of endocytosis | decreased growth rate | abolished aggregation
DBS0351510	[dscB]: rac1B(G12V): myc	rac1B	decreased pinocytosis | decreased growth rate | aberrant cytokinesis | delayed development | aberrant actin filament organization | aberrant cell morphology
DBS0351511	[dscB]: rac1B(Q61L): myc	rac1B	decreased growth rate | aberrant cytokinesis | delayed development | aberrant actin filament organization | aberrant cell morphology
DBS0351512	[dscB]: rac1B(T17N): myc	rac1B	decreased pinocytosis | decreased growth rate | aberrant cytokinesis | decreased chemotaxis to folate | delayed development | aberrant actin filament polymerization | aberrant cell morphology
DBS0350589	[dscB]: rapA	rapA	decreased pinocytosis | aberrant actin filament organization | aberrant cell morphology | increased phagocytosis
DBS0350586	[dscB]: rapA(D40E)	rapA	aberrant actin filament organization | aberrant cell morphology
DBS0350588	[dscB]: rapA(F160L)	rapA	aberrant actin filament organization | aberrant cell morphology
DBS0350590	[dscB]: rapA(G12T)	rapA	decreased pinocytosis | increased phagocytosis
DBS0237247	[dscB]: rapA(G12V)	rapA	aberrant osmosensory signaling pathway | aberrant actin filament organization | aberrant cell morphology
DBS0350585	[dscB]: rapA(S19N)	rapA	decreased phagocytosis | aberrant cell morphology
DBS0350587	[dscB]: rapA(T63Q)	rapA	aberrant cell morphology
DBS0237248	[dscB]: rasG(G12T)	rasG	decreased gene expression | decreased growth rate | increased cell-cell adhesion | decreased cell motility | decreased protein kinase activation | decreased fruiting body size | abolished aggregation | aberrant cell morphology | decreased sporulation
DBS0351227	[dscB]: rasG(G12T/ T45Q)	rasG	wild type | aberrant cell morphology
DBS0350933	[dscC]: kif2	kif2	aberrant cell cycle
DBS0351230	[ecmAO]: rasG(G12T)	rasG	aberrant prestalk gene expression | aberrant culmination
DBS0350703	[ecmA]: pkaC	pkaC	development arrests at mound stage | abolished development of tipped mound
DBS0350659	[ecmA]: pkaC(9-648)	pkaC	development arrests at tipped mound stage
DBS0350699	[ecmA]: pkaR(G135E/ G261A)	pkaR	decreased migratory slug size | delayed development of tipped mound | aberrant culmination | aberrant slug migration | decreased prestalk gene expression | increased slug migration | aberrant prestalk cell differentiation
DBS0350700	[ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ	pkaR	abolished stalk cell differentiation
DBS0350704	[ecmB]: pkaC	pkaC	development arrests at mound stage | abolished development of tipped mound
DBS0350639	[ecmF]: expl3: myc	expl3	aberrant stalk morphogenesis | delayed slug development
DBS0304865	[expl7]: expl7: GFP	expl7	aberrant late culminant morphology
DBS0237252	[gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0237253	[gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0237254	[gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization to plasma membrane
DBS0237255	[hairpin]dct	dct	aberrant cytokinesis | aberrant pseudopodium formation
DBS0238412	[inviable]arcB-	arcB	abolished vegetative growth
DBS0238407	[inviable]arpB-	arpB	abolished vegetative growth
DBS0237257	[inviable]cofA-	cofA	abolished vegetative growth
DBS0349945	[inviable]fttB	fttB	abolished vegetative growth
DBS0349872	[inviable]lkb1-	lkb1	abolished vegetative growth
DBS0237265	[inviable]phlp2-	phlp2	abolished vegetative growth
DBS0349948	[ndm]: ndm: RFP	ndm	development arrests at mound stage
DBS0236086	[pdsA-agg]: pdsA	pdsA	precocious development
DBS0236111	[pdsA-ldev]: pdsA	pdsA	development arrests at mound stage
DBS0236484	[pkaC]: pkaC	pkaC	increased gene expression | precocious prespore gene expression | decreased spore cell differentiation | aberrant fruiting body morphogenesis | precocious development | precocious gene expression | decreased cAMP level
DBS0350709	[pkaC]: pkaC/ [dscC]: lacZ	dscC-1 | dscC-2 | pkaC	aberrant gene expression
DBS0350196	[pkaC]: pkaC/ nsfA(A1854T,T1984A,C2131A,A2398T,T2574A)	nsfA | pkaC	decreased spore cell differentiation
DBS0350696	[pkaC]: pkaC/ srfA-	pkaC | srfA	aberrant spore coat morphology | aberrant gene expression
DBS0237289	[psmC1]: psmC1	psmC1	delayed development of tipped mound | aberrant cytokinesis | delayed gene expression
DBS0349928	[pspA]: lacZ	pspA	aberrant prespore gene expression
DBS0350658	[pspA]: pkaC(9-648)	pkaC	precocious sporulation | aberrant fruiting body morphogenesis
DBS0350697	[pspA]: pkaR(G135E/ G261A)	pkaR	abolished gene expression | decreased prespore gene expression | aberrant sorus color
DBS0351229	[pspA]: rasG(G12T)	rasG	increased number of mound tips | increased prestalk gene expression | decreased prespore gene expression | abolished phototaxis | increased prestalk cell differentiation
DBS0237290	[ptpA1]: ptpA1	ptpA1-1 | ptpA1-2	delayed aggregation | decreased growth rate | aberrant fruiting body morphogenesis
DBS0237291	[ptpB]ptpB	ptpB	decreased growth rate | development arrests at mound stage
DBS0351231	[rasD]: rasG(G12T)	rasG	development arrests at loose mound stage | increased number of mound tips
DBS0236867	[rasG]: rasG(G12T)	rasG	aberrant aggregation
SA601	[sglA-myc]neoR-1	sglA	decreased resistance to carboplatin | decreased growth rate | aberrant cytokinesis | decreased resistance to cisplatin
DBS0237316	[tet]: GFP(S65T): racG(G12V)	racG	increased filopodium formation | decreased positive regulation of GTPase activity | decreased actin filament polymerization | increased phagocytosis | abolished chemotaxis to cAMP
DBS0237317	[tet]: GFP(S65T): racG(T17N)	racG	abolished actin filament polymerization | abolished chemotaxis to cAMP
DBS0350110	[tet]: RNAi: raptor	raptor	decreased growth rate
DBS0238351	[tet]: [RNAi]cinC	cinC	decreased translation | precocious aggregation | decreased growth rate
DBS0237318	[tet]: pten	pten	decreased cell motility | decreased protein kinase activation
DBS0237622	[tet]: rapA(S17N)/ [act15]: gbpD	gbpD | rapA	increased establishment of cell polarity | increased cell-substrate adhesion | aberrant cell morphology
DBS0351461	[tet]rasD(G12T)	rasD	increased gene expression | increased prestalk cell differentiation
DBS0351463	[tet]rasD(G12T)/ rigA-	rasD | rigA	wild type
DBS0350494	[tgrB1]: [RNAi]abcB3/ [tgrC1]: GFP	abcB3	delayed development | decreased cAMP level
DBS0351290	[tre]: drkA: myc	drkA	decreased growth rate | increased protein tyrosine phosphorylation
DBS0304911	[tre]: paxB	paxB	abolished sporulation | aberrant endocytosis | decreased cell-substrate adhesion | aberrant chemotaxis to folate | development arrests at mound stage | decreased cell motility | increased cell-cell adhesion
DBS0350267	[tre]: secG	secG	increased filopodium formation | abolished establishment of cell polarity | development arrests at mound stage | aberrant actin cytoskeleton organization | aberrant actin filament polymerization | abolished chemotaxis to cAMP | delayed gene expression
DBS0351555	[unk]: FLAG: rab1A(Q67L)	rab1A	aberrant actin filament polymerization | aberrant pseudopodium formation
DBS0351556	[unk]: FLAG: rab1A(S22N)	rab1A	decreased actin filament polymerization | decreased chemotaxis to cAMP
DBS0351442	[unk]: GFP: RasG	rasG	increased macropinocytosis
DBS0351443	[unk]: GFP: RasG(G12T)	rasG	increased macropinocytosis
DBS0351444	[unk]: GFP: RasS	rasS	increased macropinocytosis
DBS0351445	[unk]: GFP: RasS(G12V)	rasS	increased macropinocytosis
DBS0350726	[unk]: GFP: cepE	cepE	increased number of centrosomes | aberrant cytokinesis
DBS0351454	[unk]: GFP: piaA(G963E)	piaA	delayed aggregation | decreased protein binding
DBS0351507	[unk]: GFP: wasA(I173A/ F179A)	wasA	abolished protein binding
DBS0350447	[unk]: PTEN(H385G/ N389A/ H390A)	pten	decreased protein localization to plasma membrane | decreased fruiting body size
DBS0351270	[unk]: gpgA(1-65)	gpgA	decreased protein localization to plasma membrane | abolished aggregation | aberrant actin filament organization | abolished chemotaxis to cAMP
DBS0350576	[unk]: mhkC(1-498)	mhkC	abolished protein localization to cell cortex | abolished protein phosphorylation
DBS0350405	[unk]: myc: rgaA(K273E/ K282E)	rgaA	aberrant binding
DBS0350716	[unk]: pdsA	pdsA	aberrant sorocarp development
DBS0350259	[unk]: pikA(1-492(S7A/ S11A/ S109A/ S113A/ S177A/ S181A))	pikA	increased protein localization to plasma membrane
DBS0350558	[unk]: pikI(T262E)	pikI	increased catalytic activity
DBS0350258	[unk]: rapA(G12V)	rapA	increased activation of GTPase activity
DBS0236859	[unk]: rasD(G12T)	rasD	increased myo-inositol level | decreased gene expression | increased prestalk gene expression | decreased prespore gene expression | development arrests at tipped mound stage | increased protein kinase activation
DBS0350837	[unk]: rasD(G12T)/ [rasD]: rapA	rapA | rasD	increased number of mound tips | aberrant culmination | decreased prespore cell differentiation | aberrant gene expression | decreased stalk cell differentiation
DBS0304636	[unk]: rasG(Q61L)/ rasG-	rasG	aberrant extracellular cAMP signaling pathway | increased protein modification
DBS0350597	[unk]: roco4(1018-1292;F1107L,F1161L)	roco4	decreased small molecule binding
DBS0238439	[unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis | increased vegetative cell size | decreased chemotaxis to cAMP | aberrant cytoskeleton organization
DBS0351430	[unk]: tps9(N236A)	tps9	decreased catalytic activity
DBS0350056	[unk]: tubA: GFP/ RNAi]cepG	cepG | tubA	aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant protein localization to nuclear envelope | aberrant centromere complex assembly
DBS0350913	[unk]: tubA: GFP/ [RNAi]cepD	cepD	increased number of centrosomes | aberrant mitotic spindle organization | decreased protein localization to microtubule organizing center
DBS0351237	[unk]: tubA: GFP/ [RNAi]cepL	cepL | tubA	decreased growth rate | aberrant cytokinesis | aberrant microtubule cytoskeleton organization | aberrant centromere complex assembly
DBS0351561	[unk]: vacA: myc: vasP	vacA | vasP	decreased phagocytosis | decreased growth rate | aberrant cytokinesis | increased protein level | aberrant cell morphology
DBS0350464	[unk]: vasP(1-197: 221-261: 285-380)	vasP	abolished actin filament polymerization
DBS0350463	[unk]: vasP(1-261: 285-380)	vasP	aberrant actin filament organization
DBS0350465	[unk]: vasP(1-340: 376-380)	vasP	decreased actin filament polymerization | aberrant actin filament organization
DBS0237288	[unk]skp1	fpaA | fpaB-1	aberrant fruiting body morphogenesis
HAD186	aarA-	aarA	aberrant stalk morphogenesis | aberrant Golgi localization | aberrant epithelium-like organization | decreased prespore gene expression | aberrant centrosome localization | aberrant stalk development | aberrant establishment or maintenance of cell polarity | decreased sporulation
DBS0349920	aarA-/ [act15]: GFP-mhcA	aarA	aberrant stalk morphogenesis | aberrant protein localization
DBS0350143	abcA10-	abcA10	aberrant sorocarp development | decreased sporulation
DBS0350135	abcA3-	abcA3	aberrant sorocarp development | aberrant fruiting body morphogenesis | decreased sporulation
DBS0350138	abcA4-	abcA4	aberrant fruiting body morphogenesis
DBS0350139	abcA5-	abcA5	aberrant sorocarp development | decreased sporulation
DBS0350140	abcA6-	abcA6	decreased fruiting body size
DBS0350141	abcA7-	abcA7	aberrant sorocarp development
DBS0350142	abcA9-	abcA9	aberrant fruiting body morphogenesis | decreased sporulation
DBS0350145	abcB1-	abcB1	delayed culmination
DBS0350146	abcB4-	abcB4	decreased sporulation
DBS0350147	abcB5-	abcB5	decreased growth rate | delayed culmination
DBS0350153	abcC13-	abcC13	aberrant sorocarp development | delayed culmination | decreased sporulation
DBS0350154	abcC14-	abcC14	aberrant sorocarp development | decreased fruiting body size | decreased sporulation
DBS0350148	abcC2-	abcC2	aberrant sorocarp development | delayed culmination
DBS0350149	abcC3-	abcC3	delayed culmination
DBS0350150	abcC6-	abcC6	aberrant sorocarp development | delayed culmination
DBS0350151	abcC8-	abcC8	decreased growth rate | increased number of early culminant tips | decreased sporulation
DBS0350155	abcD2-	abcD2	decreased fruiting body size
DBS0350156	abcF1-	abcF1	aberrant sorocarp development | delayed culmination | decreased sporulation
DBS0350157	abcF2-	abcF2	delayed development of tipped mound | decreased sporulation
DBS0350158	abcF4-	abcF4	aberrant sorocarp development | aberrant fruiting body morphogenesis
DBS0350164	abcG10-	abcG10	delayed development of tipped mound | decreased fruiting body size | decreased sporulation
DBS0350165	abcG15-	abcG15	aberrant sorocarp development | decreased sporulation
DBS0350166	abcG16-	abcG16	delayed culmination
DBS0350167	abcG17-	abcG17-1 | abcG17-2	decreased fruiting body size | decreased sporulation
DBS0350168	abcG18-	abcG18	decreased sporulation
DBS0350169	abcG19-	abcG19	delayed aggregation | decreased fruiting body size
DBS0350160	abcG2-	abcG2	delayed development of tipped mound | decreased fruiting body size
DBS0236539	abcG2-/ abcG18-	abcG18 | abcG2	decreased rate of endocytosis | decreased growth rate | abolished vegetative growth
DBS0236540	abcG2-/ abcG18-/ rtoA-	abcG18 | abcG2 | rtoA	decreased growth rate | abolished vegetative growth
DBS0350170	abcG22-	abcG22	delayed development of tipped mound | aberrant sorocarp development
DBS0350171	abcG24-	abcG24	decreased sporulation | delayed culmination
DBS0350161	abcG5-	abcG5	delayed culmination
DBS0350162	abcG6-	abcG6	decreased sporulation
DBS0351078	abcG6-	abcG6	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0350163	abcG7-	abcG7	delayed development of tipped mound | decreased fruiting body size | decreased sporulation
DBS0350159	abcH2-	abcH2	decreased sporulation
DBS0266687	abiA-	abiA	abolished protein localization to pseudopodium | decreased protein level | aberrant cytokinesis | decreased growth rate | decreased chemotaxis to folate
DBS0266688	abiA-	abiA	abolished protein localization to pseudopodium
DBS0351531	abiA-/ AX2	abiA	abolished protein localization to pseudopodium | decreased migratory slug size | aberrant filopodium formation | aberrant macropinocytosis | decreased cell motility | aberrant pseudopodium formation | decreased fruiting body size
DBS0350386	abiA-/ abiA(45-136)	abiA	decreased protein level | aberrant cytokinesis
DBS0350384	abiA-/ abiA(45-332)	abiA	aberrant cytokinesis
DBS0351535	abiA-/ pirA-/ AX2	abiA | pirA	aberrant macropinocytosis | decreased cell motility | aberrant cell morphology
DBS0266689	abiA-/ scrA-	abiA | scrA	decreased cell motility | decreased vegetative cell size
LAS53	abkD-	abkD	aberrant socially cooperative development
DBS0351065	abnC-	abnC	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0235459	abpA-	abpA	aberrant hyperosmotic response
DBS0235456	abpA-/ abpC-	abpA | abpC	decreased pinocytosis | decreased phagocytosis | decreased growth rate | decreased cell motility | aberrant sorocarp development | aberrant cell-cell adhesion | aberrant hyperosmotic response
DBS0305672	abpB-	abpB	increased filopodium formation
DBS0351087	abpB-/ abpA-	abpA | abpB	decreased pinocytosis | decreased growth rate | increased cell-cell adhesion | decreased vegetative cell size | aberrant fruiting body morphogenesis | aberrant hyperosmotic response | precocious gene expression | decreased chemotaxis to cAMP
DBS0351088	abpB-/ abpC-	abpB | abpC	decreased prespore gene expression | decreased prestalk gene expression | aberrant fruiting body morphogenesis | aberrant hyperosmotic response | decreased chemotaxis to cAMP
DBS0235425	abpB-/ fimA-	abpB | fimA	decreased vegetative cell size | decreased fruiting body size | decreased sporulation
HG1264	abpC-	abpC	aberrant actin cytoskeleton organization
DBS0350936	abpC-	abpC	aberrant cortical actin cytoskeleton organization | decreased phagocytosis | decreased cell motility | decreased chemotaxis to cAMP | aberrant pseudopodium formation | decreased establishment of cell polarity
DBS0236077	abpC-	abpC	decreased response to Gram-negative bacterium | aberrant thermotaxis | aberrant cortical actin cytoskeleton organization | decreased cell motility | aberrant phototaxis | decreased establishment of cell polarity | aberrant actin filament polymerization
HG1270	abpC-	abpC	aberrant phototaxis
DBS0237938	abpC-/ [act15]: GFP: abpC(9-148)	abpC	aberrant phototaxis
DBS0235426	abpC-/ [act15]: abpC	abpC	wild type
DBS0350938	abpC-/ [act15]: abpC	abpC	wild type
DBS0237945	abpC-/ [act15]: abpC(1-348: 449-857): GFP	abpC	aberrant phototaxis | aberrant actin filament organization
DBS0237946	abpC-/ [act15]: abpC(1-556: 644-857): GFP	abpC	aberrant phototaxis | aberrant actin filament organization
DBS0237941	abpC-/ [act15]: abpC(1-739): GFP	abpC	aberrant phototaxis
DBS0351553	abpC-/ [act15]: qkgA(425-1553)	abpC | qkgA-1 | qkgA-2	aberrant actin filament polymerization
DBS0237949	abpC-/ [cotB]: abpC: GFP	abpC	aberrant phototaxis
DBS0237948	abpC-/ [ecmA]: abpC: GFP	abpC	wild type
DBS0235427	abpD-	abpD	decreased cell-cell adhesion | decreased spore germination | aberrant sorocarp development | delayed development
DBS0235428	abpE-	abpE-1 | abpE-2	increased lateral pseudopodium formation
DBS0349851	abpE-	abpE-1 | abpE-2	aberrant phagosome maturation | precocious phagosome acidification | increased phagocytosis
DBS0349852	abpE-/ [act15]: abpE	abpE-1 | abpE-2	decreased phagocytosis
DBS0350529	abpG-	abpG	increased actin filament polymerization | decreased chemotaxis to cAMP | decreased fruiting body size
DBS0235562	acaA-	acaA	abolished stream development | abolished gene expression | abolished establishment of cell polarity | decreased gene expression | increased cellular thermotolerance | abolished aggregation | decreased adenylate cyclase activity | decreased cAMP level
GP6	acaA-	acaA	increased lateral pseudopodium formation | decreased chemotaxis rate | aberrant actin filament organization | aberrant cell morphology | increased protein kinase activation
DBS0235429	acaA-	acaA	decreased gene expression | abolished oscillatory cAMP signaling
DBS0350720	acaA-/ [acaA-agg]: acaA: myc	acaA	decreased gene expression | decreased fruiting body size
DBS0350721	acaA-/ [acaA-psp]: acaA: myc	acaA	decreased gene expression | decreased mound size | decreased fruiting body size
DBS0350722	acaA-/ [acaA-pst]: acaA: myc	acaA	wild type
DBS0350702	acaA-/ [act15]: HA: pkaC	acaA | pkaC	wild type | delayed development | decreased cAMP level
DBS0350725	acaA-/ [act15]: HA: pkaC/ acrA-	acaA | acrA | pkaC	decreased gene expression | abolished adenylate cyclase activity | development arrests at tipped mound stage
DBS0350737	acaA-/ [act15]: acaA	acaA	aberrant slug development
DBS0350738	acaA-/ [act15]: acaA(1-390;398-1407)	acaA	abolished aggregation
DBS0350739	acaA-/ [act15]: acaA(L394T/ K482N)	acaA	wild type
DBS0350603	acaA-/ [act15]: cap: GFP	acaA | cap	development arrests at loose mound stage | increased calcium-dependent cell-cell adhesion | wild type
DBS0350735	acaA-/ [act15]: pkaR(G135E/ G261A)	acaA | pkaR	increased cAMP level
DBS0350736	acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T)	acaA	decreased gene expression | abolished oscillatory cAMP signaling | decreased cAMP level
DBS0350734	acaA-/ [unk]: acaA(N333D,G633S)	acaA	abolished adenylate cyclase activity
DBS0350733	acaA-/ [unk]: acaA(V427I,S642F)	acaA	abolished activation of adenylate cyclase activity
DBS0350711	acaA-/ [unk]: acgA	acaA | acgA	aberrant sorocarp development
DBS0306125	acapA-	acapA	wild type
DBS0350051	acapA-	acapA	aberrant exocytosis | aberrant filopodium formation | increased defense response to Gram-negative bacterium | aberrant endocytosis | aberrant cytokinesis | aberrant stream morphology | decreased cell motility | delayed development | aberrant lysosome organization
DBS0350055	acapA-/ [act15]: acapA(R633Q): GFP	acapA	aberrant filopodium formation | aberrant lysosome organization
DBS0350054	acapA-/ [act15]: acapA: GFP	acapA	increased filopodium formation
DBS0306126	acapA-/ acapB-	acapA | acapB	decreased sporulation
DBS0306127	acapB-	acapB	wild type
TL177	acbA-	acbA	decreased response to Gram-negative bacterium | abolished cell migration to prestalk region | abolished spore cell differentiation | decreased sporulation | decreased resistance to cisplatin
DBS0350194	acbA-/ [act15]: acbA(Y72A)	acbA	abolished spore cell differentiation
AK1211	acbA-/ tagA-	acbA | tagA	increased prestalk B cell differentiation
DBS0235440	acgA-	acgA	abolished polyketide metabolic process | decreased spore germination | decreased spore cell differentiation | precocious spore germination | abolished response to biotic stimulus
DBS0237788	acgA-	acgA	decreased prespore cell differentiation | decreased prespore gene expression
DBS0237790	acgA-/ [acrA]: lacZ	acgA | acrA	aberrant prestalk gene expression
DG1100	acrA-	acrA	decreased gene expression | increased stalk length | decreased prespore gene expression | decreased sporulation
DBS0349939	acrA-	acrA	aberrant spore coat morphology | decreased stalk width
DBS0350723	acrA-/ [act15]: acaA(L394S)	acaA | acrA	precocious spore germination
DBS0237786	acrA-/ [act15]: acgA(1-401)	acgA | acrA	decreased prespore gene expression | decreased prespore cell differentiation | decreased sporulation
DBS0349970	acrA-/ [act15]: acrA(D1010A)	acrA	decreased adenylate cyclase activity
DBS0349971	acrA-/ [act15]: acrA(D1174A)	acrA	increased adenylate cyclase activity
DBS0349969	acrA-/ [act15]: acrA(N796D/ D854A/ G856A)	acrA	wild type
DBS0350724	acrA-/ [pkaC]: pkaC	acrA | pkaC	decreased spore germination | decreased fruiting body size | precocious development | decreased sporulation
DBS0351249	act5-/ [act5]: RFP/ NC4	act5	increased chemotaxis to folate | increased fruiting body size | increased growth rate
DBS0350443	adcB-	adcB	wild type
DBS0350444	adcC-	adcC	wild type
DBS0351190	adcC-/ [act15]: adcC(1-485)	adcC	decreased protein localization to plasma membrane
DBS0351189	adcC-/ [act15]: adcC(101-654): GFP	adcC	abolished protein localization to plasma membrane
DBS0350445	adcC-/ adcB-	adcB | adcC	increased oscillatory cAMP signaling | aberrant endocytosis | delayed aggregation | aberrant regulation of protein kinase activity
DBS0350538	adprt1A-	adprt1A	decreased resistance to phleomycin | decreased double-strand break repair via nonhomologous end joining
DBS0351248	adprt1A-	adprt1A	decreased gene expression | increased gene expression | decreased ATP level | delayed mitotic cell cycle | decreased growth rate | delayed aggregation | increased prestalk gene expression | decreased mound size | aberrant response to oxidative stress | decreased fruiting body size | increased mitochondrial fission | decreased cAMP level | abolished chemotaxis to cAMP
DBS0350541	adprt1A-/ adprt2-	adprt1A | adprt2	decreased resistance to phleomycin | decreased double-strand break repair via nonhomologous end joining | decreased resistance to cisplatin
DBS0264268	adprt1B-	adprt1B	wild type | decreased single-strand break repair | aberrant oscillatory cAMP signaling
DBS0350539	adprt2-	adprt2	decreased single-strand break repair | decreased double-strand break repair | decreased resistance to cisplatin
DBS0238203	adrm1-	adrm1-1	decreased catalytic activity | precocious gene expression | aberrant response to nutrient | precocious development
DBS0351596	agnA-	agnA	increased pre-miRNA processing | aberrant production of siRNA involved in RNA interference | increased gene expression | abolished transitive RNA interference
DBS0351603	agnA-/ agnB-	agnA | agnB	aberrant production of siRNA involved in RNA interference | increased gene expression
DBS0351602	agnB-	agnB	decreased gene expression
HW420	agtA-	agtA	development arrests at slug stage
HW520	agtA-/ gnt1(1-253/ H104D)	agtA | gnt1	development arrests at slug stage
DBS0235457	ahhA-	ahhA	aberrant late culminant morphology
DBS0252637	aip1-	aip1	decreased pinocytosis | delayed cytokinesis | decreased growth rate | decreased phagocytosis | increased actin filament polymerization | aberrant nucleus morphology | decreased cell motility
DBS0266759	alp-	alp	wild type
DBS0235513	alrA-	alrA	increased mound size | decreased cell motility | decreased glucose level | decreased protein secretion
DBS0235473	alrA-/ [act15]: alrA	alrA	wild type
DBS0235474	alxA-	alxA	development arrests at loose mound stage | aberrant standing slug morphology | decreased growth rate
DBS0235475	alxA-	alxA	abolished sporulation | aberrant standing slug morphology | aberrant cellular process | decreased gene expression | development arrests at mound stage
DBS0235488	alxA-/ [act15]: FLAG: alxA	alxA	delayed development
DBS0235476	alxA-/ [act15]: alxA(1-596): myc2	alxA	aberrant standing slug morphology
DBS0235477	alxA-/ [act15]: alxA(1-697): myc2	alxA	wild type
DBS0235478	alxA-/ [act15]: alxA(155-697): myc2	alxA	aberrant standing slug morphology
DBS0235479	alxA-/ [act15]: alxA(293-697): myc2	alxA	aberrant standing slug morphology
DBS0235480	alxA-/ [act15]: alxA(460-794): myc2	alxA	aberrant standing slug morphology
DBS0235481	alxA-/ [act15]: alxA(D310A/ N311A)	alxA	wild type
DBS0235482	alxA-/ [act15]: alxA(Q181E/ Q183)	alxA	wild type
DBS0235483	alxA-/ [act15]: alxA(S700A/ S704A/ S708A)	alxA	wild type
DBS0235484	alxA-/ [act15]: alxA(S700D/ S704D/ S708D)	alxA	wild type
DBS0235485	alxA-/ [act15]: alxA(Y315D)	alxA	wild type
DBS0235486	alxA-/ [act15]: alxA(Y315F)	alxA	wild type
DBS0235487	alxA-/ [act15]: alxA: myc2	alxA	wild type
DBS0235489	alyA-	alyA	increased phagocytosis
AK1350	alyL-	alyL	decreased response to Gram-negative bacterium
DG1114	amdA-	amdA	decreased spore germination | aberrant sorus color | increased prestalk A cell differentiation
HM1158	amdA-	amdA	decreased fruiting body size | decreased sporulation | increased cell differentiation
DBS0235490	amiB-	amiB	abolished aggregation
DBS0235491	amiB-	amiB	aberrant cell motility | increased gene expression | decreased gene expression | decreased oscillatory cAMP signaling | decreased cGMP-mediated signaling | abolished aggregation | decreased chemotaxis to cAMP
DBS0235493	ampA-	ampA	delayed development of tipped mound | delayed prestalk gene expression | precocious prespore gene expression | increased cell-cell adhesion | increased cell-substrate adhesion | aberrant gene expression | delayed development | decreased prestalk cell differentiation
DBS0349962	ampA-	ampA	wild type | decreased actin filament polymerization | aberrant chemotaxis to folate | increased cell-substrate adhesion | decreased pseudopodium formation
DBS0349951	ampA-/ lmbd2B-	ampA | lmbd2B	aberrant chemotaxis
DBS0235496	ampA-/ pspD: lacZ	ampA	aberrant prespore gene expression
DBS0349963	ampA-/ sma-	ampA | sma	increased chemotaxis to folate | increased cell-substrate adhesion
DBS0349953	ampA/ [ampA]: TAP	ampA	increased protein secretion | development arrests at mound stage
DBS0235495	ampA/ [ampA]: ampA	ampA	decreased cell-substrate adhesion | increased pinocytosis | increased actin filament polymerization | aberrant chemotaxis to folate | increased pseudopodium formation
DBS0349952	ampA/ [ampA]: ampA/ lmbd2B-	ampA | lmbd2B	aberrant chemotaxis
BS155	amtA-	amtA	decreased slug migration | decreased mound size | decreased fruiting body size | increased growth rate | decreased ammonia level
DBS0267100	amtA-	amtA	increased number of mounds | increased glucose level | decreased mound size | decreased ammonia level | decreased stalk length | aberrant sporulation | increased intracellular ammonia level
DBS0267101	amtA-/ [OE]: amtA	amtA	wild type
BS165	amtA-/ amtC-	amtA | amtC	decreased protein localization to nucleus | aberrant slug migration | decreased ammonia level | delayed gene expression
	amtB-	amtB
BS169	amtB-/ amtA-	amtA | amtB	decreased ammonia level
BS168	amtB-/ amtC-	amtB | amtC	decreased ammonia level
BS154	amtC-	amtC	abolished protein localization to nucleus | development arrests at slug stage | aberrant gene expression | decreased prestalk gene expression | aberrant fruiting body morphogenesis | decreased ammonia level | delayed culmination
DBS0235501	amtC-/ [act15]: cudA	amtC | cudA	delayed culmination
DBS0235502	amtC-/ [ecmA]: cudA	amtC | cudA	delayed culmination
DBS0235503	amtC-/ [pspA]: cudA	amtC | cudA	development arrests at slug stage
BS163	amtC-/ dhkC-	amtC | dhkC	aberrant gene expression
DBS0236890	amtC-/ regA-	amtC | regA	precocious sporulation
DBS0350432	aoxA-	aoxA	decreased resistance to hydrogen peroxide | aberrant cellular process | aberrant sorocarp development
DBS0349869	ap1b1-	ap1b1	aberrant aggregation | aberrant cell separation during cytokinesis | aberrant contractile vacuole organization | decreased growth rate | aberrant hypotonic response | decreased protein stabilization
DBS0305197	ap2a1-	ap2a1-1 | ap2a1-2	aberrant cell separation during cytokinesis
DBS0350296	aph1-	aph1	aberrant culmination | abolished catalytic activity | decreased prespore cell differentiation
DBS0351357	aph1-	aph1	increased protein modification | decreased phagocytosis | decreased macropinocytosis | aberrant sorocarp development | decreased protein processing in phagocytic vesicle | delayed phagosome acidification
DBS0350299	aph1-/ ncstn-	aph1 | ncstn	decreased phagocytosis | decreased prespore cell differentiation
DBS0350300	aph1-/ psenA-	aph1 | psenA	aberrant culmination | abolished catalytic activity | decreased prespore cell differentiation
DBS0350805	apl-	apl	aberrant response to cisplatin
DBS0351160	aplD-	aplD	decreased defense response to Gram-negative bacterium | decreased growth rate
DBS0351161	aplP-	aplD	decreased growth rate
DBS0235505	apm1-	apm1	decreased spore germination | aberrant contractile vacuole organization | decreased growth rate | aberrant endosome morphology | aberrant hypotonic response | delayed development | decreased stalk width
DBS0235506	apm2-	apm2	aberrant cell separation during cytokinesis
DBS0305085	apm2-/ [dscB]: GFP: vamp7A	apm2 | vamp7A	increased protein localization to plasma membrane
DBS0235507	apm3-	apm3	decreased pinocytosis | increased exocytosis | aberrant endosome morphology | decreased cellular localization | aberrant secretion | aberrant lysosome organization
DBS0305083	apm3-/ [dscB]: GFP: vamp7A	apm3 | vamp7A	increased protein localization to plasma membrane
DBS0235508	apm4-	apm4	wild type
DBS0235509	aprA-	aprA	aberrant cellular homeostasis | increased mound size | decreased spore germination | increased cell death | aberrant cytokinesis | aberrant vegetative growth | aberrant fruiting body morphogenesis | increased growth rate | abolished chemorepellant activity | decreased sporulation
DBS0235510	aprA-/ [act15]: aprA	aprA	decreased growth rate | aberrant fruiting body morphogenesis
DBS0350009	aprA-/ [act15]: bzpN: GFP	aprA | bzpN	abolished negative regulation of vegetative growth
DBS0238124	aqpA-	aqpA	decreased spore germination | decreased sporulation
DBS0351484	aqpB-	aqpB	decreased cell motility
DBS0351067	araA-	araA	delayed aggregation | increased cell-substrate adhesion | decreased cell motility | increased protein kinase activation
HM2245	arcB(I191L/ D197Y/ K206V/ A213V/ F223L/ P224S/ E232G/ I237T/ H245L/ S250S)	arcB	decreased actin filament polymerization | decreased growth rate | decreased cell motility | decreased chemotaxis rate | decreased pseudopodium formation
DBS0350886	areA-	areA	increased autophagy
DBS0350887	areB-	areB	increased autophagy
DBS0235511	arkA-	arkA	increased gene expression | aberrant fruiting body morphogenesis
DBS0235512	arkA-/ [arkA]: arkA: myc2	arkA	aberrant aggregation
DBS0350000	arpB+/ aprB-/ [act15]: myc: arpB(T235A/ T236A)	arpB	wild type
DBS0349998	arpB+/ aprB-/ [act15]: myc: arpB(Y200F/ T235A/ T236A)	arpB	decreased actin filament polymerization | delayed aggregation | decreased fruiting body size | decreased establishment of cell polarity | decreased chemotaxis to cAMP | delayed gene expression
DJK45	arpB+/ arpB-	arpB	wild type
DMZ10	arpB+/ arpB-/ [act15]: myc: arpB	arpB	wild type
MZ10	arpB-/ [act15]: myc: arpB	arpB	wild type
DBS0350191	arpin-	arpin	increased cell motility
DBS0350206	arpin-/ [act15]: GFP: arpin	arpin	wild type
DBS0350654	ase1A-	ase1A	aberrant mitotic spindle organization | aberrant cytokinesis | aberrant microtubule cytoskeleton organization
DBS0350655	ase1B-	ase1B	aberrant cell morphology
DBS0235514	aslA-	aslA-1 | aslA-2	wild type
DBS0351219	ate1-	ate1	aberrant cell motility | decreased cell-substrate adhesion | decreased vegetative cell size | aberrant actin filament organization
DBS0236305	atg1-	atg1	aberrant macroautophagy | abolished autophagosome organization
DBS0236304	atg1-	atg1	aberrant macroautophagy | aberrant mitochondrion morphology | abolished autophagosome organization
DBS0350450	atg1-	atg1	aberrant autophagy | decreased defense response to Gram-negative bacterium | aberrant defense response to bacterium | aberrant vacuole organization
DBS0350839	atg1-	atg1	decreased catalytic activity | abolished protein localization to autophagosome
HR131	atg1-	atg1	abolished macroautophagy | increased number of autophagosomes | aberrant autophagy | decreased defense response to Gram-negative bacterium | aberrant cellular response to nitrogen starvation | decreased growth rate | abolished spore cell differentiation | aberrant vacuole organization | abolished stalk cell differentiation | abolished aggregation | increased defense response to fungus | decreased defense response to Gram-positive bacterium | aberrant protein localization
DBS0238085	atg1-/ [act15]: atg1	atg1	wild type
DBS0238092	atg1-/ [act15]: atg1(1-628)	atg1	aberrant cellular response to nitrogen starvation | abolished aggregation
DBS0238087	atg1-/ [act15]: atg1(K36A)	atg1	aberrant cellular response to nitrogen starvation | abolished aggregation
DBS0238089	atg1-/ [act15]: atg1(K36A/ 1-628)	atg1	aberrant cellular response to nitrogen starvation | abolished aggregation
DBS0238093	atg1-/ [act15]: atg1(P138S)	atg1	abolished aggregation
DBS0266655	atg1-/ iplA-	atg1 | iplA	decreased necrotic cell death
DBS0252632	atg1-/ pcp-	atg1 | pcp	abolished autophagosome organization
DBS0351613	atg1-/ tsg101-	atg1 | tsg101	decreased defense response to Gram-positive bacterium
DBS0350838	atg1-/ vmp1-	atg1 | vmp1	wild type | abolished protein localization to autophagosome
DBS0350884	atg101-	atg101	increased number of tip-organizers | decreased autophagy
DBS0351232	atg12-	atg12	decreased pinocytosis | increased cell death | decreased spore germination | decreased catalytic activity | increased gene expression | increased number of mound tips | increased protein modification | decreased phagocytosis | aberrant phagosome maturation | aberrant fruiting body morphogenesis
DBS0351233	atg12-/ tipD-	atg12 | tipD	decreased pinocytosis | increased cell death | decreased spore germination | increased gene expression | increased number of mound tips | increased protein modification | decreased phagocytosis | aberrant phagosome maturation | aberrant fruiting body morphogenesis
DBS0350883	atg13-	atg13	aberrant autophagy | abolished aggregation
DBS0350885	atg17-	atg17	wild type
HR75	atg5-	atg5	increased number of tip-organizers | aberrant macroautophagy | abolished sporulation | aberrant cellular response to nitrogen starvation | abolished aggregation | aberrant protein localization
DBS0351478	atg5-	atg5	abolished sporulation | decreased gene expression | delayed development
DBS0351582	atg5-	atg5	increased cell death | decreased catalytic activity | decreased growth rate | aberrant phagocytosis | increased protein modification | decreased macropinocytosis | aberrant fruiting body morphogenesis | increased growth rate
DBS0351576	atg5-/ abpB-/ [dscB]: abpB(D93A/ D95A/ D97A): GFP	abpB | atg5	aberrant cellular component organization | abolished vegetative growth
DBS0351583	atg5-/ atg12-	atg12 | atg5	increased cell death | decreased catalytic activity | decreased growth rate | decreased phagocytosis | increased protein modification | decreased macropinocytosis | aberrant fruiting body morphogenesis
DBS0351584	atg5-/ atg12-/ tipD-	atg12 | atg5 | tipD	increased cell death | decreased catalytic activity | decreased growth rate | aberrant phagocytosis | increased protein modification | decreased macropinocytosis | aberrant fruiting body morphogenesis | increased growth rate
HR174	atg6-	atg6A	increased number of tip-organizers | aberrant macroautophagy | decreased defense response to Gram-negative bacterium | aberrant cellular response to nitrogen starvation | decreased spore cell differentiation | decreased defense response to fungus | decreased fruiting body size | decreased stalk length | decreased sporulation
HR79	atg7-	atg7	increased number of tip-organizers | aberrant macroautophagy | abolished sporulation | decreased defense response to Gram-negative bacterium | aberrant cellular response to nitrogen starvation | abolished spore cell differentiation | aberrant protein localization
DBS0351476	atg7-	atg7	aberrant sorus morphology | decreased spore germination | decreased gene expression | decreased prespore cell differentiation | delayed development
DBS0351477	atg7-/ [act15]: YFP: atg7(C563A)	atg7	aberrant sorus morphology | decreased spore germination | delayed development
DBS0351479	atg7-/ [act15]: pkaC: YFP	atg7 | pkaC	decreased gene expression | decreased sporulation
HR141	atg8-	atg8a	increased number of tip-organizers | aberrant macroautophagy | aberrant spore morphology | aberrant cellular response to nitrogen starvation | decreased spore cell differentiation | aberrant vacuole organization | decreased fruiting body size | decreased defense response to Gram-positive bacterium | decreased sporulation
DBS0351222	atg8a-	atg8a	increased cell death | decreased catalytic activity | increased number of mound tips | decreased growth rate | decreased phagocytosis | increased protein modification | delayed development | decreased fruiting body size | aberrant lysosome organization
DBS0351224	atg8a-/ atg8b-	atg8a | atg8b	increased cell death | decreased catalytic activity | decreased growth rate | decreased phagocytosis | increased protein modification | aberrant sorocarp development | aberrant lysosome organization
DBS0351223	atg8b-	atg8b	precocious development | aberrant lysosome organization
DBS0305977	atg9-	atg9	increased stalk width | decreased pinocytosis | abolished sporulation | aberrant sorus morphology | aberrant autophagy | decreased protein localization to autophagosome | increased number of mound tips | decreased gene expression | decreased phagocytosis | decreased growth rate | abolished catalytic activity | aberrant slug development | aberrant slug migration | aberrant protein modification | aberrant phagosome maturation | decreased prespore cell differentiation | aberrant fruiting body morphogenesis | delayed development | abolished phototaxis
DBS0305978	atg9-/ [act15]: GFP: atg9	atg9	wild type
DBS0305979	atg9-/ [act15]: atg9: GFP	atg9	wild type
DBS0350535	atg9-/ [act15]: cdcD(R154C): RFP	atg9 | cdcD	decreased growth rate | decreased phototaxis
DBS0351589	atg9-/ [act15]: cdcD(R154C/ E219K): RFP	atg9 | cdcD	wild type
DBS0350534	atg9-/ [act15]: cdcD: RFP	atg9 | cdcD	decreased growth rate | aberrant fruiting body morphogenesis | abolished phototaxis
DBS0351480	atg9-/ [act15]: pkaC: YFP	atg9 | pkaC	abolished sporulation
DBS0350731	atg9-/ tipD-	atg9 | tipD	decreased pinocytosis | aberrant phagosome maturation | development arrests at tipped mound stage
DBS0351043	atp1-	atp1	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant phototaxis
DBS0351044	atp6-	atp6	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant phototaxis
HM1591	axeB-	axeB	aberrant macropinocytosis | increased macropinocytosis | increased phagocytosis
DBS0351503	bcas3-	bcas3	decreased number of autophagosomes | aberrant fruiting body morphogenesis | aberrant phototaxis | decreased sporulation
DBS0351039	bzpF-	bzpF	decreased spore germination | decreased gene expression | aberrant fruiting body morphogenesis | aberrant sporulation | decreased sporulation
DBS0349965	bzpN-	bzpN	aberrant cytokinesis | abolished negative regulation of vegetative growth | increased growth rate
DBS0349966	bzpN-/ [act15]: bzpN: GFP	bzpN	wild type
DBS0350419	bzpR-	bzpR	increased stalk width | aberrant sorus morphology | decreased sporulation
DBS0351486	c2gapB-	c2gapB	increased cell motility | increased activation of GTPase activity
DBS0351619	cadA-	cadA	aberrant vegetative growth
TL97	cadA-	cadA	increased number of tip-organizers | decreased calcium-dependent cell-cell adhesion | decreased protein level | increased gene expression | abolished cell migration to prestalk region | increased chemotaxis to cAMP | aberrant cytokinesis | decreased sporulation | delayed culmination | increased prestalk cell differentiation
DBS0351372	cadA-	cadA	aberrant defense response to bacterium | decreased growth rate | aberrant response to oxidative stress
DBS0235561	cap-	cap	decreased protein level | aberrant pinocytosis | aberrant contractile vacuole organization | aberrant cytokinesis | decreased cell motility | delayed development | aberrant response to osmotic stress
JB4	carA-	carA-1 | carA-2	abolished aggregation
JS14	carA-	carA-1 | carA-2	abolished protein tyrosine phosphorylation | abolished protein localization to nucleus | aberrant phagocytosis | increased cell-substrate adhesion | decreased oscillatory cAMP signaling | decreased cGMP-mediated signaling | aberrant regulation of GTPase activity | abolished aggregation | aberrant regulation of protein kinase activity | abolished chemotaxis to cAMP
DBS0351266	carA-/ [act15]: gpbA: YFP	carA-1 | carA-2 | gpbA	abolished aggregation
DBS0350431	carA-/ [unk]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A): eYFP	carA-1 | carA-2	aberrant adaptation of signaling pathway | aberrant protein localization to plasma membrane
RI9	carA-/ carC-	carA-1 | carA-2 | carC	decreased gene expression | abolished protein localization to plasma membrane
RI4	carA-/ carC-	carA-1 | carA-2 | carC	decreased actin filament polymerization | abolished activation of GTPase activity | abolished aggregation | abolished cGMP-mediated signaling | abolished chemotaxis to cAMP
DBS0350568	carA-/ carC-/ [act15]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A)	carA-1 | carA-2 | carC	abolished stream development | aberrant activation of adenylate cyclase activity | aberrant chemotaxis to cAMP | aberrant oscillatory cAMP signaling | aberrant actin filament polymerization
DBS0235570	carB-	carB	development arrests at mound stage
DBS0350661	carB-	carB	development arrests at mound stage | abolished development of tipped mound | increased prespore gene expression | decreased prestalk gene expression
JB6	carC-	carC	wild type
DBS0235568	carD-	carD	decreased migratory slug size | decreased slug migration | increased prespore gene expression | decreased prestalk gene expression | aberrant slug migration | aberrant fruiting body morphogenesis | decreased stalk length | decreased prestalk cell differentiation
DBS0235573	carmil-	carmil	decreased pinocytosis | decreased actin filament polymerization | decreased growth rate | decreased mound size
DBS0266775	catA-	catA	abolished catalase activity
X9	catA-	catA	decreased resistance to hydrogen peroxide | abolished catalase activity
IR40	catA-	catA	abolished catalase activity
IR41	catA-	catA	abolished catalase activity
IR29	catA-	catA	decreased resistance to hydrogen peroxide
DBS0235574	catB-	catB	decreased spore resistance to hydrogen peroxide | aberrant gene expression | delayed development | delayed gene expression
DBS0350249	cbhA-	cbhA	delayed development
DBS0350250	cbhA-/ [cbhA]: cbhA	cbhA	wild type
DBS0304455	cblA-	cblA-1 | cblA-2	aberrant slug development | abolished basal disc formation | aberrant signal transduction
DBS0351096	cbpG-	cbpG	decreased cell-substrate adhesion | decreased vegetative cell size
DBS0235575	cbpJ-	cbpJ	wild type
DBS0350238	ccdc53-	ccdc53	abolished exocytosis | decreased growth rate | abolished phagosome reneutralization | abolished actin filament polymerization
DBS0235661	cdk8-	cdk8	decreased gene expression | aberrant gene expression | abolished aggregation
DBS0350435	cdk8-	cdk8	decreased spore germination | decreased gene expression | aberrant gene expression | abolished aggregation
DBS0350436	cdk8-/ [act15]: myc: cdk8	cdk8	wild type
DBS0350437	cdk8-/ [act15]: myc: cdk8(D194A)	cdk8	decreased spore germination | abolished aggregation
DBS0235578	cdk8-/ [cdk8]: cdk8	cdk8	wild type
DBS0306226	cenB-	cenB	increased number of centrosomes | aberrant cell separation during cytokinesis | aberrant nuclear envelope morphology | abolished protein localization to microtubule organizing center | aberrant nucleus morphology | aberrant cytokinesis | decreased microtubule nucleation | aberrant centrosome organization
DBS0306227	cenB-/ [act15]: RFP: cenB	cenB	wild type
DBS0349926	cepC-	cepC	aberrant mitotic spindle organization | decreased growth rate | aberrant Golgi localization | abolished vegetative growth | aberrant centrosome organization
DBS0350265	cepK-	cepK	decreased protein level | decreased protein localization to nuclear envelope | aberrant chemotaxis to cAMP | decreased growth rate | decreased mound size | decreased vegetative cell size | decreased fruiting body size
DBS0302444	cfaD-	cfaD	aberrant cellular homeostasis | increased cell death | decreased spore germination | aberrant vegetative growth | aberrant cytokinesis | aberrant fruiting body morphogenesis | increased growth rate | decreased sporulation
DBS0350010	cfaD-/ [act15]: bzpN: GFP	bzpN | cfaD	abolished negative regulation of vegetative growth
DBS0302446	cfaD-/ [act15]: cfaD	cfaD	wild type
HO101	chcA-	chcA	decreased pinocytosis | delayed cell separation during cytokinesis | aberrant cytokinesis | decreased growth rate
HO103	chcA-	chcA	abolished sporulation | abolished cytokinesis | abolished gene expression | delayed aggregation | abolished vegetative growth | aberrant fruiting body morphogenesis
DBS0350090	chcA-/ [act15]: GFP: ap2a1	ap2a1-1 | ap2a1-2 | chcA	increased protein localization
DBS0235588	chcA-/ [act15]: GFP: mhcA	chcA | mhcA	decreased positive regulation of GTPase activity
DBS0302455	chcA-/ [act15]: epnA: GFP	chcA | epnA	aberrant protein localization to clathrin-coated pit
DBS0350091	chcA-/ [act15]: gppA: GFP	chcA | gppA	aberrant protein localization to plasma membrane
DBS0235589	chcA-/ [cotB]: lacZ	chcA	aberrant prestalk gene expression | aberrant prespore gene expression
DBS0235590	chcA-/ [ecmA]: lacZ	chcA	aberrant prestalk gene expression | aberrant prespore gene expression
DBS0235591	chcA-/ [ecmB]: lacZ	chcA	aberrant prestalk gene expression | aberrant prespore gene expression
DBS0235592	chcA-/ [pspA]: lacZ	chcA	aberrant prestalk gene expression | aberrant prespore gene expression
DBS0350524	chdA-	chdA	aberrant culmination | aberrant gene expression | decreased chemotaxis to cAMP
DBS0350525	chdB-	chdB	aberrant gene expression | delayed development
DBS0350526	chdC-	chdC	decreased growth rate | development arrests at mound stage | aberrant gene expression | aberrant chromatin assembly | decreased chemotaxis to cAMP
DBS0350528	chdC-/ [ecmA]: lacZ	chdC	decreased prestalk cell differentiation
DBS0350527	chdC-/ [pspA]: lacZ	chdC	decreased prespore cell differentiation
HM1522	chlA-	chlA	abolished DIF-1 biosynthesis | aberrant slug development | aberrant fruiting body morphogenesis
LAS1	chtB-	chtB	decreased socially cooperative development | increased growth rate
CCR2	chtC-	chtC	decreased socially cooperative development | decreased prestalk A cell differentiation
LAS5	chtC-REMI	chtC	decreased socially cooperative development
DBS0305614	chtC-ins	chtC	decreased socially cooperative development | decreased prestalk A cell differentiation
DBS0235601	clc-	clc	abolished cytokinesis | decreased protein localization to plasma membrane | aberrant hypotonic response | abolished vegetative growth | aberrant fruiting body morphogenesis
DBS0235604	clc-/ [act15]: GFP-clc(146-194)	clc	abolished cytokinesis | wild type | aberrant fruiting body morphogenesis
DBS0235605	clc-/ [act15]: GFP-clc(85-124)	clc	abolished cytokinesis | wild type | aberrant fruiting body morphogenesis
DBS0235607	clc-/ [act15]GFP: clc(1-124)	clc	abolished cytokinesis | wild type | aberrant fruiting body morphogenesis
DBS0350408	cldA-	cldA	decreased gene expression
AK1338	clkB-	clkB	decreased response to Gram-negative bacterium
DBS0235608	clmA-	clmA	aberrant contractile vacuole morphology | aberrant hypotonic response
DBS0350473	cln3-	cln3	aberrant aggregation | increased protein secretion | aberrant cell separation during cytokinesis | decreased hypotonic response | aberrant cellular process | increased pinocytosis | delayed aggregation | aberrant cell adhesion | aberrant slug migration | aberrant hyperosmotic response | precocious development | increased growth rate | decreased chemotaxis to cAMP | decreased protein secretion
DBS0350474	cln3-/ [act15]: GFP: cln3	cln3	wild type
DBS0351175	cln5-	cln5	decreased cell-cell adhesion | aberrant lipid storage | decreased cell-substrate adhesion | decreased chemotaxis to cAMP
DBS0235609	cluA-	cluA	decreased mitochondrial fusion | decreased mitochondrial fission | aberrant cytokinesis | aberrant intracellular distribution of mitochondria | aberrant mitochondrion organization
DBS0349875	cluA-/ [act15]: cluA	cluA	wild type
DBS0235612	cmfB-	cmfB	decreased gene expression | abolished aggregation
DBS0235613	cnrB-	cnrB	wild type
DBS0350308	cnrF-	cnrF	aberrant contractile vacuole organization | abolished hypotonic response | decreased contractile vacuole size | aberrant regulation of GTPase activity
DBS0350309	cnrF-/ [act15]: cnrF: RFP	cnrF	wild type
DBS0350311	cnrF-/ cnrF(E623Q/ D659Q)	cnrF	aberrant contractile vacuole organization | abolished hypotonic response | decreased contractile vacuole size | aberrant regulation of GTPase activity
DBS0350310	cnrF-/ cnrF(R270A)	cnrF	aberrant contractile vacuole organization | abolished hypotonic response | decreased contractile vacuole size | aberrant regulation of GTPase activity
DBS0302655	cnrN-	cnrN	increased oscillatory cAMP signaling | increased number of mounds | decreased spore germination | increased actin filament polymerization | aberrant cytokinesis | aberrant stream morphology | increased growth rate | abolished positive regulation of chemorepellant activity | decreased sporulation
DBS0302656	cnrN-/ [act15]: cnrN	cnrN	wild type
HG1770	cnxA-	cnxA	decreased calcium ion import | aberrant calcium-mediated signaling
DBS0235615	cofB-	cofB	wild type
DBS0235616	cofC-	cofC-1	wild type
DBS0350522	comA-	comA	aberrant defense response to bacterium | aberrant phagocytosis | aberrant hyperosmotic response
DG1016	comB-	comB	abolished culmination
DBS0235618	comC-	comC	aberrant aggregation | aberrant stream morphology
DBS0235619	comD-	comD	abolished culmination
DBS0235620	comE-	comE	aberrant fruiting body morphogenesis | aberrant sorus color
DBS0235621	comF-	comF-1 | comF-2	abolished aggregation
DBS0235622	comG-	comG	increased number of tip-organizers | development arrests at mound stage
DBS0235623	comH-	comH	development arrests at mound stage
HG1570	corA-	corA	increased myosin II assembly | aberrant cytokinesis | decreased growth rate | decreased cell motility | aberrant cell morphology
HG1571	corA-	corA	increased myosin II assembly | aberrant cytokinesis | decreased growth rate | decreased cell motility | aberrant cell morphology
DBS0351402	corA-	corA	aberrant actin cytoskeleton organization | aberrant cytokinesis
HG1569	corA-	corA	decreased defense response to Gram-negative bacterium | increased myosin II assembly | aberrant cytokinesis | decreased growth rate | decreased phagocytosis | increased actin filament polymerization | decreased cell motility | aberrant cell morphology | decreased defense response to Gram-positive bacterium
DBS0350370	corA-	corA	decreased defense response to Gram-negative bacterium | decreased gene expression | aberrant chemotaxis to cAMP | aberrant response to cAMP | decreased phagocytosis | aberrant cellular response to extracellular stimulus | decreased establishment of cell polarity | abolished aggregation
DBS0351521	corA-/ [act15]: FLAG: corA(1-432)	corA	abolished aggregation
DBS0350345	corA-/ [act15]: GFP: mhkA	corA | mhkA	wild type
DBS0350346	corA-/ [act15]: GFP: mhkB	corA | mhkB	wild type
DBS0350344	corA-/ [act15]: GFP: mhkC	corA | mhkC	decreased catalytic activity | wild type
DBS0350343	corA-/ [act15]: GFP: pakA(797-1197)	corA | pakA	wild type
DBS0350371	corA-/ [act15]: corA	corA	wild type
DBS0350341	corA-/ [act15]: corA(I118A/ S119A/ P121A): GFP	corA	wild type | aberrant binding | increased myosin II assembly
DBS0350851	corA-/ aip1-	aip1 | corA	aberrant endocytosis | aberrant cytokinesis | increased actin filament polymerization | development arrests at mound stage | decreased growth rate | aberrant nucleus morphology | increased vegetative cell size | increased protein level | decreased chemotaxis to cAMP
DBS0351412	corA-/ mhcA-	corA | mhcA	aberrant cytokinesis
DBS0351413	corA-/ piaA-	corA | piaA	aberrant cytokinesis
DBS0305825	corB-	corB	increased lateral pseudopodium formation | aberrant phagocytosis | decreased growth rate | increased cell-substrate adhesion
DBS0349942	cosA-	cosA	decreased cell motility | decreased fruiting body size | decreased chemotaxis to cAMP | aberrant actin filament organization | increased pseudopodium formation
TL55	cotA-	cotA	decreased spore germination | aberrant spore coat morphology | abolished cellulose binding
TL53	cotA-/ cotB-	cotA | cotB	aberrant spore coat morphology
TL56	cotA-/ cotB-/ cotC-	cotA | cotB | cotC	decreased spore germination | aberrant spore coat morphology | abolished cellulose binding
TL57	cotA-/ cotB-/ cotC-	cotA | cotB | cotC	aberrant spore coat morphology
TL26	cotB-	cotB	decreased spore germination | aberrant spore coat morphology | abolished cellulose binding
TL54	cotB-/ cotC-	cotB | cotC	aberrant spore coat morphology
TL52	cotC-	cotC	aberrant spore coat morphology
HW07	cotE(1-235)	cotE	aberrant spore coat morphology
DBS0351045	cox3-	cox3	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant fruiting body morphogenesis | aberrant phototaxis
DBS0351538	cpnA-/ AX4	cpnA	increased contractile vacuole size
DBS0238297	cpnA-/ NC4A2	cpnA	delayed hypotonic response | increased migratory slug size | decreased post-lysosomal vacuole size | increased mound size | aberrant thermotaxis | increased contractile vacuole size | increased exocytosis | decreased growth rate | aberrant cytokinesis | aberrant stalk cell differentiation | development arrests at slug stage | decreased number of post-lysosomal vacuoles | aberrant fruiting body morphogenesis | delayed development | abolished phototaxis
DBS0238320	cpnA-/ [act15]: GFP: cpnA	cpnA	delayed hypotonic response | decreased culmination | delayed development
DBS0350869	crlA-/ AX2	crlA	wild type
DBS0235627	crlA-/ KAX3	crlA	delayed development of tipped mound | abolished polyketide metabolic process | increased mound size | decreased spore germination | decreased spore cell differentiation | decreased cell migration to prestalk region | increased growth rate
DBS0235628	crlA-/ [crlA]: crlA	crlA	increased mound size
DBS0235629	crlB-	crlB	wild type
DBS0235630	crlC-	crlC	wild type
HG1768	crtA-	crtA	decreased calcium ion import | aberrant calcium-mediated signaling
HG1772	crtA-/ cnxA-	cnxA | crtA	decreased calcium ion import | decreased growth rate | delayed response to cAMP | decreased phagocytosis | aberrant calcium-mediated signaling
DBS0235633	crtf-	crtf	abolished sporulation | decreased gene expression | abolished aggregation
DBS0351557	cryS-	cryS	decreased pinocytosis | decreased culmination | decreased phagocytosis | aberrant cytokinesis | decreased growth rate
AX2-T10	csaA-	csaA	decreased cell-cell adhesion | decreased culmination | abolished protein localization to cell-cell contact zone | delayed aggregation | increased cell-substrate adhesion | decreased sporulation
TL73	csaA-/ csbA-/ csbC-/ csbC-	csaA | csbA | csbB | csbC	increased stalk width | aberrant late culminant morphology
TL122	csaA-/ tgrC1-	csaA | tgrC1	abolished calcium-independent cell-cell adhesion
TL72	csbA-/ csbB-/ csbC-	csbA | csbB | csbC	increased resistance to cisplatin | aberrant cytokinesis | aberrant late culminant morphology
WTC127	cshA-	cshA	development arrests at loose mound stage | decreased phagocytosis | decreased growth rate | delayed aggregation
DBS0235634	csn5-KD	csn5	decreased growth rate
DBS0235624	ctnA-	ctnA	increased cGMP-mediated signaling | aberrant cellular metabolic process | increased glucose level | decreased protein level | increased mound size | decreased catalytic activity | increased guanylyl cyclase activity | decreased actin filament polymerization | decreased oscillatory cAMP signaling | increased cell-cell adhesion | increased protein level | increased cell motility | decreased myosin II assembly
DBS0235636	ctnB-	ctnB	increased number of mounds | decreased gene expression | decreased fruiting body size
DBS0304927	ctnnA-	ctnnA	wild type
DBS0304928	ctnnA-/ mhcA-	ctnnA | mhcA	aberrant cytokinesis
DG1071	ctr9-	ctr9	aberrant fruiting body morphogenesis
DG1058	ctrA-	ctrA	decreased fruiting body size
DBS0350915	ctsD-	ctsD	aberrant protein modification
DBS0235598	ctxA-	ctxA	aberrant cytokinesis | decreased cell motility | aberrant cell morphology
HS1151	ctxA-	ctxA	aberrant cytokinesis | decreased growth rate | aberrant stream morphology | aberrant cellular response to stress
DBS0237568	ctxA-/ [RNAi]enlA	ctxA | enlA	wild type
DBS0349922	ctxA-/ [act15]: GFP-mhcA	ctxA	aberrant protein localization to basolateral plasma membrane | aberrant stalk morphogenesis | aberrant development of tipped mound
DBS0237536	ctxA-/ [act15]: enlA(92-497)	ctxA | enlA	wild type
DBS0235599	ctxA-/ ctxB-	ctxA | ctxB	abolished stream development | aberrant cellular response to fluid shear stress | abolished adenylate cyclase activity | increased lateral pseudopodium formation | aberrant cytokinesis | development arrests at mound stage | aberrant chemotaxis to cAMP | decreased cell motility | aberrant regulation of GTPase activity | aberrant cell morphology | abolished aggregation | aberrant regulation of protein kinase activity | increased bleb assembly
DBS0350293	ctxA-/ ctxB-/ [act15]: GFP: arcA	arcA | ctxA | ctxB	aberrant protein localization to cell cortex
DBS0349972	ctxA-/ ctxB-/ [act15]: acaA: YFP	acaA | ctxA | ctxB	aberrant fruiting body morphogenesis
DBS0349973	ctxA-/ ctxB-/ [act15]: carA: YFP	carA-1 | carA-2 | ctxA | ctxB	abolished stream development | abolished adenylate cyclase activity | development arrests at tight mound stage
DBS0235600	ctxB-	ctxB	aberrant cytokinesis | aberrant stream morphology | aberrant cell morphology
DBS0350404	ctxC-	ctxC	increased pinocytosis | decreased oscillatory cAMP signaling | aberrant stream morphology | decreased chemotaxis to cAMP | increased growth rate | increased phagocytosis
DBS0235639	cudA-	cudA	abolished sporulation | decreased gene expression | development arrests at slug stage | decreased prespore gene expression | abolished stalk cell differentiation
DBS0238017	cudA-	cudA	abolished gene expression
DBS0235640	culA-	culA	increased number of tip-organizers | development arrests at tipped mound stage
DBS0235641	culA-/ [cotC]: culA	culA	increased sorus size | decreased stalk length | decreased sporulation
DBS0235642	culA-/ [ecmA]: culA	culA	increased sorus size | decreased stalk length
DBS0235643	culA-/ [pkaC]pkaC	culA | pkaC	wild type
DBS0266745	culB-	culB	increased number of mound tips | precocious prestalk gene expression | aberrant slug development | decreased fruiting body size | decreased sporulation
DBS0266761	culB-/ [act15]: pkaC	culB | pkaC	abolished sporulation | precocious prestalk gene expression | abolished aggregation | abolished prespore gene expression
DBS0266760	culB-/ pkaR-	culB | pkaR	abolished sporulation | precocious prestalk gene expression | abolished aggregation | abolished prespore gene expression
DBS0235651	cybA-	cybA	abolished sporulation | aberrant sorocarp development
DBS0350641	cynA-	cynA	aberrant cell motility | decreased actin filament polymerization | aberrant chemotaxis to cAMP | delayed aggregation | aberrant cell morphology
DBS0351047	cytB-	cytB	decreased defense response to Gram-negative bacterium | decreased gene expression | development arrests at mound stage | decreased growth rate | aberrant phototaxis
AK108	dagA-	dagA	abolished gene expression | decreased gene expression | abolished activation of adenylate cyclase activity | abolished aggregation | decreased chemotaxis to cAMP
BW4	dagA-	dagA	abolished positive regulation of chemorepellant activity
DBS0235652	dagA-/ [act15]: dagA	dagA	wild type
DBS0235560	dagA-/ acaA(L394S)	acaA | dagA	wild type
DBS0235653	darA-	darA	decreased mound size | abolished aggregation
DBS0350531	dclre1-	dclre1	decreased resistance to bleomycin | decreased double-strand break repair via nonhomologous end joining | aberrant double-strand break repair via homologous recombination
DBS0236307	dcsA-	dcsA	abolished cellulose biosynthesis
DG1099	dcsA-	dcsA	abolished stalk development | abolished sporulation | aberrant spore coat morphology | abolished cellulose biosynthesis | abolished stalk cell differentiation
DG1128	dcsA-	dcsA	abolished stalk development | abolished sporulation | aberrant spore coat morphology | abolished cellulose biosynthesis
TL127	dcsA-	dcsA	abolished stalk development | abolished sporulation | aberrant spore coat morphology | abolished cellulose biosynthesis | abolished stalk cell differentiation | aberrant stalk development
TL128	dcsA-/ [act15]: dcsA	dcsA	wild type
DBS0351195	dct-	dct	aberrant chemotaxis to cAMP | increased activation of GTPase activity
DBS0349967	dcx-/ lis1(D327H)	dcx | lis1	abolished aggregation
DBS0349804	detA-	detA	increased mound size | decreased growth rate | delayed development
DBS0349807	detA-/ [act6]: GFP: detA	detA	wild type
DBS0349816	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: culD	culD | detA	increased gene expression
DBS0349817	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: repE	detA | repE	increased gene expression
DBS0349813	detA-/ [cotB]: GFP	detA	decreased prespore cell differentiation
DBS0349811	detA-/ [ecm0]: lacZ	detA	aberrant prestalk O cell differentiation
DBS0349812	detA-/ [ecmA0]: GFP	detA	increased prestalk cell differentiation
DBS0349808	detA-/ [ecmA0]: lacZ	detA	increased prestalk cell differentiation
DBS0349809	detA-/ [ecmA]: lacZ	detA	increased prestalk A cell differentiation
DBS0349810	detA-/ [ecmB]: lacZ	detA	delayed development
DBS0350392	dgat1-	dgat1	aberrant cellular metabolic process | abolished lipid droplet formation | increased sporulation
DBS0350393	dgat1-/ dgat2-	dgat1 | dgat2	abolished lipid droplet formation | decreased growth rate | increased sporulation | aberrant endoplasmic reticulum membrane organization
DBS0350394	dgat1-/ dgat2-/ [act15]: GFP: dgat2	dgat1 | dgat2	wild type
DBS0349911	dgcA-	dgcA	decreased gene expression | development arrests at slug stage | abolished stalk cell differentiation
DBS0349917	dgcA-/ [act15]: dgcA(1-124): YFP	dgcA	development arrests at slug stage
DBS0349918	dgcA-/ [act15]: dgcA(1-273): YFP	dgcA	development arrests at slug stage
DBS0349914	dgcA-/ [act15]: dgcA(125-521): YFP	dgcA	wild type
DBS0349915	dgcA-/ [act15]: dgcA(274-521): YFP	dgcA	wild type
DBS0349916	dgcA-/ [act15]: dgcA(350-521): YFP	dgcA	development arrests at slug stage
DBS0349913	dgcA-/ [act15]: dgcA-Ppal: YFP	dgcA	wild type
DBS0349912	dgcA-/ [act15]: dgcA: YFP	dgcA	wild type
DBS0235695	dgkA-	dgkA	decreased spore germination | increased myosin II assembly | aberrant sorocarp development | decreased chemotaxis rate
DBS0351179	dgkA-	dgkA	aberrant cellular metabolic process | increased resistance to valproic acid | aberrant response to lithium
AK299	dhkA-	dhkA	aberrant stalk morphogenesis | increased prestalk gene expression | aberrant gene expression | aberrant fruiting body morphogenesis | increased sporulation | abolished response to biotic stimulus | decreased sporulation
DBS0350665	dhkA-/ [act15]: dhkA(D2076N)	dhkA	decreased sporulation
DBS0350664	dhkA-/ [act15]: dhkA(H1396Q)	dhkA	decreased sporulation
DBS0350666	dhkA-/ [act15]: dhkA(H2396Q)/ [act15]: dhkA(D2076N)	dhkA	wild type
DBS0235703	dhkA-/ [pkaC]: pkaC	dhkA | pkaC	aberrant stalk morphogenesis
TL134	dhkA-/ dhkB-	dhkA | dhkB	abolished sporulation | increased stalk length | decreased stalk width
HR49	dhkA-/ fbxA-	dhkA | fbxA	aberrant fruiting body morphogenesis | decreased sporulation | decreased cAMP level
HR51	dhkA-/ fbxA-	dhkA | fbxA	aberrant fruiting body morphogenesis | decreased sporulation
HR50	dhkA-/ fbxA-	dhkA | fbxA	abolished culmination | decreased sporulation
DBS0350663	dhkA-/ pkaR-	dhkA | pkaR	decreased sporulation
DBS0350662	dhkA-/ regA-	dhkA | regA	decreased sporulation
DBS0235704	dhkB-	dhkB	precocious spore germination | decreased cAMP level | aberrant sorus color
TL135	dhkC-	dhkC	precocious culmination | decreased spore germination | precocious aggregation | precocious development | precocious gene expression
DBS0350855	dhkC-	dhkC	aberrant chemotaxis to cAMP
DBS0350379	dhkD-	dhkD	abolished stream development | aberrant slug development | aberrant sorocarp development | precocious gene expression | aberrant late culminant morphology
DBS0350381	dhkD-/ [ecmAO]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350382	dhkD-/ [ecmB]: lacZ	dhkD	aberrant prestalk cell differentiation
DBS0350383	dhkD-/ [pspA]: lacZ	dhkD	aberrant prespore cell differentiation
LAS99	dhkE-	dhkE	decreased socially cooperative development
DBS0351297	dhkI-	dhkI-1 | dhkI-2	aberrant chemotaxis to cAMP | delayed aggregation
DBS0235710	dhkK-	dhkK	aberrant slug migration | delayed culmination | delayed gene expression
DBS0235712	dhkK-/ [act15]: dhkK(D1125N)	dhkK	aberrant fruiting body morphogenesis
DBS0235714	dhkK-/ regA-	dhkK | regA	precocious development
DBS0348046	dhkM-	dhkM	abolished autophagosome organization | aberrant autophagic cell death
DBS0348047	dhkM-	dhkM	abolished autophagosome organization | abolished actin filament depolymerization | abolished cellulose biosynthesis | abolished autophagic cell death
DBS0350173	dhkM-	dhkM	decreased autophagic vacuole organization | delayed development
DBS0235719	dia1-/ [act6]: trap1	dia1 | trap1	aberrant aggregation | decreased fruiting body size
DBS0235895	dimA-	dimA	increased standing slug length | increased migratory slug size | abolished prestalk cell differentiation | decreased standing slug width | aberrant fruiting body morphogenesis | increased prespore cell differentiation | decreased prestalk O cell differentiation
DBS0235899	dimA-/ dimB-	dimA | dimB	increased migratory slug size | increased standing slug length | aberrant chemotaxis to cAMP | decreased standing slug width
DBS0235901	dimB-	dimB	decreased prestalk B cell differentiation | abolished response to DIF-1 | increased gene expression | aberrant prespore gene expression | aberrant chemotaxis to cAMP
DBS0235903	dimB-/ [act15]: dimA: GFP	dimA | dimB	abolished protein localization to nucleus
DBS0235904	dimB-/ [act15]: dimB: GFP	dimB	wild type
DBS0349992	dimB-/ [btg]: lacZ	btg | dimB	increased gene expression
DBS0235902	dimB-/ [cotB]: lacZ	dimB	increased prespore cell differentiation
DBS0350573	dimB-/ [dimB]: dimB(S590A)	dimB	wild type
DBS0235906	dimB-/ [ecmAO]: lacZ	dimB	decreased prestalk O cell differentiation
DBS0349974	dimB-/ [ecmB]: lacZ	dimB	abolished prestalk gene expression
DBS0235907	dimB-/ [ecmO]: lacZ	dimB	aberrant prestalk cell differentiation
DBS0350495	dio3-	dio3	decreased cell-cell adhesion | aberrant aggregation | decreased gene expression | decreased growth rate | decreased prespore cell differentiation | decreased chemotaxis to folate | increased prestalk cell differentiation | decreased cAMP level | decreased phototaxis
DBS0350496	dio3-/ [act15]: GFP: dio3	dio3	wild type
DBS0304919	dlpA-	dlpA	aberrant cell separation during cytokinesis | aberrant cytokinesis | decreased growth rate | increased actin filament depolymerization | increased vegetative cell size | decreased protein localization | abolished protein localization to cleavage furrow | aberrant actin filament organization
DBS0351395	dlpA-/ dlpB-	dlpA | dlpB	aberrant cytokinesis
DBS0304920	dlpB-	dlpB	aberrant cell separation during cytokinesis | aberrant cytokinesis | decreased growth rate | increased vegetative cell size | abolished protein localization to cleavage furrow
DBS0304921	dlpC-	dlpC	aberrant cytokinesis
DBS0235913	dmpA-	dmpA	aberrant stream morphology | aberrant fruiting body morphogenesis | delayed development | decreased stalk cell differentiation | decreased sporulation | aberrant sorus color
HM1030	dmtA-	dmtA	delayed development of tipped mound | abolished DIF-1 biosynthesis | decreased outer basal disc size | wild type | abolished prestalk O cell differentiation | decreased standing slug width | decreased lower cup size | decreased prestalk gene expression | aberrant vacuole organization | aberrant fruiting body morphogenesis | delayed development | decreased prestalk O cell differentiation | decreased prestalk cell differentiation
DBS0350410	dmtA-/ [act15]: dmtA	dmtA	wild type
DBS0349975	dmtA-/ [dimB]: dimB	dimB | dmtA	decreased prestalk B cell differentiation
HM1196	dmtA-/ stlA-	dmtA | stlB	decreased outer basal disc size | decreased prestalk O cell differentiation
DBS0235914	dnapkcs-	dnapkcs	decreased resistance to bleomycin | decreased double-strand break repair via nonhomologous end joining
DBS0266875	dnapkcs-/ GFP: pcna	dnapkcs | pcna	aberrant response to bleomycin
DBS0350561	dnapkcs-/ adprt2-	adprt2 | dnapkcs	decreased resistance to phleomycin | decreased resistance to cisplatin
DBS0351060	dnapkcs-/ exo1-	dnapkcs | exo1	decreased resistance to phleomycin
DBS0235915	dng1-	dng1	decreased growth rate | delayed aggregation
DBS0235917	dnmA-	dnmA	decreased DNA methylation on cytosine
DBS0235916	dnmA-	dnmA	decreased DNA methylation on cytosine | aberrant late culminant morphology | aberrant sorus color | decreased sporulation
DBS0350457	docA-	docA	decreased chemotaxis to cAMP
DG2015	docA-	docA	development arrests at mound stage
LAS32	docA-	docA	decreased socially cooperative development
DBS0350458	docD-	docD	decreased cell motility | decreased chemotaxis to cAMP
DBS0350459	docD-/ docA-	docA | docD	aberrant fruiting body morphogenesis | delayed development | decreased chemotaxis to cAMP
DBS0235920	dokA-	dokA	aberrant hyperosmotic response | aberrant sorus color | decreased sporulation
DBS0349789	dotA-	dotA	aberrant response to UV | decreased growth rate | decreased spore size | delayed development | abolished histone H3-K79 methylation
HAD172	dpoA-	dpoA	increased gene expression | aberrant sorocarp development
HAD200	dpoA-	dpoA	aberrant sorocarp development
HAD201	dpoA-	dpoA	aberrant sorocarp development
HAD202	dpoA-	dpoA	aberrant sorocarp development
HAD203	dpoA-	dpoA	aberrant sorocarp development
HAD205	dpoA-/ gskA-	dpoA | gskA	aberrant sorocarp development
HM1467	drcA-	drcA	abolished catalytic activity
DBS0238474	drkC-	drkC	decreased phagocytosis | decreased phagolysosome formation
DBS0238511	drkC-/ [act15]: drkC(1-497): YFP	drkC	decreased phagocytosis
DBS0238513	drkC-/ [act15]: drkC(K518R): YFP	drkC	decreased phagocytosis
DBS0238475	drkC-/ [act15]: drkC: YFP	drkC	wild type
DBS0235922	drnA-	drnA-1	decreased gene expression
DBS0350174	drnB-	drnB	abolished pre-miRNA processing
DBS0350218	drnB-/ [act15]: pre-miRNA	drnB	abolished pre-miRNA processing
DBS0350210	drnB-/ [act6]: lacZ/ [RNAi]lacZ	drnB	abolished production of siRNA involved in RNA interference | abolished transitive RNA interference
DBS0235924	dscA-	dscA-1 | dscA-2	aberrant cell morphology
DBS0350775	dscA-	dcsA	decreased cell motility
DBS0302609	dsgg(1-571: 581-733)	dsgg	aberrant contractile vacuole organization
DBS0302608	dsgg(1-571: 581-733)/ dsgg-	dsgg	aberrant contractile vacuole organization | aberrant cellular localization
DBS0302597	dsgg-	dsgg	aberrant contractile vacuole organization | aberrant hypotonic response
DBS0302603	dsgg-/ GFP: dsgg	dsgg	wild type
DBS0302602	dsgg-/ OE]: dsgg(Delta-Fbox)	dsgg	wild type
DBS0302606	dsgg-/ [OE]: GFP: lvsD	dsgg | lvsD	wild type
DBS0302599	dsgg-/ [OE]: dsgg	dsgg	wild type
DBS0302601	dsgg-/ [OE]: dsgg(Q551A)	dsgg	aberrant contractile vacuole organization
DBS0302600	dsgg-/ [OE]: dsggR515A)	dsgg	aberrant contractile vacuole organization
DBS0302607	dsgg-/ [OE]: lvsA	dsgg | lvsA	aberrant contractile vacuole organization
DBS0302611	dsgg-/ [OE]: phgA	dsgg | phgA	aberrant contractile vacuole organization
DBS0302678	dsgg-/ [OE]: rab8A	dsgg | rab8A	aberrant contractile vacuole organization
DBS0302604	dsgg-/ lvsA-	dsgg | lvsA	wild type
DBS0302605	dsgg-/ lvsD-	dsgg | lvsD	aberrant contractile vacuole organization
DBS0351070	dspA-	dspA	delayed aggregation | increased cell-substrate adhesion | decreased cell motility | increased protein kinase activation
DBS0235925	dstA-	dstA	abolished gene expression | increased gene expression | aberrant prestalk gene expression | abolished cell migration to prestalk region | decreased gene expression | delayed aggregation | decreased prestalk gene expression | decreased cell motility | abolished stalk cell differentiation | aberrant fruiting body morphogenesis
DBS0235926	dstA-	dstA	aberrant prestalk gene expression | abolished cell migration to prestalk region | delayed aggregation | decreased cell motility | abolished stalk cell differentiation | aberrant fruiting body morphogenesis
DBS0238237	dstA-/ GFP: dstA(237-707): ORF+	dstA	abolished culmination | decreased stalk length
DBS0238236	dstA-/ GFP: dstA(237-707): ORF+/ [OE]dutA(751-1322)	dstA | dutA	decreased stalk length
DBS0252824	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C	2C | dstA	aberrant fruiting body morphogenesis
DBS0252823	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E	7E | dstA | hssB	wild type
DBS0252826	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165	DDB_G0276165 | dstA	aberrant fruiting body morphogenesis
DBS0252825	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325	DDB_G0282325 | dstA	aberrant fruiting body morphogenesis
DBS0252816	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA	dstA | hssA	wild type
DBS0252822	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssB	dstA | hssB	wild type
DBS0235928	dstA-/ [act15]: dstA	dstA	wild type
DBS0235929	dstA-/ [cprB]: dstA	dstA	wild type
DBS0235930	dstA-/ [ecmAO]: dstA	dstA	wild type
DBS0235927	dstA-/ dstB-	dstA | dstB	wild type
DBS0235931	dstB-	dstB	decreased gene expression | increased gene expression | decreased growth rate
DBS0235933	dstB-/ [act15]: dstB	dstB	wild type
DBS0235934	dstB-/ [act15]: dstB(L1025R)	dstB	wild type
DBS0235935	dstB-/ [act15]: dstB(Y1143F)	dstB	wild type
DBS0235932	dstB-/ dstC-	dstB | dstC	wild type
DBS0238125	dstC-	dstC	abolished gene expression | aberrant response to cation stress | aberrant response to osmotic stress
DBS0350425	dstC-	dstC	aberrant protein phosphorylation
DBS0235937	dtfA-	dtfA	delayed development of tipped mound | decreased cell-cell adhesion | aberrant cytokinesis | aberrant cell migration to prestalk region | aberrant fruiting body morphogenesis
DBS0350500	dupA-	dupA	increased defense response to Gram-negative bacterium | abolished aggregation
DBS0350502	dupA-	dupA	increased defense response to Gram-negative bacterium
DBS0238234	dutA-	dutA	wild type
DBS0235939	dwwA-	dwwA	aberrant cytokinesis | aberrant actin filament organization | aberrant cell morphology
DBS0350411	dydA-	dydA	increased myosin II assembly | increased actin filament polymerization | increased protein localization to plasma membrane | decreased chemotaxis to cAMP
DBS0350414	dydA-/ dydA(1-278: 501-1211)	dydA	decreased protein localization to cell cortex | increased myosin II assembly | increased actin filament polymerization | aberrant chemotaxis to cAMP
DBS0350415	dydA-/ dydA(1-586: 703-1211)	dydA	decreased protein localization to cell cortex | decreased chemotaxis to cAMP
DBS0350060	dymA-	dymA	decreased protein localization to cleavage furrow | aberrant cell separation during cytokinesis | decreased growth rate | increased vegetative cell size | aberrant actin filament organization
DBS0347874	dymA-	dymA	decreased pinocytosis | aberrant cell separation during cytokinesis | aberrant mitochondrion morphology | decreased phagolysosome size | increased basal disc size | decreased growth rate | aberrant nucleus morphology | increased vegetative cell size | aberrant endosome morphology | aberrant phagosome maturation | delayed development | aberrant stalk development | aberrant fruiting body morphogenesis | decreased establishment of cell polarity | aberrant pseudopodium formation | abolished phagosome acidification | increased phagocytosis | aberrant intracellular distribution of mitochondria
DBS0349839	dymA-/ [dymA]: dymA	dymA	wild type
DBS0350803	dymA-/ ehd-	dymA | ehd	aberrant phagosome maturation | decreased protein processing in phagocytic vesicle
DBS0347875	dymB-	dymB	decreased growth rate | aberrant hypotonic response | increased cell-cell adhesion | increased cell-substrate adhesion | decreased vegetative cell size | decreased catalase activity | aberrant actin filament organization | increased growth rate | increased phagocytosis
DBS0235940	eb1-	eb1	aberrant mitosis | aberrant cytokinesis | aberrant protein localization
HJW117	ecmA-	ecmA	increased standing slug length | decreased standing slug width | decreased slime trail
HJW01	ecmB-	ecmB	wild type
HJW03	ecmB-	ecmB	wild type
DBS0235944	ecmF-	ecmF	wild type
DBS0350904	efbA-	efbA	aberrant cytokinesis | delayed development
DBS0235945	egeA-	egeA	decreased activation of adenylate cyclase activity | decreased gene expression | abolished aggregation
DBS0350520	egeA-/ [unk]: YFP: carA	carA-1 | carA-2 | egeA	development arrests at mound stage
DBS0350521	egeA-/ [unk]: pkaC	egeA | pkaC	decreased gene expression | abolished aggregation
DBS0235946	egeB-	egeB	development arrests at mound stage
DBS0350802	ehd-	ehd	aberrant endosome morphology | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle
DBS0350804	ehd-/ [act15]: dymA: GFP	dymA | ehd	aberrant phagosome maturation | decreased protein processing in phagocytic vesicle
DBS0351166	ei24-	ei24	aberrant aggregation | decreased spore germination | increased gene expression | decreased gene expression | decreased growth rate | aberrant cell cycle | delayed development | decreased chemotaxis to cAMP | decreased fruiting body size | decreased cAMP level | decreased sporulation
DBS0302590	elmoA-	elmoA	increased protein localization to pseudopodium | decreased culmination | abolished establishment of cell polarity | increased actin filament polymerization | decreased cell motility | delayed development | increased pseudopodium formation | increased phagocytosis
DBS0302598	elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP	elmoA	decreased cell motility | increased phagocytosis
DBS0302591	elmoA-/ [act15]: elmoA: GFP	elmoA	wild type
DBS0350065	elmoE-	elmoE	decreased culmination | decreased actin filament polymerization at leading edge | decreased chemotaxis to cAMP
DBS0351604	elp3-	elp3	decreased protein level
DBS0302448	epnA-	epnA	aberrant spore morphology | decreased spore germination | abolished protein localization to cell cortex | aberrant cytokinesis | abolished protein localization to plasma membrane | aberrant actin cytoskeleton organization | abolished protein phosphorylation
DBS0302457	epnA-/ [act15]: GFP: epnA(253-677)	epnA	aberrant spore morphology | abolished protein localization to plasma membrane | abolished protein localization to clathrin-coated pit
DBS0302456	epnA-/ [act15]: epnA(1-133): GFP	epnA	aberrant localization to coated pits
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	aberrant spore morphology | abolished protein localization to plasma membrane | abolished phosphatidylinositol-4,5-bisphosphate binding | abolished protein localization to clathrin-coated pit | abolished protein phosphorylation
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology | abolished protein localization to plasma membrane
DBS0302454	epnA-/ [act15]: epnA: GFP	epnA	wild type
DBS0235947	eppA-	eppA	decreased growth rate | delayed development | decreased chemotaxis to folate | decreased chemotaxis to cAMP | decreased cAMP level
DBS0235948	eppA-/ [act6]: myc: eppA	eppA	wild type
DBS0350028	erkA-	erkA	decreased mound size | decreased chemotaxis to cAMP
DBS0350622	erkA-	erkA	aberrant development of tipped mound | aberrant stream morphology | abolished protein kinase activation | aberrant cellular response to extracellular stimulus | abolished positive regulation of chemorepellant activity
DBS0350623	erkA-	erkA	decreased mound size | precocious development
DBS0350681	erkA-/ [act15]: gpaE	erkA | gpaE	wild type
DBS0350029	erkA-/ [act15]: mekA: FLAG	erkA | mekA	increased protein localization to cell cortex
DBS0351474	erkA-/ regA-	erkA | regA	decreased mound size | aberrant fruiting body morphogenesis
DBS0351296	erkB-	erkB	abolished chemotaxis to folate | increased actin filament polymerization | abolished protein phosphorylation
HS174	erkB-	erkB	decreased catalytic activity | aberrant phagocytosis | decreased cell motility | decreased prespore gene expression | decreased prestalk gene expression | aberrant sorocarp development | decreased chemotaxis to folate | abolished aggregation | decreased chemotaxis to cAMP | aberrant cell morphology | decreased sporulation
AK240	erkB-	erkB	abolished aggregation | decreased sporulation
DBS0350606	erkB-	erkB	decreased prespore cell differentiation
DBS0350683	erkB-/ [ecmA]: lacZ	erkB	aberrant cell migration to prestalk region
DBS0350682	erkB-/ [unk]: erkB(P140S)	erkB	abolished sporulation
DBS0235949	erkB-/ regA-	erkB | regA	increased oscillatory cAMP signaling | abolished aggregation
DBS0350530	exo1-	exo1	decreased resistance to bleomycin | decreased double-strand break repair via homologous recombination
DBS0304864	expl7-	expl7	wild type
DBS0235951	fadA-	fadA	increased cellular thermotolerance
DBS0235952	fadB-	fadB	wild type
DBS0350240	fam21-	fam21	abolished exocytosis | aberrant vegetative growth | decreased protein localization to post-lysosomal vacuole | decreased protein processing in phagocytic vesicle | aberrant autophagic cell death | aberrant phagosome maturation | aberrant lysosome organization
DBS0236034	fam45-	fam45	wild type
DBS0236040	fam91-	fam91	wild type
DBS0350717	far1-	far1	aberrant binding | decreased actin filament polymerization | aberrant defense response to bacterium | aberrant macropinocytosis | decreased growth rate | aberrant phagocytosis | aberrant chemotaxis | decreased engulfment during phagocytosis | decreased chemotaxis to folate | decreased protein kinase activation | decreased folic acid binding | aberrant signal transduction
DBS0351093	far1-	far1	abolished chemotaxis to folate
DBS0351545	fatA-	fatA	aberrant lipid storage | decreased phagocytosis
DBS0235953	fbxA-	fbxA	decreased sporulation
HR6	fbxA-	fbxA	decreased socially cooperative development
HR42	fbxA-/ [act15]: myc: fbxA	fbxA	abolished culmination | decreased sporulation
DBS0235954	fbxA-/ [ecmA]: GFP(S65T)	fbxA	increased prespore cell differentiation
HR46	fbxA-/ regA-	fbxA | regA	aberrant fruiting body morphogenesis | decreased sporulation
HR48	fbxA-/ regA-	fbxA | regA	aberrant fruiting body morphogenesis | decreased sporulation
DBS0235956	fbxA1-	fbxA	development arrests at slug stage | aberrant fruiting body morphogenesis | increased slug migration | delayed culmination
DBS0235957	fbxA2-	fbxA	development arrests at slug stage | aberrant fruiting body morphogenesis | increased slug migration | delayed culmination
DBS0235958	fbxA3-	fbxA	development arrests at slug stage | aberrant fruiting body morphogenesis | increased slug migration | delayed culmination
DG1148	fcpA-	fcpA	aberrant fruiting body morphogenesis
DBS0235960	fcsA-	fcsA	decreased fatty acid level | decreased lipid droplet formation | increased sporulation
DBS0350128	fcsB-	fcsB	decreased catalytic activity | decreased phagocytosis
DBS0350129	fcsB-/ fcsA-	fcsA | fcsB	decreased catalytic activity | decreased growth rate | delayed development
DBS0350336	febA-	febA	wild type
DBS0350953	fhbA-	fhbA	increased vegetative cell size | aberrant cellular response to stress
DBS0350955	fhbA-/ fhbB-	fhbA | fhbB	aberrant cellular response to stress
DBS0350954	fhbB-	fhbB	increased vegetative cell size | aberrant cellular response to stress
DBS0235961	fimA-	fimA	decreased vegetative cell size
HM1253	fncD2-	fncD2	decreased resistance to cisplatin
HM1351	fncD2-/ rev3-	fncD2 | rev3	decreased resistance to cisplatin
HM1405	fncD2-/ xpf-	fncD2 | xpf	decreased resistance to cisplatin
HM1416	fncE-	fncE	decreased resistance to cisplatin
HM1356	fncI-	fncI	decreased resistance to cisplatin
HM1302	fncL-	fncL	decreased resistance to cisplatin
HM1407	fncM-	fncM	decreased resistance to cisplatin
DBS0235966	forA-	forA	wild type
DBS0350667	forA-	forA	aberrant cellular response to fluid shear stress | decreased cell motility | increased cell motility
DBS0350669	forA-/ [act15]: GFP: mhcA	forA | mhcA	aberrant bleb assembly
DBS0235967	forA-/ forB-	forA | forB	wild type
DBS0235968	forB-	forB	wild type
DBS0235969	forC-	forC	aberrant culmination | aberrant fruiting body morphogenesis | development arrests at tipped mound stage
DBS0350280	forC-	forC	delayed aggregation | aberrant sorocarp development | decreased chemotaxis to cAMP | decreased sporulation | abolished slug development | delayed gene expression
DBS0304905	forC-/ [act15]: GFP: forC	forC	wild type
DBS0351307	forE-/ forA-/ forH-	forA | forE | forH	aberrant cortical actin cytoskeleton organization | aberrant cytokinesis | aberrant sorocarp development | decreased cell motility | aberrant cell morphology
DBS0350287	forF-	forF	decreased fruiting body size | aberrant phototaxis | increased chemotaxis rate
DBS0350835	forG-	forG	decreased growth rate | decreased phagocytosis | aberrant actin cytoskeleton organization | decreased macropinocytosis | aberrant actin filament organization
DBS0235970	forH-	forH	decreased cell-substrate adhesion | decreased chemotaxis rate | increased cell motility | aberrant pseudopodium formation | aberrant cell morphology | decreased filopodium formation
DBS0235971	forH-/ [act15]: GFP: forH	forH	increased filopodium formation | decreased cell motility | increased cell-substrate adhesion
HW440	fpaA(P143A)	fpaA	delayed aggregation | increased response to hypoxia
HW435	fpaB-/ AX2	fpaB-1 | fpaB-2	decreased response to hypoxia | increased culmination | increased stalk length
DBS0302506	frmA-	frmA	delayed aggregation | decreased cell motility | decreased mound size | increased cell-substrate adhesion | aberrant cell morphology
DBS0304440	frmA-/ [unk]: GFP	frmA	decreased gene expression | aberrant sorocarp development | increased cell-cell adhesion | delayed development | abolished phototaxis
DBS0302507	frmA-/ [unk]: frmA-HA	frmA	wild type
DBS0350983	frmB-	frmB	aberrant aggregation | increased mound size | decreased cell-substrate adhesion | increased fruiting body size
DBS0350232	fscE-	fscE	aberrant positive regulation of chemorepellant activity | decreased growth rate | aberrant cytokinesis
DBS0350228	fslA-	fslA	aberrant cytokinesis
DBS0350230	fslB-	fslB	aberrant positive regulation of chemorepellant activity | decreased catalytic activity | aberrant cytokinesis
DBS0350229	fslK-	fslK	decreased catalytic activity | aberrant vegetative growth | aberrant cytokinesis
DBS0350252	fspA-	fspA	decreased gene expression | aberrant chemotaxis to folate | aberrant vegetative growth
DBS0350253	fspA-/ [unk]: fspA: FLAG	fspA	wild type
DBS0235976	fszA-	fszA	decreased number of mitochondria | aberrant mitochondrion morphology
DBS0235978	fszA-/ fszB-	fszA | fszB	aberrant mitochondrion morphology
DBS0235980	fszB-	fszB	aberrant mitochondrion morphology | decreased number of mitochondria | decreased growth rate
DG1066	fut1-	fut1	aberrant fruiting body morphogenesis
DBS0305025	gabT-	gabT	precocious development | decreased sporulation
DBS0305026	gabT-[pkaC]: pkaC	gabT | pkaC	aberrant protein secretion
DBS0351298	gacG-	gacG	increased chemotaxis to folate | increased actin filament polymerization at leading edge
DBS0351318	gacG-	gacG	aberrant macropinocytosis | abolished vegetative growth
DBS0351299	gacH-	gacH	aberrant chemotaxis to cAMP
DG1094	gacT-	gacT	aberrant fruiting body morphogenesis
DBS0235989	gadA-	gadA	decreased spore cell differentiation | decreased sporulation
DBS0350071	gadA-	gadA	decreased spore germination
DBS0350077	gadA-/ gadB-	gadA | gadB	delayed aggregation
DBS0350072	gadB-	gadB	delayed aggregation
DBS0350963	gapA-	gapA	aberrant cell separation during cytokinesis
DBS0349924	gapA-	gapA	decreased actin filament bundle assembly
DBS0350399	gapA-	gapA	decreased protein localization to cleavage furrow | increased myosin II assembly | increased lateral pseudopodium formation | aberrant mitotic spindle organization | increased actin filament polymerization | decreased chemotaxis to cAMP | aberrant cellular response to stress
DBS0350403	gapA-/ iqgC-	gapA | iqgC	decreased protein kinase activation | decreased chemotaxis to cAMP
TL198	gbfA-	gbfA	abolished gene expression | development arrests at mound stage
DBS0302689	gbfA-	gbfA	aberrant oscillatory cAMP signaling
DBS0305094	gbfA-	gbfA	abolished autophagosome organization | abolished autophagic cell death
DBS0235994	gbpC-	gbpC	decreased protein kinase activation | decreased fruiting body size
DBS0235995	gbpC-	gbpC	aberrant chemotaxis to cAMP | aberrant myosin II filament organization | decreased chemotaxis rate | aberrant cyclic nucleotide binding | aberrant cell morphology | decreased establishment of cell polarity | decreased fruiting body size
DBS0302680	gbpC-	gbpC	abolished protein localization to nucleus | decreased mound size | abolished protein phosphorylation
DBS0350881	gbpC-	gbpC	aberrant cyclic nucleotide binding
DBS0304912	gbpC-/ [act15]: gbpC	gbpC	wild type
DBS0304917	gbpC-/ [act15]: gbpC(1-1698: 2005-2631)	gbpC	decreased chemotaxis to cAMP
DBS0349868	gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP	gbpC	aberrant stream morphology | decreased chemotaxis to cAMP
DBS0304918	gbpC-/ [act15]: gbpC(311-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304916	gbpC-/ [act15]: gbpC(F1892A)	gbpC	decreased chemotaxis to cAMP
DBS0304915	gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A)	gbpC	decreased chemotaxis to cAMP
DBS0304913	gbpC-/ [act15]: gbpC(K342N)	gbpC	decreased chemotaxis to cAMP
DBS0304914	gbpC-/ [act15]: gbpC(K905W)	gbpC	decreased chemotaxis to cAMP
DBS0235996	gbpC-/ gbpD-	gbpC | gbpD	delayed aggregation | decreased chemotaxis rate | decreased establishment of cell polarity | increased bleb assembly
DBS0235997	gbpD-	gbpD	increased establishment of cell polarity | decreased cell-substrate adhesion | decreased lateral pseudopodium formation | increased chemotaxis rate
DBS0235998	gbpD-/ [act15]: gbpD	gbpD	increased lateral pseudopodium formation | increased cell-substrate adhesion | decreased chemotaxis rate | aberrant actin filament organization | abolished aggregation
DG1120	gbqA-	gbqA	aberrant fruiting body morphogenesis
DBS0350119	gcA-	gcA	decreased guanylyl cyclase activity
DBS0236000	gca-/ sgcA-	gcA | sgcA	decreased protein kinase activation
DBS0302679	gca-/ sgcA-	gcA | sgcA	increased lateral pseudopodium formation | aberrant activation of GTPase activity | aberrant chemotaxis to cAMP | aberrant taxis | aberrant stream morphology | decreased mound size | decreased chemotaxis rate | decreased fruiting body size
DBS0236002	gcsA-	gcsA	abolished sporulation | aberrant cellular metabolic process | decreased gene expression | increased gene expression | development arrests at mound stage | abolished vegetative growth | mitotic G1 phase arrest | abolished aggregation | abolished prespore gene expression
DBS0350387	gcsA-/ [act15]: carA	carA-1 | carA-2 | gcsA	abolished aggregation
DBS0236003	gcsA-/ [act15]: gcsA	gcsA	decreased spore germination | development arrests at mound stage
DBS0350388	gcsA-/ [act15]: yakA	gcsA | yakA	wild type
DBS0236004	gdt1-	gdt1	increased gene expression | decreased growth rate | precocious aggregation
DBS0237190	gdt1-/ [act15]: pkaR(G135E/ G261A)	gdt1 | pkaR	increased gene expression | abolished aggregation
DBS0236095	gdt1-/ gpaB-	gdt1 | gpaB	increased gene expression | abolished aggregation
DBS0236006	gdt2-	gdt2	increased gene expression | precocious aggregation
DBS0252697	gefA-	gefA	decreased taxis
RI19	gefA-	gefA	decreased actin filament polymerization | decreased gene expression | decreased activation of GTPase activity | abolished activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased chemotaxis rate | abolished aggregation | increased protein kinase activation
JB10	gefA-	gefA	abolished aggregation
DBS0350821	gefA-	gefA	decreased actin filament polymerization | decreased activation of GTPase activity | aberrant chemotaxis to cAMP | decreased protein kinase activation | abolished aggregation
DBS0350449	gefA-/ [dscB]: rasG(S17N)	gefA | rasG	decreased actin filament polymerization | decreased activation of GTPase activity | aberrant chemotaxis to cAMP | decreased protein kinase activation
DBS0351451	gefB-/ AX2	gefB	wild type
DBS0236009	gefB-/ AX3	gefB	abolished pinocytosis | delayed aggregation | increased actin filament polymerization | decreased phagocytosis | decreased growth rate | decreased mound size | abolished vegetative growth | aberrant fruiting body morphogenesis | aberrant cell morphology | increased bleb assembly | aberrant cytoskeleton organization
DBS0236010	gefB-/ rasS-	gefB | rasS	decreased phagocytosis | increased cell motility
DBS0236868	gefC-	gefC	wild type
DBS0236869 (DBS0235543)	gefD-	gefD	wild type | aberrant activation of GTPase activity
DBS0236870	gefE-	gefE	aberrant thermotaxis | aberrant activation of GTPase activity | aberrant phototaxis
DBS0350569	gefE-	gefE	decreased activation of GTPase activity | increased gene expression | decreased response to DIF-1 | increased prespore cell differentiation
DBS0351462	gefE-/ uduB-	gefE | uduB	wild type
DBS0351450	gefF: GFP	gefF	decreased macropinocytosis
DBS0350822	gefH-	gefH	decreased actin filament polymerization | decreased activation of GTPase activity | aberrant chemotaxis to cAMP | delayed development | decreased protein kinase activation
DBS0350823	gefH-/ gefA-	gefA | gefH	decreased actin filament polymerization | aberrant chemotaxis to cAMP | abolished activation of GTPase activity | decreased protein kinase activation | abolished aggregation
DBS0236012	gefK-	gefK	wild type
DBS0351618	gefK-/ gacL-	gacL | gefK	decreased response to Gram-negative bacterium | aberrant vegetative growth
DBS0236871	gefL-	gefL	aberrant thermotaxis | aberrant phototaxis
HSB61	gefM-	gefM	increased cGMP-mediated signaling | decreased lateral pseudopodium retraction | aberrant activation of adenylate cyclase activity | development arrests at mound stage | decreased chemotaxis rate
DBS0304968	gefQ-	gefQ	decreased positive regulation of GTPase activity | increased number of mound tips | increased myosin II assembly | increased lateral pseudopodium formation | abolished cell migration to prestalk region | abolished guanyl-nucleotide exchange factor activity | decreased growth rate | decreased fruiting body size | abolished phototaxis
DBS0304985	gefQ-/ [act15]: GFP: gefQ(172-654)	gefQ	abolished guanyl-nucleotide exchange factor activity | decreased phototaxis
DBS0304986	gefQ-/ [act15]: GFP: gefQ(910-1298)	gefQ	decreased phototaxis
DBS0236014	gefR-	gefR	wild type | decreased activation of GTPase activity
DBS0349892	gefS-	gefS	wild type
DBS0349904	gemA-	gemA	decreased ATP level | decreased growth rate
DBS0350811	gflB-	gflB	decreased culmination | decreased protein localization to cell cortex | aberrant G protein-coupled receptor signaling | delayed aggregation | decreased mound size | decreased chemotaxis to cAMP | aberrant protein localization to plasma membrane | increased actin filament polymerization at leading edge | decreased myosin II assembly
HA201	gflB-	gflB	decreased phagocytosis | aberrant mitotic actomyosin contractile ring contraction | increased actin filament polymerization | decreased macropinocytosis | increased substrate adhesion-dependent cell spreading
DBS0350814	gflB-/ [act15]: GFP: gflB(380-1601,T1180E)	gflB	decreased chemotaxis to cAMP
DG1109	ggtA-	ggtA	aberrant fruiting body morphogenesis
DBS0351210	gip1-	gip1	decreased protein localization to plasma membrane | aberrant chemotaxis to cAMP
DBS0266723	glcS-/ DH1	glcS	aberrant stalk morphogenesis | decreased glycogen level | decreased spore size | decreased fruiting body size
DBS0266765	glcS-/ HMX	glcS	abolished cellulose biosynthesis | decreased autophagic vacuole organization | aberrant cell morphology
DBS0350514	glk-	glk	decreased defense response to Gram-negative bacterium
DBS0351101	glkA-	glkA	aberrant aggregation | decreased protein localization to cell cortex | decreased protein level | decreased chemotaxis to cAMP | decreased myosin II assembly | increased activation of GTPase activity | increased protein kinase activation
DBS0236078	glpD-	glpD	aberrant glycogen metabolism | aberrant regulation of catalytic activity
HL250	gmd(G108D)	gmd	decreased spore germination | decreased growth rate
DBS0236079	gmsA-	gmsA	decreased sexual fusion
DBS0236080	gmsA-	gmsA	decreased sexual fusion
HW503	gnt1(1-253/ H104D)	gnt1	aberrant stalk morphogenesis | development arrests at slug stage | increased response to hypoxia
DBS0238384	gnt14-	gnt14	wild type
DBS0238382	gnt15-	gnt15	decreased gene expression | decreased growth rate | increased calcium-independent cell-cell adhesion | abolished aggregation | abolished culmination
DBS0238383	gnt15-	gnt15	decreased gene expression | decreased growth rate | increased calcium-independent cell-cell adhesion | abolished aggregation | abolished culmination
DBS0238390	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0238391	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0236081	gnt2-	gnt2	abolished catalytic activity | abolished protein modification
DBS0236082	gol-	gol	increased resistance to cisplatin
DBS0235414	gp130-	gp130	decreased response to Gram-positive bacterium | decreased cell-substrate adhesion | delayed development | increased growth rate
DBS0236087	gpaA-	gpaA	aberrant aggregation | increased stalk length | aberrant response to cAMP | decreased stalk width
JH131	gpaA-	gpaA	aberrant cellular homeostasis | wild type | increased growth rate
DBS0236091	gpaA-/ [ecmB]: lacZ	gpaA	decreased prestalk gene expression
DBS0236092	gpaA-/ [gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0236093	gpaA-/ [gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0238605	gpaA-/ rpkA-	gpaA | rpkA	delayed aggregation | abolished aggregation
DBS0236575	gpaB-	gpaB	decreased response to cAMP | abolished activation of GTPase activity | aberrant phagocytosis | decreased cGMP-mediated signaling | decreased protein kinase activation | abolished aggregation | abolished chemotaxis to cAMP
JH104	gpaB-	gpaB	decreased gene expression | decreased activation of GTPase activity | abolished activation of adenylate cyclase activity | abolished aggregation | abolished chemotaxis to cAMP
JM1	gpaB-/ [OE]: carA	carA-1 | carA-2 | gpaB	aberrant calcium-mediated signaling
DBS0236096	gpaB-/ [act15]: gpaB	gpaB	abolished aggregation
DBS0266942	gpaB-/ [act15]: gpaB	gpaB	delayed aggregation
DBS0266939	gpaB-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB | gpaD	abolished aggregation
DBS0351103	gpaB-/ [act15]: gpaB(C4A)	gpaB	abolished protein localization to plasma membrane | decreased cGMP-mediated signaling | abolished aggregation
DBS0237137	gpaB-/ [act15]: gpaB(D154V)	gpaB	aberrant aggregation | decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased oscillatory cAMP signaling | decreased chemotaxis rate
DBS0237138	gpaB-/ [act15]: gpaB(E190G)	gpaB	aberrant aggregation | decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased oscillatory cAMP signaling
DBS0351105	gpaB-/ [act15]: gpaB(G207A)	gpaB	abolished protein localization to plasma membrane
DBS0351104	gpaB-/ [act15]: gpaB(G2A)	gpaB	abolished protein localization to plasma membrane
DBS0237139	gpaB-/ [act15]: gpaB(I104S)	gpaB	aberrant aggregation | decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased oscillatory cAMP signaling | decreased chemotaxis rate
DBS0237140	gpaB-/ [act15]: gpaB(L110S)	gpaB	aberrant aggregation | decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased oscillatory cAMP signaling | decreased chemotaxis rate
DBS0237141	gpaB-/ [act15]: gpaB(L76P)	gpaB	abolished aggregation
DBS0237142	gpaB-/ [act15]: gpaB(N74D)	gpaB	decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased oscillatory cAMP signaling | decreased chemotaxis rate | abolished aggregation
DBS0237143	gpaB-/ [act15]: gpaB(R64G)	gpaB	decreased chemotaxis rate | abolished aggregation
DBS0237144	gpaB-/ [act15]: gpaB(S155P)	gpaB	decreased chemotaxis rate | abolished aggregation
DBS0351217	gpaB-/ [act15]: gpaI	gpaB | gpaI	wild type
DBS0351267	gpaB-/ [act15]: gpbA: YFP	gpaB | gpbA	abolished aggregation
DBS0351214	gpaB-/ [act15]: rasG(S17N)	gpaB | rasG	abolished activation of GTPase activity
DBS0236097	gpaB-/ [gpaA]: gpaB	gpaB	abolished aggregation
DBS0236099	gpaB-/ [gpaB]: gpaB	gpaB	wild type
DBS0236098	gpaB-/ [gpaB]: gpaB(Q208L)	gpaB	aberrant protein localization to plasma membrane
DBS0350373	gpaB-/ regA-	gpaB | regA	decreased number of mounds
DBS0235986	gpaC-	gpaC	aberrant activation of adenylate cyclase activity | decreased gene expression | increased protein kinase activity | abolished aggregation
JH417	gpaD-	gpaD	decreased gene expression | aberrant macropinocytosis | decreased spore cell differentiation | aberrant fruiting body morphogenesis | decreased chemotaxis to folate | decreased protein kinase activation | abolished protein phosphorylation | decreased cGMP biosynthesis | decreased sporulation
DBS0266944	gpaD-/ [act15]: gpaB	gpaB | gpaD	aberrant fruiting body morphogenesis | decreased chemotaxis to folate | decreased cGMP biosynthesis
DBS0266946	gpaD-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB | gpaD	aberrant fruiting body morphogenesis | decreased cGMP biosynthesis
DBS0266943	gpaD-/ [act15]: gpaD	gpaD	wild type
DBS0350608	gpaD-/ [act15]: gpaD(Q200L)	gpaD	development arrests at loose mound stage | decreased chemotaxis to folate | decreased protein kinase activation
DBS0350607	gpaD-/ [act15]: gpaD(R107E,R108E)	gpaD	development arrests at slug stage | aberrant slug development
DBS0266945	gpaD-/ [act15]: gpaE	gpaD | gpaE	aberrant fruiting body morphogenesis | decreased chemotaxis to folate | decreased cGMP biosynthesis
DBS0266947	gpaD-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD | gpaE	aberrant fruiting body morphogenesis | decreased chemotaxis to folate | decreased cGMP biosynthesis
DBS0351269	gpaD-/ [act6]: AEQ	gpaD	aberrant calcium-mediated signaling
DBS0350374	gpaD-/ regA-	gpaD | regA	aberrant aggregation | abolished slug migration | decreased sporulation
DBS0350378	gpaD-/ regA-/ [ecmB]: lacZ	gpaD | regA	increased prestalk O cell differentiation
DBS0236101	gpaE(G196T)	gpaE	wild type
DBS0236103	gpaE(Q198L)	gpaE	wild type
JH257	gpaE-	gpaE	delayed development of tipped mound | increased chemotaxis to folate | delayed prestalk gene expression | increased vegetative cell size | delayed prespore gene expression | decreased cell migration to prestalk region
DBS0266941	gpaE-/ [act15]: gpaE	gpaE	precocious development of tipped mound
DBS0266948	gpaE-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD | gpaE	precocious development of tipped mound
DBS0350678	gpaE-/ [act15]: gpaE(K10E/ K11E)	gpaE	delayed development of tipped mound | delayed gene expression
DBS0350624	gpaE-/ erkA-	erkA | gpaE	wild type | decreased mound size | precocious development
LW1	gpaG-	gpaG	wild type | decreased spore cell differentiation | aberrant GABA signaling pathway
DBS0236107	gpaH-	gpaH	wild type | increased cell death | decreased spore germination | abolished negative chemotaxis | increased growth rate | abolished positive regulation of chemorepellant activity | decreased sporulation
DBS0236108	gpaH-	gpaH	wild type
DBS0350972	gpaH-/ AX2	gpaH	increased growth rate
DBS0350975	gpaH-/ [ecmO]: lacZ	gpaH	aberrant cell differentiation
DBS0236109	gpaI-	gpaI	increased number of mounds | aberrant cellular homeostasis | increased establishment of cell polarity | increased cell death | aberrant activation of adenylate cyclase activity | increased chemotaxis to cAMP | precocious aggregation | increased actin filament polymerization | aberrant adaptation of signaling pathway | decreased mound size | decreased oscillatory cAMP signaling | decreased lateral pseudopodium formation | decreased fruiting body size | increased growth rate | aberrant protein localization to plasma membrane | increased cGMP biosynthesis
DBS0351544	gpat-	gpat	aberrant lipid storage | decreased lipid droplet formation | increased sporulation | increased phagocytosis
LW5	gpbA-	gpbA	aberrant taxis | increased resistance to N-Phenylthiourea | abolished aggregation
LW6	gpbA-	gpbA	decreased protein localization to plasma membrane | aberrant cellular homeostasis | aberrant extracellular cAMP signaling pathway | decreased positive regulation of GTPase activity | increased cell death | abolished chemotaxis to folate | aberrant phagocytosis | aberrant chemotaxis | abolished activation of adenylate cyclase activity | decreased cGMP-mediated signaling | decreased engulfment during phagocytosis | aberrant sorocarp development | decreased chemotaxis to folate | decreased protein kinase activation | decreased chemotaxis to cAMP | abolished actin filament polymerization | increased growth rate | aberrant protein localization | aberrant signal transduction
DBS0351277	gpbA-	gpbA	aberrant cytokinesis
DBS0350470	gpbA-/ [act15]: GFP: cap	cap | gpbA	decreased phagocytosis
LW14	gpbA-/ [act15]: carA	carA-1 | carA-2 | gpbA	aberrant calcium-mediated signaling | decreased protein kinase activation | abolished aggregation
LW17	gpbA-/ [act15]: carC	carC | gpbA	abolished aggregation
DBS0351260	gpbA-/ [act15]: gpbA(A99T/ Y271H/ C335M)	gpbA	abolished activation of adenylate cyclase activity | aberrant fruiting body morphogenesis
DBS0351261	gpbA-/ [act15]: gpbA(M30V/ K85R/ S104P/ Q163H)	gpbA	development arrests at mound stage | abolished activation of adenylate cyclase activity | decreased chemotaxis to cAMP
DBS0351263	gpbA-/ [act15]: gpbA(M48T/ I52T/ E310G)	gpbA	wild type | decreased activation of adenylate cyclase activity | decreased gene expression | aberrant slug development
DBS0351259	gpbA-/ [act15]: gpbA(N147D/ H149R/ N237S)	gpbA	development arrests at mound stage | abolished activation of adenylate cyclase activity | abolished chemotaxis to cAMP
DBS0351264	gpbA-/ [act15]: gpbA(R13G/ N74S/ S79P/ H149R/ V178A/ V194R/ F293L)	gpbA	decreased activation of adenylate cyclase activity | decreased gene expression | development arrests at tipped mound stage
DBS0351262	gpbA-/ [act15]: gpbA(S196G/ V199D/ C211R)	gpbA	decreased activation of adenylate cyclase activity | aberrant fruiting body morphogenesis
DBS0351258	gpbA-/ [act15]: gpbA(V88A/ F229S/ D235V)	gpbA	abolished activation of adenylate cyclase activity | aberrant fruiting body morphogenesis | decreased chemotaxis to cAMP
DBS0351268	gpbA-/ [act6]: AEQ	gpbA	aberrant calcium-mediated signaling
HO547	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP	gpbA	aberrant cortical actin cytoskeleton organization
HO543	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: YFP: FKBP	gpbA	abolished chemotaxis to folate
DBS0351198	gpbA-/ [act6]: yakA	gpbA | yakA	abolished vegetative growth
DBS0350832	gpbA-/ [unk]: gpbA(Q208L)	gpbA	aberrant adaptation of signaling pathway
DBS0351278	gpbA-/ mhcA-	gpbA | mhcA	aberrant cytokinesis
AK1353	gpi-	gpi	decreased response to Gram-positive bacterium
DBS0350477	gpr89-	gpr89	aberrant spore morphology | aberrant mitochondrion morphology | abolished cell migration to prestalk region | decreased gene expression | aberrant slug development | abolished vegetative growth | decreased cell motility | decreased fruiting body size | precocious gene expression | decreased phototaxis | delayed gene expression
DBS0350479	gpr89-/ [act15]: gpr89: GFP	gpr89	wild type
DBS0304814	grlA-	grlA	delayed prestalk gene expression | decreased prestalk gene expression | decreased spore cell differentiation | decreased sporulation | delayed culmination
DBS0304815	grlA-/ [act15]: grlA: GFP	grlA	aberrant development of tipped mound
DBS0350074	grlB-	grlB	decreased small molecule binding | aberrant positive regulation of chemorepellant activity | delayed aggregation | aberrant vegetative growth | delayed gene expression
DBS0350078	grlB-/ grlE-	grlB | grlE	decreased small molecule binding | delayed aggregation
DBS0350227	grlD-	grlD	aberrant positive regulation of chemorepellant activity | decreased growth rate | aberrant cytokinesis | abolished small molecule binding | aberrant cellular response to extracellular stimulus
DBS0236112	grlE-	grlE	decreased spore cell differentiation | aberrant GABA signaling pathway | decreased sporulation
DBS0236113	grlE-	grlE	delayed aggregation | aberrant gene expression | decreased chemotaxis to cAMP
DBS0350075	grlE-	grlE	decreased spore germination | delayed aggregation
DBS0350226	grlH-	grlH	aberrant positive regulation of chemorepellant activity | aberrant protein level | aberrant vegetative growth | abolished activation of GTPase activity | decreased protein binding | increased growth rate
DBS0351147	grlH-/ [act15]: grlH	grlH	wild type
DBS0238865	grlJ-	grlJ	increased migratory slug size | aberrant spore morphology | decreased spore germination | precocious development | decreased fruiting body size | precocious gene expression
DBS0350283	grlJ-	grlJ	aberrant spore morphology | increased resistance to N-Phenylthiourea
DBS0238866	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0350284	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0238686	grpA-	grpA	decreased spore germination | abolished protein secretion
DBS0238687	grpA-/ [act15]: grpA-FLAG	grpA	wild type
ARK200	gskA-	gskA	abolished stream development | increased gene expression | decreased gene expression | increased protein localization to plasma membrane | decreased chemotaxis to cAMP | decreased sporulation
DBS0236114	gskA-	gskA	aberrant aggregation | decreased protein localization to cell cortex | decreased slug migration | aberrant sorus morphology | aberrant extracellular cAMP signaling pathway | decreased gene expression | abolished protein localization to plasma membrane | abolished protein phosphorylation | decreased chemotaxis to folate | decreased stalk length | abolished chemotaxis to cAMP
HM338	gskA-	gskA	precocious aggregation | decreased prespore cell differentiation | aberrant mitotic spindle elongation | aberrant fruiting body morphogenesis | increased prestalk cell differentiation | decreased sporulation
DBS0349930	gskA-/ [act15]: GFP: tacA	gskA | tacA	increased protein localization to nucleus
DBS0349881	gskA-/ [act15]: gskA(Y214F)	gskA	abolished stream development
DBS0349800	gskA-/ [ecmA]: LacZ	gskA	aberrant prestalk gene expression
DBS0349801	gskA-/ [ecmB]: LacZ	gskA	aberrant prestalk gene expression
DBS0350260	gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D))	gskA | pikA	wild type
DBS0351102	gskA-/ glkA-	glkA | gskA	aberrant sorocarp development | decreased chemotaxis to cAMP | increased protein kinase activation
DBS0350427	gskA-/ gskA(K85R): GFP	gskA	aberrant aggregation
DBS0350426	gskA-/ gskA: GFP	gskA	wild type
DBS0350988	gst4-	gst4	decreased fruiting body size
DBS0266891	gtaC-	gtaC	decreased mound size | aberrant stream morphology | abolished stalk cell differentiation | aberrant prestalk B cell differentiation
DBS0350347	gtaC-	gtaC	abolished gene expression | decreased fruiting body size | abolished aggregation
DBS0350348	gtaC-/ [act15]: GFP: gtaC	gtaC	wild type
DBS0350357	gtaC-/ [act15]: GFP: gtaC(C500,503,522,525S)	gtaC	aberrant gene expression | abolished aggregation | decreased fruiting body size
DBS0350358	gtaC-/ [act15]: GFP: gtaC(T376A/ S379,380A/ C500,503,522,525S)	gtaC	aberrant protein localization to nucleus
DBS0350361	gtaC-/ [act15]: gtaC: (468-496): GFP: gtaC	gtaC	development arrests at mound stage | decreased mound size | precocious development
DBS0266892	gtaC-KD	gtaC	abolished stalk cell differentiation
DBS0266893	gtaC-KD/ [act15]: GFP: gtaC	gtaC	wild type
DBS0351091	gtaG-	gtaG	decreased gene expression | development arrests at slug stage | aberrant slug development | decreased prestalk A cell differentiation | decreased sporulation
DBS0236120	gxcA-	gxcA	decreased activation of GTPase activity | decreased actin filament polymerization | delayed development
DBS0236121	gxcB-	gxcB	decreased exocytosis | delayed development | aberrant cytoskeleton organization
DBS0350256	gxcC-	gxcC	delayed development
DBS0350257	gxcC-/ [act15]: GFP: gxcC	gxcC	wild type
DBS0238825	gxcDD-	gxcDD	aberrant stream morphology | delayed development
LAS105	gxcKK-	gxcKK	decreased socially cooperative development
DBS0350268	gxcT-	gxcT	aberrant activation of GTPase activity | increased lateral pseudopodium formation | aberrant cytokinesis | decreased growth rate | delayed aggregation | decreased establishment of cell polarity | decreased chemotaxis to cAMP | decreased fruiting body size | aberrant protein localization to plasma membrane
DBS0350269	gxcT-/ [act15]: GFP: gxcT	gxcT	wild type
DBS0350656	hatA-/ [hatB]: hatB	hatA | hatB	aberrant cellular response to stress
DBS0236129	hbx2-	hbx2	wild type
DBS0236130	hbx2-	hbx2	wild type
DBS0236131	hbx2-/ warA-	hbx2 | warA	increased basal disc size | development arrests at mound stage | decreased prespore cell differentiation | increased prestalk O cell differentiation
DBS0350324	hbx4-/ [ecmAO]: lacZ	hbx4	increased prespore cell differentiation
DBS0350879	hbx9-	hbx9	decreased cell-cell adhesion | decreased gene expression | delayed aggregation | decreased growth rate | decreased chemotaxis to cAMP
DBS0350880	hbx9-/ [ecmA]: lacZ	hbx9	increased prestalk A cell differentiation
DBS0236153	hcpA-	hcpA	decreased growth rate
DBS0236157	hcpB-	hcpB	wild type
DBS0305109	hdaB-	hdaB	decreased sporulation | decreased histone deacetylase activity
HM1012	helC-	helC	decreased gene expression | delayed development | aberrant fruiting body morphogenesis
HM444	helC-	helC	decreased gene expression | aberrant fruiting body morphogenesis | delayed development
DG1059	helE-	helE	increased slug migration
DBS0236163	helF-	helF	increased migratory slug size | increased stalk cell differentiation | delayed development | increased post-transciptional gene silencing by RNA
DBS0350878	hephA-	hephA	increased response to cAMP | delayed aggregation | aberrant sorocarp development | decreased cAMP level
DBS0350362	hfnA-	hfnA	increased phototaxis | decreased migratory slug size | increased slug migration
DBS0350363	hfnA-/ [ecmO]: lacZ	hfnA	aberrant slug development | aberrant prestalk O cell differentiation
DBS0350364	hfnA-/ abpC-	abpC | hfnA	wild type | aberrant prestalk O cell differentiation | decreased phototaxis
DBS0351593	hgrA-	hgrA | matA	aberrant macrocyst formation
DBS0351590	hgrA-/ KAX3	hgrA	aberrant macrocyst formation
DBS0351594	hgrB-	hgrB | matA	aberrant macrocyst formation
DBS0351591	hgrB-/ KAX3	hgrB	aberrant macrocyst formation
DBS0238583	hipA-	hipA	decreased spore germination | aberrant spore morphology | aberrant cortical actin cytoskeleton organization | aberrant spore coat morphology | increased protein localization to plasma membrane
DBS0305951	hipA-/ epnA-	epnA | hipA	decreased spore germination | aberrant spore morphology
DBS0351165	hspb1-	hsbp1-1 | hsbp1-2	decreased exocytosis | decreased protein level | aberrant protein localization to lysosomal membrane
DBS0351532	hspc300-/ AX2	hspc300	aberrant macropinocytosis | aberrant cytokinesis | decreased cell motility | decreased filopodium formation | abolished protein level
DBS0350289	hspc300-/ [act15]: myc: hspc300	hspc300	wild type
DBS0252818	hssA-	hssA	wild type
DBS0351066	htmA-	htmA	decreased gene expression | aberrant sorocarp development | increased cell-substrate adhesion | decreased cell motility
DBS0349776	htt-	htt	aberrant cell separation during cytokinesis | decreased growth rate | decreased chemotaxis rate | delayed development | delayed gene expression | decreased myosin II assembly
DBS0349788	htt-	htt	aberrant aggregation | abolished stream development | development arrests at loose mound stage | aberrant cellular response to starvation | aberrant spore morphology | decreased spore germination | abolished cell motility in response to calcium ion | increased number of mound tips | aberrant sorocarp development | aberrant hypotonic response | aberrant actin filament organization | abolished culmination | decreased sporulation | aberrant prespore cell differentiation | abolished calcium-independent cell-cell adhesion | abolished protein level | abolished chemotaxis to cAMP
DBS0351281	htt-	htt	abolished gene expression | aberrant sorus morphology | decreased gene expression | decreased growth rate | aberrant slug development | aberrant sorocarp development | delayed development | decreased cAMP level | aberrant prestalk cell differentiation
DBS0349786	htt-/ [act15]: htt: GFP	htt	wild type | aberrant protein level
DBS0350438	ibrA-	ibrA	aberrant substrate adhesion-dependent cell spreading | aberrant contractile vacuole organization | decreased phagocytosis | decreased growth rate | aberrant cytokinesis | aberrant hypotonic response | decreased contractile vacuole discharge
DBS0349794	ibrA-	ibrA	aberrant stalk development
DBS0252699	icmA-	icmA-1 | icmA-2	abolished sporulation | abolished stream development | aberrant extracellular cAMP signaling pathway | abolished establishment of cell polarity | development arrests at mound stage | abolished vegetative growth | aberrant oscillatory cAMP signaling | aberrant fruiting body morphogenesis | aberrant protein localization to nucleus | delayed gene expression | aberrant protein localization
DBS0252702	icmA-/ [act15]: TAP: YFP: rasG	icmA-1 | icmA-2 | rasG	abolished C-terminal protein methylation
DBS0252701	icmA-/ [act15]: hICMT	icmA-1 | icmA-2	wild type
DBS0252700	icmA-/ [act15]: icmA	icmA-1 | icmA-2	wild type
DBS0236421	icpA-	icpA	abolished protein localization to mitotic spindle | aberrant mitosis | aberrant cytokinesis | abolished protein localization to cleavage furrow | abolished protein localization to mitotic spindle midzone | aberrant protein localization
DBS0238521	icpA-/ [act15]: GFP: icpA(1-1013)	icpA	aberrant protein localization to mitotic spindle
BS153	ifkA-	ifkA	increased mound size | precocious aggregation | precocious gene expression | decreased protein secretion
BS161	ifkA-/ ifkB-	ifkA | ifkB	increased mound size | increased number of mound tips | increased cell-cell adhesion | increased cell-substrate adhesion | aberrant fruiting body morphogenesis
BS160	ifkB-	ifkB	increased prestalk gene expression
DBS0236425	ino1-	ino1	increased number of mound tips | decreased phagocytosis | abolished vegetative growth | increased 2,3-bisphosphoglycerate level | decreased myo-inositol level
DBS0350801	ino1-	ino1	aberrant cellular metabolic process | increased number of autophagosomes | decreased cell-substrate adhesion | aberrant phosphatidylinositol metabolism | aberrant cytokinesis | abolished vegetative growth | aberrant fruiting body morphogenesis | decreased myo-inositol level
DBS0266326	iplA-	iplA	abolished cellulose biosynthesis | abolished autophagosome organization | abolished autophagic cell death | aberrant autophagic cell death
HM1038	iplA-	iplA	aberrant cell motility | precocious aggregation | delayed aggregation | aberrant chemotaxis | aberrant calcium-mediated signaling | increased bleb assembly | increased chemotaxis to arachidonic acid | abolished positive regulation of chemorepellant activity
DBS0351539	iplA-/ AX2	iplA	abolished response to DIF-1 | abolished response to cAMP | aberrant GABA signaling pathway
DBS0350439	iplA-/ [act15]: GFP: iplA	iplA	wild type
DBS0252878	iptA-	iptA	decreased spore germination | aberrant sporulation
DBS0350400	iqgC-	iqgC	decreased myosin II assembly
DBS0351225	iqgC-	iqgC	aberrant cytokinesis | increased macropinocytosis | increased phagocytosis
DBS0351435	ireA-	ireA	increased number of autophagosomes | decreased protein level | aberrant vacuole organization | aberrant gene expression | aberrant cellular response to stress | aberrant endoplasmic reticulum organization | aberrant protein localization
DBS0351436	ireA-/ [act15]: ireA(K603N): GFP	ireA	decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress
DBS0351437	ireA-/ [act15]: ireA(N927A): GFP	ireA	decreased protein level | aberrant endoplasmic reticulum organization | aberrant cellular response to stress
DBS0236031	kctd9-	kctd9	wild type
DBS0350057	keaA-	keaA	aberrant extracellular cAMP signaling pathway | decreased gene expression | delayed aggregation | decreased growth rate | decreased cAMP level
DBS0350472	kif1-	kif1	aberrant transport
DBS0350959	kif10-/ [act15]: dhcA(1384-4725)	dhcA | kif10	wild type
DBS0350038	kif11-	kif11	wild type
DBS0236489	kif12-	kif12	aberrant protein localization to mitotic spindle | aberrant cell separation during cytokinesis | aberrant cytokinesis | aberrant myosin II filament organization | increased bleb assembly
DBS0236490	kif12-/ [act15]: FLAG: kif12	kif12	wild type
DBS0302534	kif13-	kif13	precocious mitotic spindle elongation | aberrant mitotic spindle organization
DBS0350039	kif4-	kif4	decreased growth rate
DBS0350042	kif4-/ [act15]: dhcA(1384-4725)	dhcA | kif4	aberrant mitotic spindle organization
DBS0350021	kif5-	kif5	wild type
DBS0350022	kif5-/ [act15]: FLAG: kif5	kif5	aberrant cytokinesis | aberrant cell morphology
DBS0350023	kif5-/ [act15]: FLAG: kif5(342-990)	kif5	aberrant cell morphology
DBS0350024	kif5-/ [act15]: GFP: kif5(805-990)	kif5	aberrant cytokinesis
DBS0236494	kif7-	kif7	decreased cell migration to prestalk region
DBS0350040	kif8-	kif8	aberrant microtubule cytoskeleton organization
DBS0350947	kif8-/ [act15]: dhcA(1384-4725)	dhcA | kif8	wild type
DBS0349964	kif9-	kif9	aberrant mitotic spindle organization | aberrant mitosis | decreased growth rate | aberrant protein localization to nuclear envelope | aberrant centrosome localization | aberrant centromere complex assembly | aberrant centrosome organization
DBS0236491	kil1-	kil1	abolished defense response to Gram-negative bacterium | increased defense response to fungus
DBS0351457	kil1-/ lrrkA-	drkD | kil1	aberrant defense response to bacterium
DBS0350043	kil2-	kil2	aberrant response to cation stress | aberrant defense response to bacterium | decreased protein processing in phagocytic vesicle | abolished defense response to Gram-negative bacterium | increased defense response to fungus
DBS0350874	kil2-	kil2	aberrant defense response to bacterium | decreased growth rate
DBS0350044	kil2-/ [act15]: kil1	kil1 | kil2	abolished defense response to bacterium
DBS0351458	kil2-/ lrrkA-	drkD | kil2	aberrant defense response to bacterium
DBS0350875	kil2-/ vps13F-	kil2 | vps13F	aberrant defense response to bacterium | decreased growth rate
DBS0351502	knkA-	knkA	decreased spore germination | aberrant spore morphology | decreased number of autophagosomes | decreased prespore gene expression | aberrant fruiting body morphogenesis | aberrant phototaxis | decreased sporulation
DBS0236492	krsA-	krsA	decreased chemotaxis to cAMP
DBS0238720	krsA-	krsA	abolished stream development | precocious culmination | abolished activation of adenylate cyclase activity | decreased vegetative cell size | decreased mound size | aberrant hyperosmotic response | precocious gene expression | decreased cAMP level
DBS0236493	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238721	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238722	krsA-/ [act15]: GFP: krsA(K49R)	krsA	aberrant stream morphology
DBS0238723	krsA-/ [act15]: GFP: krsA(T173A)	krsA	abolished stream development
DBS0238725	krsA-/ [act15]: GFP: krsA(deltaC)	krsA	aberrant stream morphology
DBS0238724	krsA-/ [act15]: GFP: krsA(deltaKinase)	krsA	abolished stream development
DBS0238726	krsA-/ [act15]: GFP: krsA(deltaNS)	krsA	abolished stream development
DBS0350598	krsB-	krsB	aberrant stream morphology | decreased cell motility | increased cell-substrate adhesion | delayed development | decreased chemotaxis to cAMP
DBS0350599	krsB-/ [tet]: krsB(T176A): GFP	krsB	aberrant stream morphology
DBS0350600	krsB-/ krsA-	krsA | krsB	aberrant stream morphology | delayed development
DBS0236495	ku80-	ku80	decreased resistance to bleomycin | decreased double-strand break repair via nonhomologous end joining
DBS0350536	ku80-/ dclre1-	dclre1 | ku80	wild type
DBS0350537	ku80-/ myc: ku80(1-782)	ku80	decreased double-strand break repair via nonhomologous end joining
DBS0236498	lagD-	tgrD1	aberrant aggregation | abolished stream development | aberrant extracellular cAMP signaling pathway
DBS0236499	limB-	limB	decreased cell-substrate adhesion | abolished cell migration to prestalk region | development arrests at mound stage | delayed prestalk gene expression | aberrant cell-cell adhesion | decreased prestalk gene expression | decreased chemotaxis rate | aberrant actin filament organization | decreased establishment of cell polarity
DBS0236502	limB-/ [act15]: paxB: GFP	limB | paxB	development arrests at mound stage
DBS0236500	limB-/ [cotC]: limB	limB	development arrests at mound stage
DBS0236501	limB-/ [ecmAO]: limB	limB	wild type
DBS0236729	limB-/ paxB-	limB | paxB	development arrests at mound stage
DBS0350563	limC-	limC	delayed aggregation | decreased growth rate | aberrant cytokinesis | aberrant response to osmotic stress
DBS0350564	limD1-	limD1	increased lateral pseudopodium formation | delayed aggregation | decreased growth rate | aberrant cytokinesis | aberrant response to osmotic stress | decreased chemotaxis to cAMP | decreased establishment of cell polarity | aberrant actin filament organization
DBS0350565	limD1-/ limC-	limC | limD1	delayed aggregation | aberrant cytokinesis | abolished vegetative growth | aberrant response to osmotic stress | decreased chemotaxis to cAMP | aberrant actin filament organization | decreased establishment of cell polarity
DBS0236503	limE-	limE	aberrant cytokinesis
DBS0236506	limF-	limF	decreased phagocytosis
DBS0236511	lipA-	lipA	wild type
DBS0236512	lipA-	lipA	wild type
DG1006	lipA-	lipA	abolished culmination
DG1056	lipB-	captC	aberrant fruiting body morphogenesis
DBS0236515	lis1(D327H)	lis1	aberrant microtubule cytoskeleton organization | increased actin phosphorylation | aberrant Golgi localization
DBS0349950	lmbd2B-	lmbd2B	aberrant chemotaxis | delayed development | aberrant cell morphology | increased pseudopodium formation
DBS0349982	lmnB-	lmnB	aberrant chromatin assembly | aberrant centrosome localization
DBS0350354	lmpA-	lmpA	decreased lysosomal protein degradation | decreased pinocytosis | decreased protein level | decreased phagocytosis | decreased growth rate | decreased cell motility | decreased protein processing in phagocytic vesicle | aberrant phagosome maturation | decreased fruiting body size | decreased defense response to Gram-positive bacterium | decreased sporulation
DBS0351481	lmpB-	lmpB	decreased phagocytosis
DBS0351482	lmpC-	lmpC	decreased protein localization to cell surface | increased protein localization to cell surface
DBS0350452	lpten-	lpten	aberrant cell motility | decreased lateral pseudopodium retraction
DBS0350453	lpten-/ [act15]: lpten: RFP	lpten	wild type
DBS0236516	lrrA-	lrrA	increased mound size | decreased spore germination | decreased cell-substrate adhesion | abolished establishment of cell polarity | decreased gene expression | development arrests at mound stage | increased actin filament polymerization | abolished positive chemotaxis | abolished aggregation | delayed gene expression
DBS0350407	lrrB-	lrrB	aberrant thermotaxis | delayed slug development | aberrant gene expression | aberrant sorocarp development | decreased prestalk gene expression | aberrant phototaxis | aberrant late culminant morphology
DBS0350478	lrrB-/ [ecmB]: lacZ	lrrB	aberrant prestalk B cell differentiation
DBS0350476	lrrB-/ [ecmO]: lacZ	lrrB	aberrant prestalk O cell differentiation
DBS0351456	lrrkA-	drkD	aberrant defense response to bacterium | decreased protein processing in phagocytic vesicle | abolished vegetative growth
DBS0236517	lst8-	lst8	aberrant activation of adenylate cyclase activity | decreased actin filament polymerization | decreased chemotaxis rate | abolished aggregation | decreased myosin II assembly | abolished positive regulation of chemorepellant activity
DBS0350106	lst8-	lst8	increased phagocytosis
DBS0350114	lst8-/ [act15]: GFP: rheb(Q64L)	lst8 | rheb	increased phagocytosis
DBS0309063	lvsA-	lvsA	increased bleb assembly
AD60	lvsA-	lvsA	abolished cytokinesis | decreased pinocytosis | aberrant contractile vacuole organization | decreased phagocytosis | aberrant hypotonic response | increased cell-substrate adhesion
AD63	lvsA-	lvsA	abolished cytokinesis | abolished contractile vacuole dissociation from plasma membrane | aberrant calcium-mediated signaling
DBS0237207	lvsA-/ [act6]: GFP: lvsA(1828- 3619)	lvsA	abolished cytokinesis
DBS0236521	lvsB-	lvsB	increased secretion of lysosomal enzymes | increased lysosome size | increased exocytosis | increased pinocytosis | aberrant protein localization to post-lysosomal vacuole | aberrant phagosome maturation | increased endosome size | aberrant post-lysosomal vacuole exocytosis | increased endosomal vesicle fusion | aberrant lysosome organization
DBS0350567	lvsB-/ [act15]: FLAG: Rab14(N121I)	lvsB | rab14	wild type
DBS0238218	lvsB-[act6]: TAP: GFP: lvsB	lvsB	wild type
DBS0236522	lvsC-	lvsC	wild type
DBS0236523	lvsD-	lvsD	wild type
DBS0236524	lvsE-	lvsE	wild type
DBS0236525	lvsF-	lvsF	wild type
DBS0351162	lyC2-	lyC2	decreased growth rate
DBS0349933	macA-	macA	aberrant macrocyst formation | decreased sexual fusion
DBS0236536	malA-	malA	wild type
DBS0351251	matA-	matA	abolished mating type determination
HM1524	matA-	matA	abolished mating type determination
DBS0350211	mef2A-	mef2A	decreased growth rate | aberrant sorocarp development | aberrant stream morphology | decreased sporulation
DBS0350212	mef2A-	mef2A	decreased growth rate | aberrant stream morphology | aberrant sorocarp development | aberrant gene expression | decreased sporulation
DBS0350213	mef2A-/ [ecmA]: lacZ	mef2A	aberrant prestalk A cell differentiation
DBS0350214	mef2A-/ [ecmB]: lacZ	mef2A	aberrant prestalk B cell differentiation
DBS0350215	mef2A-/ [pspA]: lacZ	mef2A	decreased prespore cell differentiation
DBS0236543	mekA-	mekA	decreased mound size | precocious development | abolished chemotaxis to cAMP
DBS0350030	mekA-/ [act15]: Myc: erkA	erkA | mekA	abolished protein localization to cell cortex
DBS0350036	mekA-/ [act15]: mekA(299-360)	mekA	decreased mound size
DBS0350035	mekA-/ [act15]: mekA(K321A)	mekA	decreased mound size
DBS0350032	mekA-/ [act15]: mekA(S444A/ T448A)	mekA	decreased mound size
DBS0350031	mekA-/ [act15]: mekA(S444E/ T448E)	mekA	development arrests at mound stage
DBS0238098	mekA-/ ppp4C-	mekA | ppp4c	decreased mound size
DBS0238109	mekA-/ ppp4C-/ [act15]: FLAG: pppC	ppp4c	decreased mound size | precocious development
DBS0236542	mekA-/ smkA-	mekA | smkA	decreased mound size
DBS0236544	mfeA-	mfeA	aberrant cellular metabolic process | decreased protein level | aberrant extracellular cAMP signaling pathway | development arrests at mound stage
DBS0351543	mfsd8-	mfsd8	increased protein secretion
DBS0266843	mgp1-	mgp1	increased phototaxis | abolished stream development | increased filopodium formation | aberrant contractile vacuole organization | decreased cell motility | decreased fruiting body size | decreased stalk width | decreased stalk length
DBS0266846	mgp1-/ mgp2-	mgp1 | mgp2	increased filopodium formation | aberrant contractile vacuole organization | aberrant culmination | decreased cell motility | decreased phototaxis | decreased stalk length
DBS0266844	mgp2-	mgp2	increased migratory slug size | increased mound size
HS1	mhcA-	mhcA	development arrests at mound stage | aberrant cytokinesis | decreased growth rate | increased actin filament polymerization | aberrant hypotonic response | aberrant regulation of GTPase activity | abolished bleb assembly | aberrant regulation of protein kinase activity | aberrant cellular response to stress
HS2205	mhcA-	mhcA	abolished cell motility | decreased cell motility
HS2207	mhcA-	mhcA	abolished cytokinesis | development arrests at mound stage
DBS0350064	mhcA-	mhcA	decreased cell motility | decreased establishment of cell polarity
HS2206	mhcA-	mhcA	aberrant cellular response to fluid shear stress | abolished bleb assembly
HK321	mhcA-	mhcA	aberrant cortical actin cytoskeleton organization | aberrant chemotaxis to folate | aberrant cell morphology
HK323	mhcA-	mhcA	decreased cell motility | aberrant stream morphology
DBS0266674	mhcA-/ [act15]: GFP: abpC(9-148)	abpC | mhcA	decreased uropod retraction | decreased pseudopodium retraction
DBS0237564	mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA	ctxA | enlA | mhcA	aberrant mitotic actomyosin contractile ring contraction
DBS0266675	mhcA-/ [act15]: GFP: mhcA(E476K)	mhcA	decreased pseudopodium retraction
DBS0350489	mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1	mhcA | rmd1	abolished protein localization to cleavage furrow
DBS0236548	mhcA-/ [act15]: GFP: pats1(2087-2351)	mhcA | pats1	aberrant cytokinesis
DBS0350291	mhcA-/ [act15]: gppA: GFP	gppA | mhcA	aberrant contractile vacuole morphology | decreased contractile vacuole discharge
DBS0236549	mhcA-/ [act15]: limE(1-145): GFP	limE | mhcA	increased actin filament polymerization
DBS0350808	mhcA-/ [act15]: mhcA(1-933: 1455-2116]	mhcA	wild type | aberrant cytokinesis | aberrant fruiting body morphogenesis
DBS0238158	mhcA-/ [act15]: mhcA(81-2116)	mhcA	decreased growth rate | development arrests at tipped mound stage
CW0401	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	increased myosin II assembly | decreased growth rate | aberrant chemotaxis
DBS0236550	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased filopodium formation
DBS0236551	mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D)	mhcA	increased filopodium formation
DBS0238399	mhcA-/ [act15]: rapA(G12V)	mhcA | rapA	increased establishment of cell polarity | increased actin filament polymerization | aberrant myosin II filament organization
DBS0236552	mhcA-/ [mhcA]: mhcA(1-1224)	mhcA	aberrant cytokinesis | development arrests at mound stage
DBS0350948	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(E683K)	mhcA	aberrant catalytic activity
DBS0350949	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R686C)	mhcA	aberrant catalytic activity
DBS0238157	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H)	mhcA	decreased actin filament sliding
DBS0236547	mhcA-/ [unk]: GFP: icpA	icpA | mhcA	decreased protein localization to cleavage furrow
DBS0350668	mhcA-/ forA-	forA | mhcA	abolished cell motility | decreased cell motility
DBS0351411	mhcA-/ piaA-	mhcA | piaA	aberrant cytokinesis
CW0371	mhkA-	mhkA	increased myosin II assembly | aberrant chemotaxis | decreased cell motility | aberrant protein localization to pseudopodium
DBS0236557	mhkA-/ [act15]: mhkA	mhkA	decreased growth rate | development arrests at mound stage | aberrant cytokinesis | decreased myosin II assembly
CW0431	mhkA-/ mhkB-/ mhkC-	mhkA | mhkB | mhkC	increased myosin II assembly | decreased growth rate | aberrant cytokinesis | aberrant chemotaxis | decreased cell motility
DBS0236556	mhkA-/ mhkC-	mhkA | mhkC	increased myosin II assembly | decreased growth rate | aberrant cytokinesis
CW0394	mhkA/ mhkB	mhkA | mhkB	increased myosin II assembly | decreased growth rate | aberrant cytokinesis
CW0166	mhkB-	mhkB	increased myosin II assembly | decreased cell motility
CW0403	mhkC-	mhkC	increased myosin II assembly | aberrant cytokinesis | aberrant chemotaxis
DG1069	mhkC-	mhkC	aberrant fruiting body morphogenesis
CW0435	mhkD-	mhkD	increased myosin II assembly | decreased cell motility
DBS0236559	midA-	midA	decreased pinocytosis | aberrant cellular homeostasis | aberrant spore morphology | decreased glycogen level | increased ammonia level | decreased thermotaxis | increased autophagy | decreased mitochondrial fission | decreased growth rate | decreased phagocytosis | decreased vegetative cell size | increased slug migration | increased glutamate level | decreased phototaxis
DBS0350123	midA-/ [act15]: GFP: atg18	atg18 | midA	increased number of autophagosomes
DBS0350136	midA-/ [act15]: GFP: tkt	midA | tkt-1 | tkt-2	increased autophagy
DBS0351180	midA/ [act15]: midA(E200A)	midA	aberrant cellular homeostasis | decreased growth rate | decreased phototaxis
DBS0351182	midA/ [act15]: midA(G170V/ G172V)	midA	aberrant cellular homeostasis | decreased growth rate | decreased phototaxis
DBS0351181	midA/ [act15]: midA(N205A)	midA	aberrant cellular homeostasis | decreased growth rate | decreased phototaxis
DG1020	migA-	migA	abolished slug migration | decreased mound size | aberrant fruiting body morphogenesis | decreased fruiting body size
DBS0350958	migA-	migA	decreased gene expression | aberrant chemotaxis to cAMP
DBS0350025	mip1-	mip1-1 | mip1-2	increased mound size | decreased chemotaxis to cAMP
DBS0350027	mip1-/ [act15]: mekA: FLAG	mekA | mip1-1 | mip1-2	aberrant protein localization to cytoplasm
DBS0266620	mipp1-	mipp1	aberrant inositol phosphate metabolic process | increased response to lithium
DBS0309109	mipp1-/ dpoA-	dpoA | mipp1	aberrant inositol phosphate metabolic process | increased response to lithium
DBS0236560	mkcA-	mkcA	decreased prestalk gene expression
DBS0236561	mkcA-/ tagB-	mkcA | tagB	decreased sporulation
DBS0236562	mkcA-/ tagC-	mkcA | tagC	decreased sporulation
DG1101	mkcB-	mkcB	decreased fruiting body size
DBS0236564	mkkA-	mkkA	precocious culmination | decreased sorus size | increased stalk length
DG1121	mkpA-	mkpA	abolished aggregation
DBS0236566	mlcE-	mlcE	aberrant cytokinesis | decreased growth rate | delayed aggregation | aberrant taxis | aberrant sorocarp development | decreased cell motility | aberrant gene expression
DBS0238058	mlcE-/ [act15]: myc: mlcE	mlcE	wild type
DBS0236567	mlcR-	mlcR	aberrant cytokinesis | development arrests at mound stage | aberrant myosin II filament organization
DBS0351550	mlcR-/ [ecmAO]: GFP	mlcR	aberrant development of tipped mound
HS183	mlkA-	mlkA	aberrant cytokinesis
DBS0349919	mlkA-/ [act15]: GFP-mhcA	mlkA	aberrant stalk morphogenesis
DG1033	modA-	modA	decreased response to Gram-negative bacterium | abolished catalytic activity | aberrant fruiting body morphogenesis
DBS0266903	mpl1-	mpl1	abolished stream development | decreased cell motility | decreased chemotaxis to cAMP | abolished aggregation
DBS0266904	mpl1-/ [act15]: flag: mpl1	mpl1	wild type
DBS0349986	mrfA-	mrfA	aberrant slug migration | delayed development
DBS0350391	mrfA-/ [act15]: myc: mrfA(K772A): FLAG	mrfA	aberrant protein modification
DBS0350390	mrfA-/ [act15]: myc: mrfA(S767A): FLAG	mrfA	aberrant protein modification | delayed development
DBS0350389	mrfA-/ [act15]: myc: mrfA: FLAG	mrfA	wild type
DBS0349987	mrfA-/ [emcA]: lacZ	mrfA	decreased prestalk A cell differentiation
DBS0349988	mrfA-/ dimB-/ [emcA]: lacZ	dimB | mrfA	decreased prestalk A cell differentiation
DBS0350960	mroh1-	mroh1	aberrant exocytosis | decreased lysosome size
DBS0236569	mrps4-	mrps4	delayed aggregation | aberrant fruiting body morphogenesis
DBS0304881	mrps4-	mrps4	delayed aggregation
DBS0351541	mscS-/ mclN-/ pkd2-	mcln | mscS | pkd2	aberrant calcium-mediated signaling
DBS0304882	mtDNA-	DidioMp05 | DidioMp21 | DidioMp26 | DidioMp27 | DidioMp30 | DidioMp35 | DidioMp36 | ai2a | ai2b | ai3 | ai4 | atp1 | atp4 | atp6 | atp8 | atp9 | cox1/ 2 | cox3 | cytB | mrpl11 | mrpl14 | mrpl16 | mrpl2 | mrpl6 | mrps12 | mrps13 | mrps14 | mrps19 | mrps2 | mrps4 | mrps7 | mrps8 | nad1 | nad11 | nad2 | nad3 | nad4 | nad4L | nad5 | nad6 | nad7 | nad9 | rnlA	abolished vegetative growth | abolished aggregation
DBS0350868	mtpn-	mtpn	decreased actin filament polymerization | decreased growth rate | decreased cell motility | aberrant stream morphology | decreased macropinocytosis
HM1464	mus81-	mus81	wild type
DBS0350866	mvpA-	mvpA	aberrant cell morphology
DBS0351489	mvpA-/ mvpB-	mvpA | mvpB	decreased growth rate | aberrant cellular component organization
DBS0236570	mybB-	mybB	decreased gene expression | decreased activation of adenylate cyclase activity | decreased cGMP-mediated signaling | abolished aggregation
DBS0236571	mybB-	mybB	abolished aggregation
HM388	mybC-	mybC	decreased gene expression | development arrests at slug stage | decreased prespore gene expression | abolished culmination
DBS0236572	mybE-	mybE	increased migratory slug size | increased gene expression | abolished outer basal disc formation
DBS0349993	mybE-/ [btg]: lacZ	btg | mybE	increased gene expression
DBS0237709	mybE-/ [mrrA]: lacZ	mrrA | mybE	aberrant prestalk cell differentiation
DBS0236573	mybE-/ mybE: GFP	mybE	wild type | aberrant prestalk cell differentiation
HDT1	myoA-	myoA	aberrant aggregation | decreased lateral pseudopodium retraction | delayed aggregation | decreased cell motility | decreased chemotaxis rate | aberrant pseudopodium formation | decreased chemotaxis to cAMP
HDT2	myoA-	myoA	increased secretion of lysosomal enzymes | delayed aggregation
HDT5	myoA-/ myoB-	myoA | myoB	decreased pinocytosis | increased secretion of lysosomal enzymes | increased filopodium formation | aberrant aggregation | aberrant endosomal transport | decreased defense response to Gram-negative bacterium | aberrant cortical actin cytoskeleton organization | increased lateral pseudopodium formation | decreased growth rate | delayed aggregation | decreased cell motility | decreased fruiting body size | aberrant actin filament organization | decreased chemotaxis to cAMP | aberrant cytoskeleton organization
DBS0350990	myoA-/ myoB-/ [act15]: myoB	myoA | myoB	delayed aggregation
DBS0350991	myoA-/ myoB-/ [act15]: myoB(1-1057)	myoA | myoB	decreased pinocytosis | decreased growth rate | aberrant actin filament organization
DBS0350992	myoA-/ myoB-/ [act15]: myoB(S332)	myoA | myoB	decreased pinocytosis | decreased growth rate | aberrant actin filament organization
DBS0351038	myoA-/ myoF-	myoA | myoF	decreased lateral pseudopodium retraction | decreased cell motility | decreased chemotaxis to cAMP | aberrant cell morphology | abolished aggregation
DBS0236579	myoB-	myoB	increased secretion of lysosomal enzymes | aberrant aggregation | decreased lateral pseudopodium retraction | decreased cell motility | decreased chemotaxis to cAMP
DBS0236580	myoB-	myoB	increased lateral pseudopodium formation | decreased phagocytosis | delayed aggregation | decreased cell motility
DBS0349853	myoB-	myoB	decreased phagolysosome size | delayed phagosome reneutralization | aberrant phagosome maturation
DBS0236583	myoB-/ [AS]myoD	myoB | myoD	decreased pinocytosis | aberrant aggregation | decreased growth rate | decreased phagocytosis | decreased mound size | decreased cell motility
DBS0236584	myoB-/ [AS]myoD/ [KD]myoC	myoB | myoC | myoD	decreased pinocytosis | aberrant aggregation | decreased pinosome size | decreased growth rate | decreased phagocytosis | decreased mound size | decreased cell motility | increased number of pinosomes
DBS0351378	myoB-/ [act15]: GFP: myoB(1-720)	myoB	abolished protein localization to plasma membrane
DBS0351379	myoB-/ [act15]: GFP: myoB(1-800,813-1111)	myoB	abolished protein localization to actin wave | abolished protein localization to plasma membrane
DBS0351380	myoB-/ [act15]: GFP: myoB(713-1111)	myoB	abolished protein localization to leading edge
DBS0351367	myoB-/ [act15]: myoB(S332A)	myoB	abolished protein phosphorylation
HDT6	myoB-/ myoC-	myoB | myoC	increased secretion of lysosomal enzymes | decreased pinocytosis | increased filopodium formation | decreased growth rate | decreased cell motility | decreased fruiting body size | aberrant actin filament organization | aberrant cytoskeleton organization
DBS0236585	myoC-	myoC	decreased phagocytosis
HDT4	myoC-	myoC	decreased pinocytosis | decreased phagocytosis
DBS0236587	myoD-	myoD	wild type
DBS0351031	myoD-/ myoE-	myoD | myoE	decreased fruiting body size
DBS0351034	myoD-/ myoE-/ myoF-	myoD | myoE | myoF	decreased actin filament polymerization | aberrant engulfment during phagocytosis | decreased chemotaxis to cAMP | decreased fruiting body size
DBS0351033	myoD-/ myoF-	myoD | myoF	decreased fruiting body size
DBS0351032	myoE-/ myoF-	myoE | myoF	decreased fruiting body size
HDT8	myoF-	myoF	aberrant aggregation | wild type | increased lateral pseudopodium formation | decreased cell motility | decreased chemotaxis to cAMP | aberrant cell morphology
DBS0350251	myoG-	myoG	decreased protein localization to plasma membrane | decreased actin filament polymerization | abolished establishment of cell polarity | aberrant chemotaxis to cAMP | abolished aggregation
DBS0236589	myoI-	myoI	decreased spore germination
DBS0236592	myoI-	myoI	decreased cell-substrate adhesion | aberrant cytokinesis | decreased phagocytosis | aberrant cell morphology
HDT15	myoI-	myoI	decreased phagocytosis
HDT17	myoI-	myoI	decreased cell-cell adhesion | decreased protein level | decreased cell-substrate adhesion | decreased phagocytosis | decreased filopodium formation
DBS0266889	myoI-/ [act15]: GFP: myoI	myoI	wild type
DBS0351400	myoI-/ [act15]: GFP: myoI(1-1020)	myoI	abolished protein localization to pseudopodium | decreased filopodium formation
DBS0351398	myoI-/ [act15]: GFP: myoI(2057-2357)	myoI	increased filopodium formation
DBS0266890	myoI-/ [act15]: GFP: myoI(809-1154)	myoI	decreased phagocytosis
DBS0351399	myoI-/ [act15]: GFP: myoI(K23333A,K2336A)	myoI	increased filopodium formation
DBS0237617	myoI-/ [act15]: gbpD	gbpD | myoI	increased cell-substrate adhesion | aberrant cell morphology | increased pseudopodium formation
HTD7	myoJ-	myoJ	wild type
DBS0350931	myoJ-	myoJ	decreased hypotonic response | aberrant contractile vacuole discharge | aberrant contractile vacuole localization
DBS0349844	myoK-	myoK	aberrant cortical actin cytoskeleton organization | delayed aggregation | decreased phagocytosis | aberrant engulfment during phagocytosis | aberrant phagosome maturation | decreased chemotaxis rate | aberrant cell morphology | delayed phagosome acidification
DBS0349846	myoK-/ [act15]: YFP: myoK(1-121: 262-858)	myoK	decreased phagocytosis
DBS0349850	myoK-/ [act15]: myoK	myoK	increased phagocytosis
DBS0349854	myoK-/ [act15]: pakB(1-337: 563-852)	myoK | pakB	wild type
DBS0236595	myoM-	myoM	wild type
DBS0351046	nad2-	nad2	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant fruiting body morphogenesis | aberrant phototaxis
DBS0351048	nad5-	nad5	decreased defense response to Gram-negative bacterium | decreased gene expression | decreased growth rate | aberrant phototaxis
AK1372	nagB1-	nagB1	decreased response to Gram-positive bacterium
DBS0236596	napA-	napA	aberrant cellular response to extracellular stimulus
SB12	napA-	napA	decreased cell-cell adhesion | decreased cell-substrate adhesion | decreased actin filament polymerization | decreased cell motility | decreased vegetative cell size | decreased establishment of cell polarity | decreased phototaxis
DBS0351534	napA-/ AX2	napA	decreased protein level | increased membrane ruffling | aberrant cytokinesis | increased vegetative cell size | decreased cell motility
SB14	napA-/ pirA-	napA | pirA	decreased actin filament polymerization
HC476	ncsA-	ncsA	increased cAMP level | precocious gene expression | precocious development
HC477	ncsA-	ncsA	increased cAMP level | precocious gene expression | precocious development
DBS0350297	ncstn-	ncstn	aberrant culmination | abolished catalytic activity | decreased prespore cell differentiation
DBS0350307	ncstn-	ncstn	wild type | aberrant sorocarp development | decreased macropinocytosis
DBS0350301	ncstn-/ psenA-	ncstn | psenA	aberrant culmination | decreased prespore cell differentiation
DBS0349947	ndm-	ndm	aberrant chemotaxis | increased pinocytosis | decreased fruiting body size | aberrant pseudopodium formation
DBS0349895	ndrA-	ndrA	decreased engulfment during phagocytosis
DBS0349896	ndrA-/ [unk]: GFP: ndrA	ndrA	wild type
DBS0350446	ndrC-	ndrC	increased positive regulation of GTPase activity | increased number of centrosomes | aberrant cell separation during cytokinesis
DBS0350121	ndufaf5-	ndufaf5	aberrant spore morphology | decreased growth rate | delayed development | aberrant phototaxis | decreased fruiting body size | decreased sporulation
DBS0350125	ndufaf5--/ [act15]: ndufaf5(G86V): GFP: TAP	ndufaf5	decreased growth rate
DBS0350126	ndufaf5--/ [act15]: ndufaf5(L165F): GFP: TAP	ndufaf5	decreased growth rate
DBS0350127	ndufaf5--/ [act15]: ndufaf5(L235P): GFP: TAP	ndufaf5	decreased growth rate
DBS0350124	ndufaf5--/ [act15]: ndufaf5: GFP: TAP	ndufaf5	wild type
DBS0350122	ndufaf5-/ [act15]: GFP: atg18	atg18 | ndufaf5	increased number of autophagosomes
DBS0350134	ndufaf5-/ [act15]: GFP: tkt	ndufaf5 | tkt-1 | tkt-2	increased autophagy
DBS0350137	ndufaf5-/ [act15]: [AS]snfA	ndufaf5 | snfA	aberrant phototaxis
DBS0304633	nfaA-	nfaA	aberrant extracellular cAMP signaling pathway | aberrant activation of GTPase activity | increased actin filament polymerization | delayed aggregation | decreased cell motility | aberrant regulation of GTPase activity | aberrant regulation of protein kinase activity | aberrant protein localization to plasma membrane | decreased chemotaxis to cAMP | increased pseudopodium formation
DBS0304634	nfaA-/ rasG-	nfaA | rasG	decreased establishment of cell polarity
DBS0351061	ngap-	ngap	aberrant regulation of fruiting body formation | aberrant extracellular cAMP signaling pathway | aberrant adaptation of signaling pathway | increased actin filament polymerization | aberrant chemotaxis to cAMP | aberrant regulation of protein kinase activity | decreased establishment of cell polarity | increased activation of GTPase activity
DBS0236604	nhe1-	nhe1	abolished cell motility in response to calcium ion | decreased intracellular pH | abolished establishment of cell polarity | decreased actin filament polymerization | decreased chemotaxis rate | delayed development | aberrant actin filament organization | decreased establishment of cell polarity | abolished chemotaxis to cAMP
DBS0350003	nhe1-/ [act15]: GFP: aip1	aip1 | nhe1	decreased establishment of cell polarity | decreased chemotaxis to cAMP
DBS0350006	nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A)	aip1 | nhe1	abolished aggregation | abolished chemotaxis to cAMP
DBS0350001	nhe1-/ [act15]: aip1(168-597)	aip1 | nhe1	delayed development
DBS0350002	nhe1-/ [act15]: aip1(383-597): FLAG	aip1 | nhe1	decreased actin filament polymerization | abolished establishment of cell polarity | abolished chemotaxis to cAMP
DBS0349841	nhe1-/ [act15]: mhcA: GFP	mhcA | nhe1	abolished protein localization to trailing edge
DBS0236605	nhe1-/ [act15]: nhe1: HA	nhe1	wild type
DBS0350508	nlp-	nlp	wild type
DBS0350509	nlp-/ slp-	nlp | slp	decreased actin filament polymerization | aberrant organelle organization | abolished protein localization to cytoplasmic vesicle | decreased chemotaxis to cAMP
DBS0351466	nola4(I23T)	nola4	decreased resistance to bleomycin | decreased growth rate | increased growth rate | aberrant response to oxidative stress
DBS0351467	nola4(T33M)	nola4	decreased resistance to bleomycin | decreased gene expression | decreased growth rate | increased growth rate | aberrant response to oxidative stress
DBS0236606	nosA null (15-S-12)	nosA	development arrests at mound stage
DBS0236607	nosA null (2E4)	nosA	development arrests at mound stage
DBS0235950	nosA-	nosA	development arrests at mound stage | aberrant protein modification
DBS0236941	nosA-/ sonA-	nosA | sonA	wild type
DBS0236608	noxA-	noxA	abolished sporulation | aberrant sorocarp development
DBS0236611	noxA-/ [act15]: noxA: myc2	noxA	aberrant fruiting body morphogenesis
DBS0236610	noxA-/ noxB	noxA | noxB	abolished sporulation | aberrant sorocarp development | decreased superoxide generation
DBS0350768	noxA-/ noxB-/ noxC-	noxA | noxB | noxC	aberrant defense response to bacterium
DBS0236612	noxB-	noxB	abolished sporulation | aberrant sorocarp development | decreased superoxide generation
DBS0236613	noxC-	noxC	abolished sporulation | aberrant sorocarp development
DBS0238849	npcA-	npcA	wild type
HSB60	nramp1-	nramp1	decreased defense response to Gram-negative bacterium | decreased defense response to Gram-positive bacterium | abolished iron ion transport
DBS0236696	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0236697	nramp1-/ [act15]: nramp1: GFP	nramp1	increased defense response to Gram-negative bacterium
DBS0350092	nrampB-	nrampB	decreased defense response to Gram-negative bacterium | delayed aggregation
DBS0350093	nrampB-/ nramp1-	nramp1 | nrampB	increased number of tip-organizers | decreased defense response to Gram-negative bacterium | delayed aggregation
HM1060	nsfA(A1847G, A1939T, T1977C, T2005G, A2025T, A2366T)	nsfA	decreased rate of endocytosis | decreased phagocytosis | abolished cell motility | decreased actin filament polymerization at leading edge
HM1067	nsfA(A1854T, T1984A, C2131A, A2398T, T2574A)	nsfA	decreased rate of endocytosis | abolished cell motility | decreased cell motility | aberrant hypotonic response | decreased actin filament polymerization at leading edge | increased phagocytosis
DBS0236955	nxnA-	nxnA	decreased lysosomal protein degradation | decreased culmination | decreased growth rate | delayed development | decreased chemotaxis to cAMP
DBS0351164	nxnA-	nxnA	aberrant cellular response to stress
DBS0236702	nxnA-/ [act15]: GFP: nxnB	nxnA | nxnB	development arrests at mound stage
DBS0350857	odc-	odc	aberrant cellular metabolic process | aberrant cell cycle | abolished vegetative growth
DBS0236704	osbA-	osbA	increased slug migration | precocious development
DBS0238357	p2xA-	p2xA	aberrant hypotonic response
DBS0304487	p2xA-	p2xA	wild type
DBS0350312	p2xA-	p2xA	aberrant contractile vacuole organization | abolished hypotonic response | decreased contractile vacuole size | aberrant regulation of GTPase activity
DBS0350484	p2xA-/ AX2	p2xA	wild type | aberrant contractile vacuole discharge
DBS0350485	p2xA-/ AX4	p2xA	aberrant contractile vacuole discharge | aberrant hypotonic response
DBS0238362	p2xA-/ [act15]: p2xA: GFP	p2xA	wild type
DBS0350315	p2xA-/ p2xA(K67A/ K289A)	p2xA	abolished hypotonic response
DBS0350314	p2xA-/ p2xA(R285K)	p2xA	decreased hypotonic response
DBS0350313	p2xA-/ p2xA(R63A)	p2xA	precocious hypotonic response
DBS0306169	p2xA-/ p2xB-/ p2xC-/ p2xD-/ p2xE-	p2xA | p2xB | p2xC | p2xD | p2xE	delayed hypotonic response | decreased growth rate
DBS0306166	p2xB-	p2xB	wild type
DBS0306167	p2xC-	p2xC	wild type
DBS0306168	p2xD-	p2xD	wild type
DBS0304486	p2xE-	p2xE	wild type
DBS0304465	padA(1-276)	padA	aberrant aggregation | decreased cell-cell adhesion | decreased gene expression | development arrests at slug stage | delayed aggregation | aberrant stalk cell differentiation | aberrant chemotaxis to cAMP | aberrant stream morphology | aberrant fruiting body morphogenesis | delayed development
DBS0350013	pah-	pah	abolished catalytic activity | abolished vegetative growth
DBS0350014	pah-/ [act15]: 6xHis: pah	pah	wild type
DBS0350016	pah-/ [act15]: 6xHis: pah(92-415)	pah	abolished vegetative growth
DBS0350015	pah-/ [act15]: 6xHis: pah(92-441)	pah	wild type
DBS0236705	pakA-	pakA	aberrant cytokinesis | delayed development | decreased myosin II assembly
DBS0236706	pakA-	pakA	wild type
DBS0349885	pakA-	pakA	delayed development | decreased chemotaxis to cAMP | increased bleb assembly
DBS0236707	pakA-/ [act15]: pakA	pakA	wild type
DBS0350810	pakA-/ [act15]: pakA(T579A)	pakA	decreased chemotaxis to cAMP
DBS0349889	pakA-/ [act15]: pakA: GFP	pakA	wild type
DBS0236709	pakB-	pakB	decreased growth rate | decreased bleb assembly
DBS0236708	pakB-	pakB	abolished establishment of cell polarity | decreased lateral pseudopodium retraction
DBS0236712	pakB-/ [act15]: GFP-pak(1-600)	pakB	abolished cytokinesis
DBS0236710	pakB-/ [act15]: GFP-pakB(1-337: 563-851)	pakB	abolished cytokinesis | increased pinocytosis | increased phagocytosis
DBS0350428	pakB-/ [act15]: RFP: abpE	abpE-1 | abpE-2 | pakB	decreased chemotaxis to cAMP | aberrant establishment or maintenance of cell polarity | abolished aggregation | abolished protein localization to leading edge
DBS0350430	pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180)	abpE-1 | abpE-2 | pakB	wild type
DBS0236715	pakB-/ pakC-	pakB | pakC	decreased chemotaxis rate
DBS0236717	pakC(K121H/ E124L)	pakC	abolished protein binding
DBS0236719	pakC(R34C)	pakC	decreased lateral pseudopodium retraction | decreased chemotaxis rate
DBS0236720	pakC(S466A/ P470A)	pakC	decreased lateral pseudopodium retraction | decreased chemotaxis rate
DBS0236716	pakC-	pakC	decreased lateral pseudopodium retraction | decreased bleb assembly | decreased chemotaxis rate
DBS0350281	pakD-	pakD	aberrant cellular homeostasis | aberrant filopodium formation | aberrant actin cytoskeleton organization | abolished negative regulation of vegetative growth | abolished aggregation | aberrant actin filament polymerization | aberrant establishment or maintenance of cell polarity | decreased chemotaxis to cAMP | increased growth rate | aberrant cellular response to extracellular stimulus | abolished positive regulation of chemorepellant activity
DBS0350282	pakD-/ [act15]: pakD	pakD	development arrests at mound stage
DBS0350395	pakD-/ [act15]: pakD: GFP	pakD	wild type
HC392	patB-	patB	abolished vegetative growth
DBS0236726	pats1-	pats1	aberrant cytokinesis
DBS0350097	pats1-	pats1	aberrant cytokinesis
LAS45	pats1-	pats1	decreased socially cooperative development
DBS0236727	pats1-/ [act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0236728	paxB-	paxB	decreased exocytosis | decreased cell-substrate adhesion | abolished slug migration | increased chemotaxis to cAMP | development arrests at mound stage | decreased prespore gene expression | aberrant fruiting body morphogenesis | decreased cell migration to prestalk region | increased phagocytosis
DBS0304926	paxB-	paxB	aberrant cell separation during cytokinesis | decreased cell-substrate adhesion | aberrant cytokinesis | decreased cell motility
DBS0304930	paxB-/ [act15]: GFP: paxB	paxB	wild type
DBS0350973	paxB-/ [act15]: gpaH	gpaH | paxB	aberrant cytokinesis
DBS0350094	paxB-/ [act15]: pldB	paxB | pldB	wild type | increased phagocytosis
DBS0236730	paxB-/ [ecmA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0236732	paxB-/ [pspA]: paxB: GFP	paxB	decreased cell migration to prestalk region
DBS0304929	paxB-/ mhcA-	mhcA | paxB	aberrant cytokinesis
DBS0236733	pcp-	pcp	wild type | aberrant hypotonic response
DBS0236734	pde4-	pde4	decreased culmination | abolished stream development | delayed slug development | increased number of early culminant tips | increased protein level | delayed culmination
DBS0236735	pde4-/ [act15]: pde4: GFP	pde4	wild type
DBS0235991	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity
DBS0236736	pdeD-	pdeD	aberrant calcium-mediated signaling
DBS0350517	pdeD-	pdeD	decreased 3',5'-cyclic-GMP phosphodiesterase activity | increased fruiting body size | aberrant stream morphology
DBS0351194	pdeD-	pdeD	decreased protein localization to cell cortex | abolished protein localization to cell cortex | aberrant chemotaxis to cAMP | aberrant actin filament polymerization | decreased myosin II assembly | increased activation of GTPase activity
DBS0350518	pdeD-/ [act15]: pdeD: YFP	pdeD	wild type
DBS0235992	pdeD-/ pdeE-	pdeD | pdeE	decreased protein localization to cell cortex | decreased 3',5'-cyclic-GMP phosphodiesterase activity | decreased 3',5'-cyclic-AMP phosphodiesterase activity | decreased lateral pseudopodium formation | increased protein kinase activation
DBS0350893	pdeD-/ pdeE-/ [unk]: pdeE	pdeD | pdeE	delayed aggregation
DBS0350900	pdeE-	pdeE	increased oscillatory cAMP signaling | abolished 3',5'-cyclic-AMP phosphodiesterase activity
DBS0235993	pdeE-	pdeE	decreased 3',5'-cyclic-AMP phosphodiesterase activity | aberrant chemotaxis to cAMP
DBS0236740	pdiA-	pdiA	decreased mound size | aberrant oscillatory cAMP signaling | decreased fruiting body size
DBS0350797	pdkA-	pdkA	aberrant macropinocytosis | decreased protein kinase activation
DBS0350817	pdkA-	pdkA	decreased mound size | decreased protein kinase activation
DBS0350799	pdkA-/ pdkB-	pdkA | pdkB	aberrant chemotaxis to cAMP | development arrests at mound stage | decreased protein kinase activation | decreased establishment of cell polarity
DBS0350819	pdkA-/ pdkB-	pdkA | pdkB	aberrant sorocarp development
DBS0350798	pdkB-	pdkB	increased macropinocytosis
DBS0350818	pdkB-	pdkB	decreased mound size
DBS0237029	pdsA-	pdsA	aberrant chemotaxis to cAMP | aberrant stream morphology
UK7	pdsA-	pdsA	decreased 3',5'-cyclic-AMP phosphodiesterase activity | decreased gene expression | aberrant sorocarp development | abolished aggregation
HPX235	pdsA-	pdsA	abolished catalytic activity | abolished aggregation
DBS0236741	pefA-	pefA	wild type
DBS0236742	pefA-/ pefB-	pefA | pefB	wild type
DBS0236744	pefB-	pefB	wild type
DBS0236745	pefB-/ cybA-	cybA | pefB	wild type
DBS0236746	pefB-/ noxA-	noxA | pefB	wild type
DBS0236747	pefB-/ noxA-/ [act15]: pefB	noxA | pefB	aberrant sorocarp development
DBS0236748	pefB-/ noxB-	noxB | pefB	wild type
DBS0236749	pefB-/ noxC-	noxC | pefB	abolished sporulation | aberrant sorocarp development
HW260	pgtA-	pgtA	increased vegetative cell size
DBS0305022	pgtB-	pgtB	aberrant cellular metabolic process | aberrant spore coat morphology | aberrant hyperosmotic response
DBS0305024	pgtB-/ pgtC-	pgtB | pgtC	aberrant cellular metabolic process | aberrant spore coat morphology | aberrant hyperosmotic response
DBS0305023	pgtC-	pgtC	aberrant cellular metabolic process | aberrant hyperosmotic response
DBS0236752	phdA-	phdA	decreased actin filament polymerization | decreased mound size | decreased chemotaxis rate | decreased fruiting body size
DBS0236753	phdA-/ [act15]: phdA	phdA	wild type
DBS0236754	phdA-/ [act15]: phdA: GFP	phdA	wild type
DBS0350865	phdG-	phdG	decreased chemotaxis to cAMP
DBS0236755	phg1A-	phg1A	increased secretion of lysosomal enzymes | decreased lysosomal protein degradation | decreased protein level | decreased cell-substrate adhesion | decreased gene expression | aberrant defense response to bacterium | aberrant cytokinesis | decreased phagocytosis | abolished defense response to bacterium | decreased growth rate | development arrests at slug stage | decreased protein localization to cell surface | aberrant phagocytosis | increased lysosomal pH | decreased protein stabilization
DBS0351549	phg1A-	phg1A	decreased cell-substrate adhesion | decreased phagocytosis
DBS0236757	phg1A-/ [act15]: kil1	kil1 | phg1A	decreased lysosomal protein degradation | increased secretion of lysosomal enzymes | wild type | increased lysosomal pH | decreased protein stabilization
DBS0304869	phg1A-/ [act15]: phg1A(1-276): phg1B221-587)	phg1A | phg1B	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1B	phg1A | phg1B	increased secretion of lysosomal enzymes | wild type | decreased cell-substrate adhesion | aberrant protein level | decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1B(1-220): phg1a(277-642)	phg1A | phg1B	decreased phagocytosis
DBS0304872	phg1A-/ phg1B-	phg1A | phg1B	increased secretion of lysosomal enzymes | decreased cell-substrate adhesion | decreased phagocytosis | decreased growth rate | development arrests at tipped mound stage | abolished culmination
DBS0304866	phg1B-	phg1B	increased secretion of lysosomal enzymes | decreased protein level | decreased phagocytosis | decreased growth rate | abolished culmination
DBS0236758	phg2-	phg2	decreased cell-substrate adhesion | decreased phagocytosis | aberrant cytokinesis | decreased cell motility | aberrant cell morphology | aberrant actin filament organization | precocious development | precocious gene expression | aberrant response to nutrient
DBS0238400	phg2-	phg2	increased filopodium formation | increased actin filament polymerization | increased cell-substrate adhesion | decreased chemotaxis to cAMP | aberrant cell morphology | increased phagocytosis
DBS0350578	phg2-	phg2	abolished gene expression | decreased protein phosphorylation | aberrant protein localization to nucleus
DBS0236760	phg2-/ [act15]: GFP: phg2(199-1389)	phg2	decreased phagocytosis
DBS0237615	phg2-/ [act15]: gbpD	gbpD | phg2	aberrant cell morphology | abolished chemotaxis to cAMP | increased pseudopodium formation
DBS0350580	phg2-/ [act15]: myc: ptpC	phg2 | ptpC	abolished protein phosphorylation
HG1648	phgA-	phgA	increased contractile vacuole size | aberrant contractile vacuole organization | aberrant hypotonic response | aberrant pore formation during contractile vacuole discharge
DBS0302610	phgA-/ [OE]: dsgg	dsgg | phgA	aberrant contractile vacuole organization
DBS0236761	phgA-/ lvsA-/ [act6]: GFP: lvsA	lvsA | phgA	aberrant protein localization to contractile vacuole
DBS0236762	phlp1-	phlp1	decreased response to cAMP | aberrant regulation of protein modification | abolished chemotaxis to folate | decreased growth rate | abolished protein localization to plasma membrane | decreased cGMP-mediated signaling | abolished aggregation | abolished chemotaxis to cAMP
DBS0236763	phlp1-/ [OE]: phpl1	phlp1	wild type
DBS0236764	phlp3-	phlp3	wild type
DBS0350824	phr-	phr	aberrant chemotaxis to cAMP | delayed development
HW288	phyA-	phyA	abolished sporulation | abolished stalk development | abolished peptidyl-proline hydroxylation | abolished culmination | increased response to hypoxia
DBS0266771	phyA-/ [ecmA]: phyA(D132N): myc	phyA	decreased peptidyl-proline hydroxylation
DBS0266770	phyA-/ [ecmA]: phyA(R276A): myc	phyA	abolished peptidyl-proline hydroxylation | abolished culmination
	piaA(G917D)	piaA
DBS0236769	piaA(G917D)/ [act15]: piaA	piaA	delayed aggregation
DBS0351455	piaA(G917D)/ [unk]: GFP: piaA(G963E)	piaA	abolished aggregation
DBS0350882	piaA(G917D)/ acrA-	acrA | piaA	abolished gene expression | abolished establishment of cell polarity | abolished chemotaxis to cAMP
DBS0350877	piaA(G917D)/ hephA-	hephA | piaA	increased response to cAMP | wild type | abolished activation of adenylate cyclase activity | decreased cAMP level
DBS0236767	piaA-	piaA	aberrant activation of adenylate cyclase activity
DBS0236770	piaA-	piaA	aberrant cytokinesis
DBS0236771	piaA-	piaA	abolished aggregation | decreased myosin II assembly | increased phagocytosis
DBS0304637	piaA-	piaA	decreased cell motility | decreased chemotaxis rate | decreased establishment of cell polarity | aberrant protein tyrosine phosphorylation
DBS0351319	piaA-	piaA	decreased taxis
DBS0349879	piaA-	piaA	decreased protein phosphorylation | decreased protein kinase activity | abolished protein phosphorylation | decreased chemotaxis to cAMP | aberrant protein localization to plasma membrane | increased activation of GTPase activity | abolished positive regulation of chemorepellant activity
DBS0351403	piaA-	piaA	aberrant cytokinesis
DBS0236779	pik6-	pik6	decreased gene expression | abolished aggregation
DBS0236772	pikA-	pikA	wild type
DBS0236766	pikA-/ pikB-	pikA | pikB	aberrant negative chemotaxis | decreased response to bacterium | decreased actin filament polymerization | decreased activation of GTPase activity | abolished protein localization to plasma membrane | aberrant chemotaxis to cAMP | decreased cell motility | abolished protein kinase activation | abolished protein localization to trailing edge | decreased chemotaxis to folate | decreased chemotaxis to cAMP | decreased myosin II assembly
DBS0236773	pikA-/ pikB-	pikA | pikB	abolished stream development | decreased pinocytosis | aberrant aggregation | decreased exocytosis | aberrant activation of adenylate cyclase activity | aberrant macropinocytosis | abolished protein localization to plasma membrane | delayed aggregation | decreased spore cell differentiation | increased cAMP level | abolished vegetative growth | aberrant sorocarp development | aberrant phagolysosome formation | aberrant phagosome maturation | decreased phosphatidylinositol biosynthesis | aberrant fruiting body morphogenesis | aberrant actin filament organization | aberrant cell morphology
HM1141	pikA-/ pikB-	pikA | pikB	decreased pinocytosis | decreased growth rate | decreased cell motility | decreased taxis
DBS0350471	pikA-/ pikB-/ [act15]: GFP: cap	cap | pikA | pikB	wild type
DBS0252703	pikA-/ pikB-/ pikC-	pikA | pikB | pikC	decreased protein localization to leading edge | increased cell motility
HM1200	pikA-/ pikB-/ pikC-/ pikF-/ pikG-	pikA | pikB | pikC | pikF | pikG	aberrant aggregation | decreased pinocytosis | decreased protein tyrosine phosphorylation | increased chemotaxis to folate | aberrant macropinocytosis | decreased growth rate | decreased phagocytosis | decreased cell motility | increased bleb assembly | decreased chemotaxis to cAMP | aberrant protein localization to plasma membrane | aberrant signal transduction
HM1284	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pikH-	pikA | pikB | pikC | pikF | pikG | pikH	decreased defense response to Gram-negative bacterium | decreased cell motility
HM1295	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pten-	pikA | pikB | pikC | pikF | pikG | pten	aberrant aggregation | decreased defense response to Gram-negative bacterium | decreased growth rate | decreased cell motility | increased resistance to N-Phenylthiourea
DBS0238073	pikA-/ pikB-/ plaA-	pikA | pikB | plaA	decreased actin filament polymerization | delayed aggregation | aberrant chemotaxis to cAMP | abolished positive chemotaxis
DBS0236774	pikB-	pikB	wild type
DBS0236776	pikC-	pikC	wild type
DBS0236777	pikD1	pikD	abolished slug migration | delayed aggregation | decreased mound size | aberrant fruiting body morphogenesis | decreased sporulation
DBS0236778	pikE-	pikE	wild type
HM1241	pikF-	pikF	decreased pinocytosis | decreased growth rate | aberrant pinosome maturation
LAS31	pikG-	pikG	aberrant socially cooperative development
HM1513	pikI-	pikI	decreased catalytic activity | decreased actin filament polymerization | decreased growth rate | aberrant chemotaxis to cAMP | decreased cGMP-mediated signaling | aberrant calcium-mediated signaling | decreased protein kinase activation | increased bleb assembly
DBS0350828	pinA-/ [ecmAO]: lacZ	pinA	aberrant prestalk cell differentiation
DBS0350827	pinA-/ [pspA]: lacZ	pinA	aberrant prespore cell differentiation
DBS0351429	pip5k3-/ AX2	pip5k3	decreased defense response to Gram-negative bacterium | aberrant defense response to bacterium | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle | decreased protein localization to phagocytic vesicle
DBS0351428	pip5k3-/ AX3	pip5k3	aberrant macropinocytosis | decreased growth rate
SB16	pirA-	pirA	decreased vegetative cell size | increased cell motility
SB3	pirA-	pirA	increased actin filament polymerization | increased vegetative cell size | decreased cell motility | aberrant cellular response to stress | increased pseudopodium formation
DBS0351205	pirA-	pirA	decreased cell motility | aberrant pseudopodium formation | abolished protein level
DBS0351533	pirA-/ AX2	pirA	decreased protein level | aberrant macropinocytosis | aberrant cytokinesis | increased vegetative cell size | decreased cell motility | decreased pseudopodium formation | increased bleb assembly | decreased filopodium formation
DBS0351206	pirA-/ pirA(K193D/ R194D): EGFP	pirA	abolished protein localization to cell periphery | decreased protein phosphorylation
DBS0349901	pisA-	pisA	increased gene expression | precocious development | decreased fruiting body size | aberrant prestalk cell differentiation
DBS0236783	pkaC-	pkaC	abolished gene expression | increased protein phosphorylation | aberrant response to abiotic stimulus | decreased protein level | decreased gene expression | decreased activation of GTPase activity | abolished catalytic activity | aberrant response to cAMP | increased cellular thermotolerance | aberrant myosin II filament organization | decreased protein kinase activation | abolished aggregation | aberrant actin filament organization | aberrant protein localization to plasma membrane | aberrant protein localization to cell cortex | abolished chemotaxis to cAMP | increased protein kinase activation | increased activation of GTPase activity | abolished positive regulation of chemorepellant activity
DBS0350694	pkaC-/ [act15]: pkaC	pkaC	abolished culmination
DBS0350708	pkaC-/ [act6]: pkaC(303-648)	pkaC	wild type
DBS0350707	pkaC-/ [act6]: pkaC(330-648)	pkaC	abolished aggregation
DBS0350710	pkaC-/ [dscC]: LUC	pkaC	decreased gene expression | increased macropinocytosis
DBS0236782	pkaC-/ gdt1-	gdt1 | pkaC	increased gene expression | abolished aggregation
HTY217	pkaR(A31T)	pkaR	abolished protein kinase activation | precocious development
DBS0235411	pkaR-	pkaR	abolished stream development | increased resistance to valproic acid | decreased spore germination | aberrant extracellular cAMP signaling pathway | aberrant response to lithium | increased gene expression | precocious sporulation | increased lateral pseudopodium formation | aberrant chemotaxis to cAMP | decreased cell motility | decreased fruiting body size | aberrant cell morphology
DBS0351315	pkbA-	pkbA	decreased macropinocytosis
DBS0236784	pkbA-	pkbA	decreased pinocytosis | decreased protein phosphorylation | aberrant macropinocytosis | decreased bleb assembly | abolished protein kinase activation | abolished protein localization | abolished protein localization to trailing edge | aberrant phagosome maturation | increased phagocytosis | decreased myosin II assembly
DBS0349876	pkbA-	pkbA	aberrant cellular response to extracellular stimulus | increased protein kinase activation
DBS0350113	pkbA-/ [act15]: GFP: rheb(Q64L)	pkbA | rheb	decreased phagocytosis
DBS0236785	pkbA-/ pkgB-	pkbA | pkgB	aberrant chemotaxis to cAMP | abolished vegetative growth | decreased chemotaxis rate | abolished protein phosphorylation | abolished aggregation | aberrant cellular response to extracellular stimulus | increased activation of GTPase activity | increased protein kinase activation
DBS0304640	pkbA-/ pkgB-	pkbA | pkgB	aberrant cell motility | abolished vegetative growth
DBS0351317	pkbA-/ pkgB-	pkbA | pkgB	aberrant macropinocytosis | abolished vegetative growth | abolished macropinocytosis
DBS0350916	pkcA-	pkcA	decreased cell-cell adhesion | decreased protein level | increased chemotaxis to cAMP | decreased gene expression | increased number of mound tips | increased actin filament polymerization | aberrant oscillatory cAMP signaling | decreased fruiting body size | abolished positive regulation of chemorepellant activity
DBS0350918	pkcA-	pkcA	aberrant aggregation | decreased catalytic activity | aberrant cytokinesis | aberrant sorocarp development
DBS0350919	pkcA-/ [act15]: pldB	pkcA | pldB	aberrant aggregation | decreased sporulation
DBS0350917	pkcA-/ [ecmA]: GFP	pkcA	aberrant prestalk gene expression
DBS0350475	pkd2-	pkd2	increased resistance to naringenin | decreased growth rate
DBS0350367	pkd2-	pkd2	aberrant cellular response to fluid shear stress | aberrant exocytosis
DBS0351540	pkd2-/ AX2	pkd2	aberrant calcium-mediated signaling
DBS0351542	pkd2-/ iplA-	iplA | pkd2	aberrant calcium-mediated signaling
DBS0236786	pkgB-	pkgB	decreased protein phosphorylation | development arrests at mound stage | abolished spore cell differentiation
DBS0350328	pkgB-	pkgB	aberrant sorocarp development
DBS0351316	pkgB-	pkgB	decreased macropinocytosis
DBS0304638	pkgB-	pkgB	decreased cell-substrate adhesion | development arrests at mound stage | decreased chemotaxis rate | decreased taxis | increased cell motility | increased bleb assembly
DBS0236787	pkgB-/ [act15]: pkbA	pkbA | pkgB	wild type
DBS0236789	pkgB-/ [act15]: pkgB(K182M)	pkgB	development arrests at mound stage
DBS0350329	pkgB-/ [emcB]: lacZ	pkgB	abolished prestalk gene expression
DBS0236790	pkgB-/ [gbfA]: pkbA	pkbA | pkgB	wild type
DBS0236791	pkgB-/ [gbfA]: pkgB	pkgB	wild type
DBS0350319	pks17-	pks17	decreased fatty acid level | increased gene expression | delayed development | decreased fruiting body size
LAS44	pks2-	pks2	decreased socially cooperative development
LAS19	pks26-	pks26	aberrant socially cooperative development
DBS0238068	plaA-	plaA	aberrant chemotaxis to cAMP | abolished aggregation | abolished positive regulation of chemorepellant activity
DBS0238067	plaA-	plaA	abolished aggregation
DBS0306196	plaA-	plaA	aberrant chemotaxis to cAMP | decreased bleb assembly | decreased necrotic cell death
DBS0350831	plaA-/ piaA-	piaA | plaA	decreased taxis | decreased chemotaxis to cAMP | aberrant actin filament organization
DBS0350486	plaA-/ sgcA-	plaA | sgcA	aberrant chemotaxis to cAMP
DBS0350487	plaA-/ sgcA-/ pkgB-	pkgB | plaA | sgcA	aberrant chemotaxis to cAMP
DG1067	plbG-	plbG	decreased stalk width | decreased stalk length
HAD236	plc-	plc	decreased protein localization to plasma membrane | aberrant chemotaxis to cAMP | decreased protein localization to cytoplasm | decreased protein kinase activation | abolished aggregation
HD1.19	plc-	plc	aberrant negative chemotaxis
HD10	plc-	plc	aberrant cellular homeostasis | wild type | aberrant spore germination
DBS0267125	plc-/ [OE]: dagA(PH): GFP/ [OE]: plc	dagA | plc	increased protein localization to plasma membrane | decreased chemotaxis to cAMP
DBS0350047	plc-/ [act15]: pten: GFP	plc | pten	wild type | aberrant protein localization to cytoplasm
DBS0236796	pldB-	pldB	decreased catalytic activity | precocious aggregation
DBS0236797	pldB-/ [act15]: pldB: GFP	pldB	abolished aggregation
DBS0350604	pldB-/ [unk]: GFP	pldB	increased cell migration to prestalk region
DBS0350605	pldB-/ [unk]: lacZ	pldB	increased cell migration to prestalk region
DBS0236799	plip-	plip	delayed aggregation
DBS0351187	plnA-	plnA	aberrant defense response to bacterium
DBS0350007	png-	png	delayed aggregation | decreased mound size | aberrant fruiting body morphogenesis
DBS0350492	png-/ [ecmAO]: lacZ	png	aberrant prestalk cell differentiation
DBS0350491	png-/ [ecmA]: lacZ	png	aberrant prestalk A cell differentiation
DBS0350493	png-/ [pspA]: lacZ	png	decreased prespore cell differentiation
DBS0236820	ponA-	ponA	precocious aggregation | decreased actin nucleation | aberrant sorocarp development | aberrant pseudopodium formation
DBS0236821	ponA-	ponA	precocious aggregation | decreased actin nucleation | aberrant sorocarp development | aberrant pseudopodium formation
DG1057	potA-	potA	aberrant fruiting body morphogenesis
DBS0351064	poxA-	poxA	aberrant defense response to bacterium
DBS0236824	ppk1-	ppk1	decreased growth rate | decreased phagocytosis | decreased fruiting body size | delayed culmination | decreased sporulation
ASH01	ppk1-	ppk1	aberrant cellular homeostasis | decreased ATP level | decreased growth rate | aberrant spore germination | aberrant macromolecule biosynthesis | decreased fruiting body size | increased growth rate
DBS0351356	ppk1-/ [act15]: GFP: hsp48	hsp48 | ppk1	decreased protein level
DBS0236825	ppk1-/ [act15]: ppk1	ppk1	wild type
DBS0238099	ppp4C-	ppp4c	development arrests at mound stage | delayed development
DBS0238110	ppp4C-/ [act15]: smkA	ppp4c | smkA	development arrests at mound stage | delayed development
DBS0238033	proC-	proC	increased lateral pseudopodium formation | decreased chemotaxis rate | decreased establishment of cell polarity
DBS0238034	proC-/ [unk]: FLAG: proC	proC	wild type
DBS0266716	pscA-	pscA	wild type
DBS0266803	psenA-	psenA	aberrant culmination | decreased prespore cell differentiation
DBS0350302	psenA-	psenA	decreased prespore cell differentiation | aberrant calcium-mediated signaling
DBS0350304	psenA-/ psenB-	psenA | psenB	increased gene expression | abolished prespore cell differentiation | development arrests at mound stage | increased protein modification | decreased phagocytosis | aberrant calcium-mediated signaling | increased cAMP level | aberrant sorocarp development | decreased macropinocytosis | aberrant phagosome maturation | decreased protein processing in phagocytic vesicle | decreased prestalk gene expression | decreased stalk cell differentiation
DBS0350305	psenA-/ psenB-/ [act15]: GFP: psenB	psenA | psenB	wild type
DBS0350306	psenA-/ psenB-/ [act15]: psenB(D348A/ D394A)	psenA | psenB	wild type
DBS0350295	psenB-	psenB	decreased phagocytosis | abolished catalytic activity
DBS0350303	psenB-	psenB	decreased prespore cell differentiation | aberrant calcium-mediated signaling
DBS0351095	psenB-	psenB	aberrant response to chemical
DBS0350298	psenB-/ psenA-	psenA | psenB	aberrant culmination | decreased phagocytosis | abolished catalytic activity | decreased prespore cell differentiation
HOK2	psiA-	psiA	abolished prespore cell division
DBS0351581	psiA-/ [ecmB]: lacZ	psiA	precocious prestalk gene expression
DBS0351578	psiA-/ [rnrB]: lacZ	psiA	aberrant prespore gene expression
DBS0236021	psiM-	psiM	wild type
DBS0236022	psiM-	psiM	wild type
DBS0236828	pslA-	pslA	abolished sporulation | increased mound size | decreased sorus size | aberrant prestalk gene expression | increased stalk length | abolished stalk cell differentiation | abolished prespore gene expression
DBS0236829	psmC1-	psmC1	increased resistance to spectinomycin | aberrant standing slug morphology | abolished slug migration | increased vegetative cell size
HW70	pspB-	pspB	aberrant spore coat morphology | precocious spore germination
DBS0302352	psrA-	psrA	decreased culmination | increased protein phosphorylation | decreased activation of GTPase activity | delayed prestalk gene expression | decreased cell motility | delayed development | increased protein kinase activation
DBS0351094	psrA-	psrA	aberrant response to chemical
DBS0302356	psrA-/ [act15]: FLAG: gskA	gskA | psrA	increased protein kinase activation
DBS0302353	psrA-/ [act15]: ecmA: lacZ	psrA	aberrant prestalk gene expression
DBS0302354	psrA-/ [act15]: ecmB: lacZ	psrA	aberrant prestalk gene expression
DBS0302357	psrA-/ [act15]: gskA(K84M/ K85M)	gskA | psrA	decreased culmination | decreased prespore gene expression | delayed development | increased protein kinase activation
DBS0302355	psrA-/ [act15]: psrA	psrA	wild type
DBS0350829	psrA-/ [unk]: FLAG: rasD(G12T)	psrA | rasD	increased protein kinase activation
HM1289	pten-	pten	aberrant cell motility | decreased lateral pseudopodium retraction | decreased cell motility | decreased macropinocytosis | abolished aggregation | decreased chemotaxis to cAMP
DBS0236830	pten-	pten	decreased response to Gram-negative bacterium | decreased positive regulation of GTPase activity | decreased actin filament polymerization | decreased lateral pseudopodium retraction | abolished protein localization to plasma membrane | decreased growth rate | increased actin filament polymerization | decreased phagocytosis | decreased bleb assembly | decreased cell motility | increased protein localization to plasma membrane | decreased chemotaxis to cAMP | abolished aggregation | aberrant pseudopodium formation | increased pseudopodium formation | aberrant signal transduction | abolished positive regulation of chemorepellant activity
DBS0349884	pten-	pten	aberrant cytokinesis | increased protein kinase activity | decreased chemotaxis to cAMP | decreased establishment of cell polarity
DBS0350660	pten-	pten	decreased uropod retraction | decreased protein localization to cleavage furrow | decreased growth rate | aberrant cytokinesis | decreased protein localization to pseudopodium
DBS0350454	pten-/ [act15]: lpten: RFP	lpten | pten	wild type
DBS0349890	pten-/ [act15]: pakA: GFP	pakA | pten	aberrant cytokinesis
DBS0350754	pten-/ [act15]: pten(186-515): GFP	pten	aberrant sorocarp development | decreased chemotaxis to cAMP
DBS0350755	pten-/ [act15]: pten(C124S): GFP	pten	aberrant sorocarp development | decreased chemotaxis to cAMP
DBS0351587	pten-/ [act15]: pten(G129E)	pten	increased lateral pseudopodium formation | aberrant localization
DBS0236831	pten-/ [act15]: pten: GFP	pten	wild type
DBS0349888	pten-/ gefS-	gefS | pten	aberrant cytokinesis | decreased chemotaxis to cAMP
DBS0349891	pten-/ pakA-	pakA | pten	decreased chemotaxis to cAMP
DBS0349893	pten-/ pakA-/ [act15]: pakA(T585A): GFP	pakA | pten	decreased chemotaxis to cAMP
DBS0349900	pten-/ pakA-/ [act15]: pakA(T585E): GFP	pakA | pten	aberrant cytokinesis | decreased chemotaxis to cAMP
DBS0349899	pten-/ pakA-/ [act15]: pakA: GFP	pakA | pten	aberrant cytokinesis
DBS0349887	pten-/ piaA-	piaA | pten	decreased protein kinase activity | decreased chemotaxis to cAMP
DBS0349880	pten-/ pkbA-	pkbA | pten	decreased chemotaxis to cAMP
DBS0349886	pten-/ pkgB-	pkgB | pten	aberrant cytokinesis | increased protein kinase activation
DBS0236832	ptpA1-	ptpA1-1 | ptpA1-2	decreased prespore cell differentiation | precocious development | increased prestalk O cell differentiation
DBS0236833	ptpB-	ptpB	increased migratory slug size
DBS0350675	ptpB-/ [act15]: 6xHis: erkA	erkA | ptpB	aberrant stream morphology
DBS0236834	ptpC+/ -	ptpC	aberrant cytokinesis | decreased growth rate
DBS0236835	pufA-	pufA	increased protein kinase activity | aberrant fruiting body morphogenesis | increased protein level | precocious development
DBS0304391	pyk3-	pyk3	increased prespore gene expression | decreased prestalk gene expression | increased prespore cell differentiation | delayed culmination
DBS0350577	pyk3-	pyk3	decreased protein phosphorylation | decreased gene expression | aberrant protein localization to nucleus
DBS0350581	pyk3-	pyk3	decreased protein phosphorylation | decreased gene expression
DBS0304393	pyk3-/ [act15]: T7: pyk3	pyk3	wild type
DBS0350579	pyk3-/ phg2-	phg2 | pyk3	abolished gene expression | decreased protein phosphorylation | aberrant protein localization to nucleus
DBS0236836	pykA-	pykA	decreased growth rate | abolished aggregation
DBS0236837	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid | abolished uracil biosynthetic process
DBS0236838	pyr56-	pyr56	increased resistance to 5-Fluoroorotic acid | abolished uracil biosynthetic process
DBS0351499	pzoA-	pzoA	aberrant cellular response to fluid shear stress | aberrant chemotaxis to cAMP
DBS0350017	qdpr-	qdpr	decreased spore germination | decreased growth rate | abolished catalytic activity | aberrant response to oxidative stress
DBS0350018	qdpr-/ [act15]: pah	pah | qdpr	decreased growth rate
DBS0236839	qkgA-	qkgA-1 | qkgA-2	increased mound size | delayed aggregation | aberrant vegetative growth | aberrant nucleus organization | increased growth rate | abolished negative chemotaxis
DBS0351552	qkgA-	qkgA-1 | qkgA-2	aberrant aggregation | decreased actin filament polymerization | aberrant cytokinesis | decreased cell motility | decreased chemotaxis to cAMP
DBS0350011	qkgA-/ [act15]: bzpN: GFP	bzpN | qkgA-1 | qkgA-2	abolished negative regulation of vegetative growth
DBS0351560	qtrt1-	qtrt1	aberrant response to stimulus
DBS0350263	rab7A-	rab7A	decreased growth rate
DBS0236841	racB-	racB	decreased actin filament polymerization | delayed aggregation | aberrant fruiting body morphogenesis | decreased chemotaxis rate | decreased myosin II assembly
DBS0236842	racC-	racC	decreased protein localization to plasma membrane | decreased actin filament polymerization | aberrant cytokinesis | aberrant stream morphology | decreased chemotaxis rate | aberrant cell morphology | aberrant protein localization
DBS0350272	racC-	racC	aberrant cytokinesis | decreased growth rate | abolished positive regulation of chemorepellant activity
DBS0237191	racC-/ [act15]: CFP: racC	racC	increased actin filament polymerization
DBS0235413	racE-	racE	abolished cytokinesis | aberrant cortical actin cytoskeleton organization | abolished protein localization to cell cortex
DBS0350271	racE-	racE	decreased protein phosphorylation | increased lateral pseudopodium formation | aberrant cytokinesis | delayed aggregation | decreased growth rate | aberrant regulation of GTPase activity | aberrant protein localization to plasma membrane | decreased establishment of cell polarity | decreased chemotaxis to cAMP
DBS0351308	racE-	racE	aberrant cortical actin cytoskeleton organization | abolished protein localization to cell cortex | aberrant cytokinesis | decreased cell motility | aberrant cell morphology
DBS0351348	racE-/ [act15]: GFP: racE(G20V)	racE	decreased protein phosphorylation | decreased chemotaxis to cAMP
DBS0351349	racE-/ [act15]: GFP: racE(G23V)	racE	increased protein phosphorylation
DBS0351350	racE-/ [act15]: GFP: racE(S192D)	racE	increased protein phosphorylation | wild type
DBS0351347	racE-/ [act15]: GFP: racE(T25N)	racE	wild type
DBS0351614	racE-/ [act15]: GFP: racE(T25N/ S192D)	racE	wild type
DBS0351351	racE-/ [act15]: GFP: rasC(Q62L)	racE | rasC	decreased protein phosphorylation
DBS0349949	racE-/ [act15]: fttB	fttB | racE	decreased growth rate
DBS0349946	racE-/ [act15]: fttB: GFP	fttB | racE	abolished protein localization to cell cortex
DBS0350956	racE-/ [act15]racE(G20V)	racE	wild type
DBS0350957	racE-/ [act15]racE(T25N)	racE	abolished cytokinesis
DBS0351505	racF1-	racF1	wild type
DBS0236844	racF2(G12V)	racF2	decreased cell-cell adhesion
DBS0236845	racF2(N17T)	racF2	increased cell-cell adhesion | decreased sexual fusion
DBS0236843	racF2-	racF2	increased mound size | increased cell-cell adhesion | decreased sexual fusion
DBS0236849	racG-	racG	decreased cell motility | decreased protein localization to phagocytic vesicle
DBS0236850	racH-	racH	decreased exocytosis | aberrant protein localization to cytoplasmic vesicle | decreased pinocytosis | decreased defense response to Gram-negative bacterium | aberrant defense response to bacterium | decreased defense response to bacterium
DBS0351149	rapC-	rapC	increased number of mound tips | aberrant cytokinesis | increased cell-substrate adhesion | decreased cell motility | aberrant cell morphology
DBS0266936	rapgap1-	rapgap1	decreased positive regulation of GTPase activity | increased actin filament polymerization | increased cell-substrate adhesion | decreased cell motility | decreased myosin II assembly | increased protein kinase activation
DBS0266937	rapgap1-/ [act15]: GFP: rapgap1	rapgap1	increased positive regulation of GTPase activity | increased lateral pseudopodium formation | decreased cell-substrate adhesion | increased myosin II assembly | increased actin filament polymerization | increased cell motility
DBS0351487	rapgap3-	rapgap3	increased cell motility | increased activation of GTPase activity
DBS0350864	rapgap3-/ AX2	rapgap3	delayed aggregation | decreased chemotaxis to cAMP | decreased fruiting body size
DBS0350863	rapgap3-/ KAX3	rapgap3	delayed development of tipped mound | increased calcium-dependent cell-cell adhesion | decreased cell motility | aberrant cell migration to prestalk region | aberrant regulation of GTPase activity
DBS0350316	rapgap9-	rapgap9	increased filopodium formation | increased actin filament polymerization | aberrant cytokinesis | decreased spore size | increased cell-substrate adhesion | decreased chemotaxis to cAMP
DBS0350317	rapgap9-/ [act15]: GFP: rapgap9	rapgap9	wild type
DBS0350628	rapgapB-	rapgapB	aberrant aggregation | increased cell-substrate adhesion | aberrant regulation of GTPase activity | aberrant actin filament organization
DBS0350630	rapgapB-/ [ecmAO]: RFP	ecmA | rapgapB	aberrant cell-cell adhesion
DBS0350631	rapgapB-/ [ecmA]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350632	rapgapB-/ [ecmO]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350629	rapgapB-/ [pspA]: RFP	pspA | rapgapB	aberrant cell-cell adhesion
DBS0236852	rasB-	rasB	decreased growth rate
DBS0350836	rasB-	rasB	decreased phagocytosis | decreased macropinocytosis | aberrant actin filament organization
DBS0236853	rasC-/ AX2	rasC	increased rate of endocytosis | aberrant response to cAMP | decreased cell motility | increased vegetative cell size | abolished protein kinase activation | decreased protein kinase activation | decreased taxis | abolished aggregation | aberrant pseudopodium formation | aberrant actin filament organization | aberrant protein localization to cell cortex | aberrant cellular response to extracellular stimulus
DBS0236854	rasC-/ JH10	rasC	wild type | aberrant gene expression | decreased protein kinase activation | abolished aggregation | abolished chemotaxis to cAMP
DBS0237614	rasC-/ [act15]: gbpD	gbpD | rasC	increased cell-substrate adhesion | aberrant cell morphology
DBS0350740	rasC-/ [rasC]: rasG	rasC | rasG	abolished activation of adenylate cyclase activity | abolished aggregation
DBS0350742	rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189)	rasC | rasG	wild type
DBS0350741	rasC-/ [rasC]: rasG(D30A)	rasC | rasG	aberrant aggregation | decreased activation of adenylate cyclase activity
DBS0236855	rasC-/ dmpA-	dmpA | rasC	abolished stream development
DBS0236856	rasC-/ pikD1	pikD | rasC	increased establishment of cell polarity | increased chemotaxis to cAMP | aberrant gene expression | aberrant fruiting body morphogenesis | decreased protein kinase activation | abolished aggregation
DBS0236857	rasC-/ rasD-	rasC | rasD	abolished aggregation
DBS0236858	rasC-/ rasG-	rasC | rasG	aberrant cell separation during cytokinesis | wild type | aberrant cell motility | decreased activation of adenylate cyclase activity | decreased gene expression | abolished guanylyl cyclase activity | abolished chemotaxis to folate | decreased growth rate | aberrant chemotaxis to folate | abolished protein kinase activation | abolished vegetative growth | decreased cell motility | increased protein level | abolished aggregation | delayed gene expression | abolished chemotaxis to cAMP | abolished positive regulation of chemorepellant activity
DBS0266697	rasC-/ rasG-/ [act15]: carA	carA-1 | carA-2 | rasC | rasG	decreased activation of adenylate cyclase activity | abolished activation of GTPase activity | decreased growth rate | abolished vegetative growth | abolished protein kinase activation | abolished cGMP-mediated signaling | abolished chemotaxis to cAMP
DBS0350480	rasC-/ rasG-/ [rasG]: rasD	rasC | rasD | rasG	decreased chemotaxis to folate
DBS0350482	rasC-/ rasG-/ [rasG]: rasD(1-104): rasG(103-189)	rasC | rasD | rasG	decreased chemotaxis to folate
DBS0350481	rasC-/ rasG-/ [rasG]: rasG	rasC | rasG	wild type
DBS0350483	rasC-/ rasG-/ [rasG]: rasG(1-104): rasD(103-187)	rasC | rasD | rasG	wild type
DBS0351062	rasC-/ rasG-/ [unk]: carA	carA-1 | carA-2 | rasC | rasG	decreased protein localization to plasma membrane
DBS0351449	rasC-/ rasS-	rasC | rasS	increased macropinocytosis
DBS0351213	rasC-[act15]: rasG(S17N)	rasC | rasG	abolished activation of GTPase activity | decreased chemotaxis to cAMP
DBS0236860	rasD-	rasD	aberrant thermotaxis | aberrant phototaxis
DBS0351459	rasD-/ AX3	rasD	increased gene expression | increased prespore cell differentiation
DBS0236862	rasG-/ AX2	rasG	decreased pinocytosis | decreased gene expression | delayed aggregation | aberrant taxis | decreased cGMP-mediated signaling | decreased protein kinase activation | delayed gene expression
IR15	rasG-/ AX2	rasG	aberrant cell separation during cytokinesis | aberrant filopodium formation | decreased actin filament polymerization | decreased growth rate | increased vegetative cell size | decreased macropinocytosis | decreased cell motility | decreased protein kinase activation | decreased establishment of cell polarity | aberrant actin filament organization
IR17	rasG-/ AX3	rasG	aberrant cytokinesis | decreased cell motility | increased vegetative cell size
DBS0351460	rasG-/ AX3	rasG	increased prestalk cell differentiation
DBS0236863	rasG-/ JH10	rasG	aberrant cell separation during cytokinesis | wild type | decreased gene expression | delayed aggregation | abolished activation of GTPase activity | aberrant chemotaxis to folate | decreased growth rate | decreased cGMP-mediated signaling | decreased protein kinase activation | delayed gene expression
DBS0236864	rasG-/ [OE]: rasB	rasB | rasG	decreased growth rate
DBS0350572	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R)	rasG	aberrant cytokinesis
DBS0350571	rasG-/ [act15]: FLAG: rasG(K169R,K173R,K176R,K178R,K179R,K180R,K184R)	rasG	decreased protein modification
DBS0350448	rasG-/ [dscB]: rasG(S17N)	rasG	decreased positive regulation of GTPase activity | decreased actin filament polymerization | decreased protein kinase activation | decreased chemotaxis to cAMP
DBS0351447	rasG-/ rasS-	rasG | rasS	decreased macropinocytosis
DBS0236872	rasS-/ AX2	rasS	decreased macropinocytosis | decreased cell motility | aberrant pinosome maturation | decreased establishment of cell polarity
DBS0351446	rasS-/ AX2	rasS	aberrant macropinocytosis
DBS0236873	rasS-/ DH1	rasS	decreased rate of endocytosis | decreased growth rate | increased actin filament polymerization | abolished vegetative growth | increased cell motility | aberrant cytoskeleton organization
DBS0351314	rasS-/ DdB	rasS	decreased macropinocytosis | increased cell motility
DBS0236874	rasZ-	rasZ	wild type
DBS0351598	rbdB-	rbdB	abolished pre-miRNA processing
DBS0350261	rbg3-	rbg3	precocious development | increased growth rate
DBS0236877	rblA-	rblA	increased cell migration to prestalk region | decreased spore germination | decreased gene expression | increased gene expression | abolished negative regulation of vegetative growth | decreased growth rate | aberrant vegetative growth | decreased vegetative cell size | precocious development | increased prestalk cell differentiation
DBS0349999	rblA-/ [act15]: GFP	rblA	increased cell migration to prestalk region
DBS0349996	rblA-/ [act15]: GFP/ [act15]: myc: btg	btg | rblA	increased cell migration to prestalk region
DBS0349994	rblA-/ [btg]: lacZ	btg | rblA	decreased gene expression
DBS0236878	rbrA-	rbrA	increased gene expression | decreased gene expression | development arrests at slug stage | aberrant prespore gene expression | decreased cell migration to prestalk region | decreased phototaxis | decreased sporulation
DBS0236879	rbrA-/ [unk]: rbrA	rbrA	wild type
DBS0305613	rccA-	rccA	increased resistance to cheating during development
DBS0236880	rckA-	rckA	increased mound size | precocious aggregation | delayed slug development | delayed prestalk gene expression | delayed prespore gene expression | increased chemotaxis rate
DBS0236885	rckA-/ [act15]: myc: rckA	rckA	delayed development | decreased chemotaxis rate
DBS0236881	rckA-/ [act15]: myc: rckA(C551A)	rckA	delayed slug development | decreased chemotaxis rate
DBS0236882	rckA-/ [act15]: myc: rckA(E510G)	rckA	wild type | decreased chemotaxis rate
DBS0236883	rckA-/ [act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug development | decreased chemotaxis rate
DBS0236884	rckA-/ [act15]: myc: rckA(K867A)	rckA	development arrests at mound stage | decreased chemotaxis rate
FR17	rdeA-	rdeA	precocious aggregation | decreased mound size | aberrant fruiting body morphogenesis | precocious development | precocious gene expression
HH201	rdeA-	rdeA	aberrant chemotaxis to cAMP | increased cAMP level
WTC10	rdeA-	rdeA	aberrant chemotaxis to cAMP | increased cAMP level | decreased macropinocytosis
FR17	rdeA-	rdeA	precocious aggregation | decreased mound size | aberrant fruiting body morphogenesis | precocious development | precocious gene expression
DBS0236886	rdeA-/ [act15]: rdeA	rdeA	wild type
DBS0350688	rdeA-/ acaA-	acaA | rdeA	increased cAMP level | decreased sporulation
DBS0350468	rdiA-	rdiA	decreased pinocytosis | decreased protein localization to cell cortex | decreased protein level | decreased actin filament polymerization | aberrant contractile vacuole morphology | decreased growth rate | aberrant cytokinesis
DBS0351504	rdiA-	rdiA	aberrant cytokinesis
DBS0236887	recA-	recA	decreased resistance to hydrogen peroxide | aberrant response to UV | decreased resistance to mitomycin C
DBS0266664	redA-	redA	development arrests at mound stage | aberrant mound color
DBS0350511	redA-	redA	decreased defense response to Gram-negative bacterium
DG1047	redA-	redA	development arrests at mound stage | aberrant mound color
DBS0236889	regA-	regA	increased resistance to cisplatin | aberrant chemotaxis to cAMP | increased cAMP level | aberrant fruiting body morphogenesis
DBS0236958	regA-	regA	decreased spore germination | precocious sporulation | abolished protein localization to cell cortex | increased lateral pseudopodium formation | aberrant chemotaxis to cAMP
HM332	regA-	regA	decreased lateral pseudopodium retraction
HR45	regA-	regA	aberrant fruiting body morphogenesis
HM1015	regA-	regA	increased cAMP level | decreased macropinocytosis | aberrant oscillatory cAMP signaling
DBS0350372	regA-/ KAX3	regA	precocious sporulation | increased sporulation
DBS0235706	regA-/ [act15]: dhkK(D1125N)	dhkK | regA	aberrant fruiting body morphogenesis | precocious development
DBS0235708	regA-/ [act15]: dhkK(H825Q)	dhkK | regA	aberrant fruiting body morphogenesis | precocious development
DBS0351475	regA-/ [act15]: erkA	erkA | regA	delayed slug development
DBS0351472	regA-/ [act15]: regA(R588A,R589A,L594A,I595A,L596A)	regA	delayed development
DBS0351284	regA-/ [act15]: regA(S142A)	regA	aberrant fruiting body morphogenesis | precocious development
DBS0351283	regA-/ [act15]: regA(S142E)	regA	delayed development
DBS0351285	regA-/ [act15]: regA(S413A)	regA	increased mound size | delayed development
DBS0351286	regA-/ [act15]: regA(S413E)	regA	increased mound size | delayed development
DBS0351287	regA-/ [act15]: regA(T676A)	regA	delayed sporulation
DBS0351288	regA-/ [act15]: regA(T676E)	regA	aberrant fruiting body morphogenesis | precocious development
DBS0350689	regA-/ [regA]: regA	regA	wild type
DBS0350670	regA-/ [regA]: regA(D212N)	regA	precocious sporulation
DBS0350380	regA-/ dhkD-	dhkD | regA	aberrant fruiting body morphogenesis
DBS0351473	regA-/ regA(R588A,R589A,L594A,I595A,L596)	regA	precocious sporulation | decreased mound size | increased protein binding | aberrant fruiting body morphogenesis
DBS0236891	regA-/ tagB-	regA | tagB	decreased sporulation
DBS0236892	regA-/ tagC-	regA | tagC	decreased sporulation
DBS0266818	repB(1-754)	repB	aberrant response to UV
HM1351	rev3-	rev3	aberrant vegetative growth | decreased resistance to cisplatin
HM1451	rev3-/ xpf-	rev3 | xpf	decreased resistance to cisplatin
DBS0236893	rgaA-	rgaA	abolished cell migration to prestalk region | aberrant cytokinesis | abolished stalk cell differentiation | decreased protein kinase activation | abolished culmination | decreased sporulation
DBS0349935	rgaA-	rgaA	aberrant stalk morphogenesis | increased number of tip-organizers | aberrant cellular response to fluid shear stress | increased actin filament polymerization | increased growth rate | increased cell motility | aberrant actin filament organization
DBS0350398	rgaA-	rgaA	increased lateral pseudopodium formation | decreased myosin II assembly | increased chemotaxis rate
DBS0349921	rgaA-/ [act15]: GFP-mhcA	rgaA	aberrant stalk morphogenesis | aberrant development of tipped mound | abolished protein localization to apical plasma membrane
DBS0349937	rgaA-/ ctxA-	ctxA | rgaA	aberrant cytokinesis | abolished protein localization to cleavage furrow
DBS0349936	rgaA-/ gapA-	gapA | rgaA	aberrant cellular response to fluid shear stress | aberrant cytokinesis | abolished protein localization to cleavage furrow | increased cell motility
DBS0350401	rgaA-/ gapA-	gapA | rgaA	decreased protein localization to cleavage furrow | increased myosin II assembly | aberrant mitotic spindle organization | increased actin filament polymerization | decreased chemotaxis to cAMP | increased protein kinase activation
DBS0350406	rgaA-/ gapA-/ [unk]: myc: gapA(R308E/ K317E)	gapA | rgaA	increased protein kinase activation
DBS0350402	rgaA-/ iqgC-	iqgC | rgaA	decreased myosin II assembly | increased protein kinase activation
DBS0351526	rgbA-/ AX2	rgbA	aberrant macropinocytosis | aberrant activation of GTPase activity | decreased macropinocytosis | aberrant engulfment during phagocytosis | decreased chemotaxis to folate
DBS0351527	rgbA-/ DdB	rgbA	aberrant macropinocytosis | increased activation of GTPase activity
DBS0350019	rgfA-	rgfA	wild type
DBS0350020	rgfA-/ [act15]: rgfA	rgfA	decreased chemotaxis to folate | delayed development
DBS0350108	rheb-	rheb	increased phagocytosis
DBS0236894	rhgA-	rhgA	wild type
DBS0350192	ric8-	ric8	abolished gene expression | abolished chemotaxis to folate | decreased chemotaxis to cAMP | abolished aggregation | aberrant signal transduction
DBS0350193	ric8-/ [act15]: GFP: ric8	ric8	wild type
DBS0236900	ripA-	ripA	decreased guanylyl cyclase activity | abolished activation of adenylate cyclase activity | decreased chemotaxis rate | decreased taxis | abolished aggregation | decreased establishment of cell polarity | aberrant regulation of protein kinase activity | decreased myosin II assembly | increased phagocytosis
DBS0350770	ripA-/ [act15]: GFP: rapA(G12V)	rapA | ripA	decreased protein kinase activation
DBS0350115	ripA-/ [act15]: GFP: rheb(Q64L)	rheb | ripA	increased phagocytosis
DBS0236902	ripA-/ [unk]: ripA(K680E/ R681E)	ripA	aberrant sorocarp development | decreased chemotaxis rate
DBS0236901	ripA-/ [unk]ripA	ripA	wild type
DBS0351068	rnf113-	rnf113	delayed aggregation | increased cell-substrate adhesion | decreased cell motility
DBS0351042	rnlA-	rnlA	decreased thermotaxis | decreased growth rate | decreased defense response to bacterium | decreased phototaxis
DBS0236903	rnpA-	rnpA	increased gene expression
DBS0350096	roco11-	roco11	increased stalk length
DBS0350095	roco4-	roco4	delayed slug development | aberrant stalk development | delayed culmination
DBS0350100	roco4-/ [unk]: roco4(1018-1292(G1179S))	roco4	increased catalytic activity
DBS0350098	roco4-/ [unk]: roco4(1018-1292(S1187A))	roco4	abolished catalytic activity
DBS0350099	roco4-/ [unk]: roco4(1018-1292(S1189A))	roco4	decreased catalytic activity
DBS0238225	rpkA-	rpkA	development arrests at loose mound stage | decreased defense response to Gram-negative bacterium | aberrant cellular response to nitrogen starvation | decreased phagocytosis | decreased cell motility | decreased establishment of cell polarity | abolished aggregation | aberrant cellular response to extracellular stimulus
DBS0236906	rrpA-	rrpA	abolished post-transciptional gene silencing by RNA
DBS0350178	rrpA-/ rrpB-/ rrpC-	rrpA | rrpB | rrpC	increased gene expression | decreased gene expression
DBS0350189	rrpA-/ rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA | rrpB | rrpC	abolished transitive RNA interference
DBS0350176	rrpA-/ rrpC-	rrpA | rrpC	increased gene expression | decreased gene expression
DBS0350187	rrpA-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpA | rrpC	aberrant production of siRNA involved in RNA interference
DBS0350182	rrpA-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA | rrpC	abolished transitive RNA interference
DBS0350177	rrpB-/ rrpC-	rrpB | rrpC	increased gene expression | decreased gene expression
DBS0350185	rrpB-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpB | rrpC	aberrant production of siRNA involved in RNA interference
DBS0350184	rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpB | rrpC	abolished transitive RNA interference
DBS0350209	rrpC-	rrpC	decreased gene expression | increased gene expression
DBS0350219	rrpC-/ [act15]: pre-miRNA	rrpC	increased pre-miRNA processing
DBS0350216	rrpC-/ [act6]: LacZ/ [RNAi]lacZ	rrpC	abolished transitive RNA interference
DBS0350217	rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpC	aberrant production of siRNA involved in RNA interference
DBS0236875	rtoA-	rtoA	decreased rate of endocytosis | increased defense response to Gram-negative bacterium | increased prestalk cell differentiation | delayed culmination
DBS0236911	rtoA-	rtoA	delayed development
DBS0236914	rzpA-	rzpA	aberrant aggregation | decreased slug migration | increased mound size | increased prespore gene expression | decreased prestalk gene expression | delayed development
DBS0309040	sadA-	sadA	abolished protein localization to cell surface | decreased phagocytosis | decreased protein stabilization
DBS0236921	sadA-	sadA	abolished cell-substrate adhesion | decreased phagocytosis | aberrant cytokinesis | increased growth rate | aberrant actin filament organization | aberrant cell morphology
DBS0350974	sadA-/ [act15]: gpaH	gpaH | sadA	aberrant cytokinesis
DBS0349790	sadA-/ [act15]: sadA(1-923): GFP	sadA	decreased cell-substrate adhesion
DBS0349792	sadA-/ [act15]: sadA(S924A/ S925A): GFP	sadA	wild type
DBS0349791	sadA-/ [act15]: sadA(S924E/ S925E): GFP	sadA	decreased cell-substrate adhesion
DBS0236922	sadA-/ [act15]: sadA: GFP	sadA	wild type
DBS0351564	sbdS(1-30,TS18,31-274)	sbds	development arrests at loose mound stage | aberrant cellular process | abolished vegetative growth
DBS0351566	sbdS(1-30,TS18,31-274)/ [act15]: eIF(T56K)	eIF6 | sbds	wild type
DG1105	scaA-	scaA	abolished aggregation
DBS0350825	scaA-	scaA	decreased actin filament polymerization | aberrant chemotaxis to cAMP | abolished activation of GTPase activity | decreased protein kinase activation | abolished aggregation
DBS0236924	scrA-	scrA	increased number of tip-organizers | abolished protein localization to endolysosome | decreased exocytosis | decreased pinocytosis | decreased actin filament polymerization | increased lateral pseudopodium formation | decreased phagocytosis | decreased vegetative cell size | decreased fruiting body size | precocious development
IR46	scrA-	scrA	aberrant mitotic spindle organization | aberrant cytokinesis | abolished activation of GTPase activity | decreased vegetative cell size | decreased cell motility | aberrant cellular response to stress | aberrant pseudopodium formation | increased bleb assembly | abolished positive regulation of chemorepellant activity
IR48	scrA-	scrA	decreased growth rate | aberrant cytokinesis | decreased bleb assembly | decreased phototaxis
DBS0236925	scrA-	scrA	increased filopodium formation | decreased protein level | aberrant macropinocytosis | aberrant cytokinesis | decreased macropinocytosis | decreased cell motility | aberrant actin filament organization | aberrant pseudopodium formation
DBS0351524	scrA-/ [act15]: scrA(R177A,R179A,K180A,R183A,R184A,R187A,K190A,K191A,K194A)	scrA	decreased bleb assembly | increased cellular localization | aberrant pseudopodium formation
DBS0351611	scrA-/ [act15]: scrA(S287,290,301,335,339,384,388,389,430,432,433,437,440A)	scrA	aberrant pseudopodium formation
DBS0351522	scrA-/ [act15]: scrA(S430A,S432A,S433A,S437A,S440A)	scrA	decreased bleb assembly | increased cellular localization | aberrant pseudopodium formation
DBS0351523	scrA-/ [act15]: scrA(S430D,S432D,S433D,S437D,S440D)	scrA	decreased pseudopodium size
DBS0349927	scrA-/ [act15]: wasA: GFP/ [ act8]: RFP: arcD	scrA	decreased establishment of cell polarity | decreased pseudopodium formation
DBS0350063	scrA-/ [tet]: scrA/ mhcA-	mhcA | scrA	aberrant cytokinesis
DBS0351610	scrA-/ [tet]: scrA/ wasA-	scrA | wasA	aberrant cell motility | abolished vegetative growth | abolished bleb assembly | aberrant pseudopodium formation
DBS0238440	scrA-/ [unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis | increased vegetative cell size | decreased chemotaxis to cAMP | aberrant cytoskeleton organization
DBS0238446	scrA-/ [unk]: scrA: GFP	scrA	wild type
SB18	scrA-/ napA-	napA | scrA	decreased actin filament polymerization | decreased cell motility
SB7	scrA-/ pirA-	pirA | scrA	decreased vegetative cell size
HM1163	sec1-/ sec1(M213K/ E258G/ M427V/ K527I/ T541N/ F558S/ N581D)	sec1	abolished cell motility
HM1325	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)	sec1	abolished cytokinesis | aberrant hypotonic response | abolished cell motility | aberrant plasma membrane organization | aberrant cell morphology
DBS0350286	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)/ gppA: GFP	gppA | sec1	abolished contractile vacuole discharge
DBS0350101	sec7-	sec7	aberrant cell motility | decreased phagocytosis | decreased growth rate | aberrant phototaxis | decreased protein secretion
DBS0306234	secG-	secG	decreased cell-substrate adhesion | decreased chemotaxis rate
DBS0351035	seiP-	seiP	aberrant lipid droplet formation
DBS0350264	sepA-	sepA	aberrant cytokinesis | delayed aggregation | decreased growth rate | decreased fruiting body size
DBS0351077	sepA-	sepA	aberrant gene expression | increased cell-substrate adhesion | decreased cell motility
DBS0350906	sepA-	sepA	decreased protein phosphorylation | aberrant pseudopodium formation
DBS0351252	sesn-	sesn	increased mound size | aberrant standing slug morphology | decreased gene expression | decreased autophagy | aberrant response to oxidative stress
DBS0236928	set1-	set1	precocious aggregation | abolished histone H3-K4 methylation | precocious gene expression
HG1132	sevA-	sevA	wild type
DG1008	sfbA-	sfbA	decreased fruiting body size
DBS0350889	sgcA-/ AX2	sgcA	aberrant aggregation | decreased guanylyl cyclase activity | aberrant chemotaxis to cAMP
DBS0350888	sgcA-/ AX3	sgcA	aberrant aggregation | decreased guanylyl cyclase activity | aberrant chemotaxis to cAMP
SA576	sgkA-	sgkA	decreased resistance to carboplatin | decreased growth rate | decreased resistance to cisplatin
HM1093	sgkA-/ sgkB-	sgkA | sgkB	decreased resistance to carboplatin | decreased growth rate | decreased resistance to cisplatin
HM1091	sgkB-	sgkB	decreased resistance to carboplatin | decreased growth rate | decreased resistance to cisplatin
SA555	sglA-	sglA	increased stalk width | increased resistance to cisplatin | increased mound size | decreased lateral pseudopodium retraction | decreased gene expression | abolished slug migration | decreased cell motility | decreased chemotaxis rate | decreased fruiting body size | aberrant cytoskeleton organization | decreased sporulation | increased resistance to carboplatin
SA554	sglA-	sglA	delayed aggregation | decreased mound size
DBS0236934	shkA-	shkA	aberrant aggregation | decreased phagocytosis | aberrant cytokinesis | decreased chemotaxis rate | decreased fruiting body size | decreased establishment of cell polarity | aberrant actin filament organization
DBS0236935	sibA-	sibA	decreased cell-substrate adhesion | decreased phagocytosis
DBS0302653	sibC-	sibC	decreased phagocytosis
DBS0236936	sigB-	sigB	wild type
DBS0236937	sigD-	sigD	wild type
DBS0266513	sigN(group1)-	sigN1 | sigN105-1 | sigN2 | sigN25 | sigN3 | sigN4 | sigN5	wild type
DBS0266514	sigN(group2)-	DDB_G0271820 | sigN10 | sigN11 | sigN12 | sigN14 | sigN6 | sigN7 | sigN8 | sigN9	wild type
DBS0351170	sir2A-	sir2A	abolished slug migration | increased number of mound tips | increased gene expression | decreased gene expression | decreased growth rate | aberrant sorocarp development | decreased autophagy | decreased chemotaxis to cAMP | decreased cAMP level
DBS0350859	sir2D-	sir2D	decreased gene expression | increased gene expression | increased number of mound tips | delayed aggregation | decreased growth rate | decreased autophagy | decreased mound size | decreased stalk length
DBS0350860	sir2D-/ [ecmAO]: lacZ	sir2D	decreased prestalk cell differentiation
DBS0350861	sir2D-/ [pspA]: lacZ	sir2D	aberrant prespore cell differentiation
DBS0350985	slc4-	slc4	aberrant transport
DBS0349958	sma-	sma	increased chemotaxis to folate | decreased gene expression | increased cell-substrate adhesion | decreased vegetative cell size | increased cell-cell adhesion
DBS0349957	sma-/ ampA/ [ampA]: ampA	ampA | sma	decreased chemotaxis to folate
DBS0350327	smdA-/ [pspA]: lacZ	smdA	aberrant gene expression
DBS0236938	smkA-	smkA	aberrant cytokinesis | delayed development | decreased chemotaxis rate | decreased myosin II assembly
HDB7YA	smlA-	smlA	increased oscillatory cAMP signaling | decreased cell-cell adhesion | aberrant cellular metabolic process | decreased response to Gram-negative bacterium | increased resistance to cisplatin | decreased protein level | decreased guanylyl cyclase activity | increased myosin II assembly | increased actin filament polymerization | decreased cGMP-mediated signaling | decreased mound size | increased protein level | decreased secretion of lysosomal enzymes | increased cell motility | decreased fruiting body size
DBS0302657	smlA-/ cnrN-	cnrN | smlA	decreased fruiting body size
DBS0236940	smlA-/ ctnA-	ctnA | smlA	increased cell-cell adhesion
DBS0304496	smlA-/ sslA1(CR11)	smlA | sslA1	increased fruiting body size
DBS0350977	snfA-	snfA	decreased pinocytosis | increased cell death | decreased autophagic cell death | decreased phagocytosis | decreased number of autophagosomes | aberrant sorocarp development | decreased prespore cell differentiation | aberrant gene expression | aberrant protein modification | increased growth rate | aberrant prestalk cell differentiation | aberrant sporulation
DBS0302523	sodC-	sodC	aberrant cytokinesis
DBS0302524	sodC-	sodC	aberrant aggregation | decreased positive regulation of GTPase activity | decreased actin filament polymerization | increased actin filament polymerization | aberrant chemotaxis to cAMP | increased protein localization to plasma membrane | decreased chemotaxis rate | aberrant regulation of GTPase activity | aberrant protein localization to plasma membrane | aberrant cell morphology | increased protein kinase activation
DBS0351063	sodC-/ [unk]: rasG(C118A)	rasG | sodC	aberrant regulation of GTPase activity
DBS0350894	sodD-	sodD	aberrant response to UV
DBS0351196	sogA-	sogA	aberrant chemotaxis to cAMP | increased activation of GTPase activity
DBS0350966	spaA-	spaA	abolished sporulation
AK1346	spc3-	spc3	decreased response to Gram-negative bacterium
DBS0350891	spdA-	spdA	decreased substrate adhesion-dependent cell spreading | decreased phagocytosis
DBS0350892	spdA-ins	spdA	decreased growth rate | increased substrate adhesion-dependent cell spreading | increased phagocytosis
HL351	spiA-	spiA	decreased spore germination
DBS0236943	spkA-1-/ spkA-2-	spkA-1 | spkA-2	decreased cell-substrate adhesion | aberrant cytokinesis | decreased mound size | decreased chemotaxis rate | decreased establishment of cell polarity | aberrant cell morphology | decreased fruiting body size
DBS0236944	spkA-1-/ spkA-2-/ [act15]: spkA: FLAG	spkA-1 | spkA-2	aberrant aggregation | decreased chemotaxis rate | aberrant actin filament organization | decreased establishment of cell polarity
DBS0236945	splA-	splA	abolished sporulation | aberrant spore morphology | increased sorus size | aberrant sorus color | decreased stalk length
DBS0350131	splB-	splB	abolished protein tyrosine phosphorylation | abolished protein localization to nucleus | abolished response to DIF-1 | decreased gene expression
DBS0350582	splB-/ pyk3-	pyk3 | splB	abolished gene expression | abolished protein localization to nucleus | aberrant sorocarp development | abolished protein phosphorylation
DBS0236947	spnA-	spnA	abolished prespore cell differentiation | development arrests at mound stage | abolished prestalk cell differentiation | aberrant sorocarp development
DBS0236948	spnA-/ arkA-	arkA | spnA	decreased gene expression | increased sorus size | decreased stalk length | delayed gene expression
DBS0236949	spr-	spr	decreased spore germination | decreased pteridine level | decreased cytochrome C oxidase activity | decreased growth rate
DBS0350914	spsA-	spsA	decreased stalk length
DBS0351174	srcp1-	srcp1	aberrant protein modification
DBS0236950	srfA(1-8): lacZ	srfA	decreased slug migration | aberrant fruiting body morphogenesis | delayed culmination
DBS0236951	srfA-	srfA	aberrant spore morphology | decreased spore germination | aberrant spore coat morphology | decreased gene expression
DBS0266691	srfB-	srfB	abolished stream development | aberrant extracellular cAMP signaling pathway | increased lateral pseudopodium formation | precocious aggregation | decreased growth rate | increased pinocytosis | aberrant cytokinesis | precocious gene expression
DBS0304409	srsA-	srsA	increased mound size | decreased gene expression | increased gene expression | delayed aggregation
DBS0304497	sslA1-/ sslA1(CR11)	sslA1	increased fruiting body size | decreased oscillatory cAMP signaling | decreased cGMP-mediated signaling
DBS0236952	stkA-	stkA	decreased gene expression | increased prestalk gene expression | delayed prespore gene expression | aberrant fruiting body morphogenesis | increased prestalk cell differentiation
HM1157	stlA-	stlA	aberrant aggregation | abolished sporulation | wild type | increased gene expression | decreased gene expression | aberrant stream morphology | decreased spore cell differentiation | decreased chemotaxis to cAMP | aberrant sorus color | abolished MPBD level | decreased cAMP level | aberrant sporulation
DBS0350222	stlA-/ [cotB]: lacZ	stlA	decreased sporulation | aberrant prespore cell differentiation
DBS0350223	stlA-/ stlB-	stlA | stlB	decreased gene expression | increased gene expression | aberrant gene expression | decreased stalk width
DBS0350224	stlA-/ stlB-/ [ecmA]: lacZ	stlA | stlB	decreased prestalk cell differentiation
HM1154	stlB-	stlB	abolished DIF-1 biosynthesis | abolished prestalk B cell differentiation | aberrant gene expression | aberrant fruiting body morphogenesis | decreased prestalk O cell differentiation | abolished lower cup formation | abolished outer basal disc formation | decreased prestalk cell differentiation
DBS0351220	stlB-	stlB	abolished autophagosome organization | abolished autophagic cell death
DBS0350409	stlB-/ [act15]: stlB	stlB	wild type
DBS0349941	sunB-	sunB	increased number of tip-organizers | aberrant cytokinesis
DBS0304547	svkA-	svkA	delayed cell separation during cytokinesis | aberrant cytokinesis | aberrant fruiting body morphogenesis
DBS0236055	swip-	swip	aberrant protein localization to cytoplasm | abolished exocytosis | abolished phagosome reneutralization | abolished actin filament polymerization | aberrant protein localization
AK1321	swp1-	swp1	decreased response to Gram-positive bacterium
AK1200	tagA-	tagA	decreased spore cell differentiation | aberrant fruiting body morphogenesis
AK859	tagA-	tagA	decreased spore germination | increased number of mound tips | decreased spore cell differentiation | increased prestalk A cell differentiation | delayed culmination | decreased sporulation
AK1201	tagA-/ [ecmA]: GFP	tagA	abolished cell migration to prestalk region
AK228	tagB-	tagB	abolished sporulation | abolished DIF-1 biosynthesis | development arrests at mound stage | aberrant prestalk A cell differentiation
DBS0350637	tagB-/ [pkaC]: pkaC	pkaC | tagB	aberrant response to biotic stimulus | abolished spore cell differentiation
DBS0350672	tagB-/ pkaR-	pkaR | tagB	decreased sporulation
DBS0236974	tagB-/ psmA1-	psmA1 | tagB	abolished sporulation
DBS0236975	tagC-	tagC	abolished sporulation | development arrests at mound stage
DBS0350698	tagC-/ [pkaC]: pkaC	pkaC | tagC	development arrests at mound stage | abolished spore cell differentiation
DBS0236976	talA-	talA	decreased protein level | decreased cell-substrate adhesion | aberrant cytokinesis | decreased phagocytosis | aberrant cell morphology
HG1666	talA-	talA	decreased cell-cell adhesion | decreased cell-substrate adhesion | aberrant cytokinesis | decreased growth rate | decreased phagocytosis | increased cell-substrate adhesion
HG1663	talA-	talA	decreased cell-substrate adhesion
HG1664	talA-	talA	decreased uropod retraction | decreased growth rate | decreased phagocytosis | aberrant mitotic actomyosin contractile ring contraction
HG1665	talA-	talA	decreased cell-cell adhesion | aberrant cytokinesis
DBS0304585	talA-/ [act15]: FLAG: talB	talA | talB	decreased cell-substrate adhesion
DBS0237616	talA-/ [act15]: gbpD	gbpD | talA	increased cell-substrate adhesion | aberrant cell morphology | increased pseudopodium formation
DBS0238395	talA-/ [act15]: rapA(G12V)	rapA | talA	increased cell-substrate adhesion
DBS0350442	talA-/ sibA-	sibA | talA	wild type
DBS0304581	talA-/ talB-	talA | talB	development arrests at loose mound stage | abolished cell-substrate adhesion | aberrant cytokinesis | abolished cell motility | increased bleb assembly
DBS0304582	talA-/ talB-/ [act15]: FLAG: talB	talA | talB	wild type
DBS0350713	talA-/ talB-/ [act15]: talB(K16A)	talA | talB	decreased cell-substrate adhesion
HKT104	talB-	talB	decreased slug migration | aberrant extracellular cAMP signaling pathway | aberrant cellular process | decreased cell motility | development arrests at tipped mound stage | increased protein level | aberrant signal transduction
DBS0302472	talB-	talB	abolished autophagosome organization | abolished autophagic cell death | aberrant autophagic cell death
DBS0304586	talB-/ [act15]: talA: GFP	talA | talB	aberrant fruiting body morphogenesis
DBS0350712	talB-/ [act15]: talB(K16A)	talB	development arrests at tipped mound stage
DBS0351501	talB-/ pikB-	pikB | talB	aberrant cellular process
DBS0351346	tert-	tert	increased gene expression | decreased gene expression | aberrant cell adhesion | aberrant chemotaxis to cAMP | aberrant sorocarp development | delayed development | aberrant oscillatory cAMP signaling | decreased cAMP level
DBS0351559	tert-	tert	decreased catalytic activity | increased gene expression
AK1505	tgrB1-	tgrB1	development arrests at loose mound stage | delayed sporulation | decreased cell motility | decreased sporulation
DBS0351148	tgrB1-/ tgrB1(1-827): HA	tgrB1	development arrests at mound stage
AK1540	tgrB1-/ tgrC1-	tgrB1 | tgrC1	development arrests at loose mound stage | abolished cell-cell self recognition | aberrant oscillatory cAMP signaling
AK1549	tgrB1-/ tgrC1-/ QS31|tgrB1/ tgrC1	tgrB1 | tgrC1	wild type
AK1552	tgrB1-/ tgrC1-/ QS38|tgrB1/ tgrC1	tgrB1 | tgrC1	wild type
AK1555	tgrB1-/ tgrC1-/ QS45|tgrB1/ tgrC1	tgrB1 | tgrC1	wild type
AK1546	tgrB1-/ tgrC1-/ QS4|tgrB1/ tgrC1	tgrB1 | tgrC1	wild type
AK1664	tgrB1-/ tgrC1-/ alg9(-19ins)	alg9 | tgrB1 | tgrC1	decreased sporulation
DBS0351131	tgrB1-/ tgrC1-/ tgrB1(G275D)	tgrB1 | tgrC1	wild type
DBS0351132	tgrB1-/ tgrC1-/ tgrB1(G307D)	tgrB1 | tgrC1	wild type
DBS0351133	tgrB1-/ tgrC1-/ tgrB1(L846F)	tgrB1 | tgrC1	aberrant standing slug morphology | increased number of mound tips | decreased fruiting body size
AK127	tgrC1-	tgrC1	development arrests at loose mound stage | aberrant aggregation | abolished gene expression | increased mound size | decreased gene expression
AK1521	tgrC1-	tgrC1	abolished sporulation | development arrests at loose mound stage | decreased cell motility
AK1657	tgrC1-/ (QS38|tgrC1)/ alg9(-19ins)	alg9 | tgrC1	delayed development | decreased fruiting body size | decreased sporulation
AK1661	tgrC1-/ alg9(-19ins)	alg9 | tgrC1	delayed development | decreased fruiting body size | decreased sporulation
DBS0350743	tgrC1-/ alg9(-19ins)-REMI	alg9 | tgrC1	decreased sporulation
DBS0350625	tgrC1-/ stcA-	stcA | tgrC1	decreased mound size | delayed development | decreased sporulation
DBS0350626	tgrC1-/ stcB-	stcB | tgrC1	decreased mound size | delayed development | decreased sporulation
DBS0350627	tgrC1-/ stcC-	stcC | tgrC1	aberrant stream morphology | delayed development | decreased fruiting body size | decreased sporulation
AK244	tipA-	tipA	increased number of tip-organizers | increased mound size | development arrests at mound stage | decreased prestalk gene expression
JS64	tipA-/ tipB-/ [act15]: lacZ	tipA | tipB	increased mound size | increased number of mound tips | development arrests at mound stage
JS98	tipA-/ tipC-/ [ecmA]: lacZ	tipA | tipC	development arrests at loose mound stage
JS128	tipA-/ tipD-/ [ecmA]: lacZ	tipA | tipD	development arrests at loose mound stage
DBS0351500	tipB-	tipB	increased number of mound tips
JS56	tipB-	tipB	increased number of tip-organizers | increased mound size | increased number of mound tips | development arrests at mound stage
JS99	tipB-/ tipC-/ [ecmA]: lacZ	tipB | tipC	increased number of mound tips | development arrests at tipped mound stage
JS129	tipB-/ tipD-/ [ecmA]: lacZ	tipB | tipD	increased number of mound tips | development arrests at tipped mound stage
JS55	tipC-	tipC	increased number of tip-organizers | increased mound size | development arrests at mound stage | decreased number of autophagosomes | decreased autophagy
DBS0350729	tipC-/ [unk]: tipC(2725-3848): GFP	tipC	decreased fruiting body size
JS130	tipC-/ tipD-/ [ecmA]: lacZ	tipC | tipD	development arrests at loose mound stage
JS93	tipD-	tipD	increased number of tip-organizers | increased mound size | development arrests at mound stage | aberrant vacuole organization | decreased autophagy
DBS0350730	tipD-	tipD	decreased pinocytosis | increased cell death | decreased spore germination | decreased catalytic activity | increased gene expression | increased number of mound tips | increased protein modification | aberrant phagosome maturation | aberrant slug development | aberrant fruiting body morphogenesis | abolished protein localization to autophagosome
DBS0304519	tirA-	tirA	decreased response to Gram-negative bacterium | decreased defense response to Gram-negative bacterium | aberrant defense response to bacterium | decreased growth rate | aberrant phagocytosis | aberrant vegetative growth
YLD31A	tlp2-	tlp2	decreased growth rate
DBS0236016	tmcB-/ V12	tmcB	decreased macrocyst size | aberrant macrocyst formation
DBS0236018	tmcC-/ V12	tmcC	aberrant macrocyst formation
DBS0351084	tnlA/ tnlB-REMI	tnlA | tnlB	decreased gene expression | delayed aggregation | increased cell-substrate adhesion | decreased cell motility | increased protein kinase activation
DBS0350285	tom1-	tom1	decreased rate of endocytosis
DBS0237017	torA-	torA	delayed aggregation | decreased growth rate | decreased cell motility | decreased chemotaxis rate
DBS0237018	torA-/ [act15]: torA: GFP	torA	abolished vegetative growth
DBS0351498	tpc2-	tpc2	increased number of autophagosomes | increased gene expression | decreased gene expression | aberrant vegetative growth | aberrant calcium-mediated signaling | increased protein kinase activity | delayed development | increased lysosomal pH
DBS0350506	tpp1-	tpp1	aberrant response to chemical
DBS0350504	tpp1-	tpp1	increased autophagic cell death | decreased catalytic activity | aberrant response to chemical | aberrant cell morphology | precocious development | decreased sporulation
DBS0350505	tpp1-/ [cotB]: tpp1	tpp1	wild type
DBS0350507	tpp1-/ stpA-	stpA | tpp1	wild type
DBS0351017	tpp1F-	tpp1F	wild type
DBS0351558	tpt1-	tpt1	decreased spore germination | decreased gene expression | decreased growth rate | aberrant cytokinesis | decreased number of mounds | decreased macropinocytosis | delayed development | aberrant fruiting body morphogenesis | increased prestalk cell differentiation
DBS0351265	trfA-	trfA	aberrant aggregation | aberrant vegetative growth | decreased chemotaxis to cAMP
DBS0237924	triA-	triA	decreased cell-cell adhesion | increased stalk width | increased number of mounds | decreased spore germination | aberrant upper cup formation | aberrant cell motility | aberrant stream morphology | decreased spore size | decreased cell fate determination | aberrant late culminant morphology
DBS0237996	triA-	triA	aberrant late culminant morphology
DBS0237997	triA-	triA	aberrant late culminant morphology
DBS0237998	triA-/ [act15]: GFP	triA	aberrant late culminant morphology
DBS0237999	triA-/ [ecmAO]: lacZ: [ecmAO]: gus	triA	increased prestalk O cell differentiation
DBS0238001	triA-/ [psA]: lacZ: [psA]: gus	triA	increased prespore cell differentiation
DBS0351605	trm9-	trm9	decreased protein level
DBS0350107	tsc2-	tsc2	decreased phagocytosis
DBS0237022	tsg101-	tsg101	decreased fruiting body size
DBS0351612	tsg101-	tsg101	aberrant cellular process | decreased protein localization | increased defense response to Gram-positive bacterium
DBS0350816	tspC-	tspC	aberrant response to osmotic stress
HM1725	tstD-	tstD	decreased growth rate | decreased plasma membrane organization | increased growth rate
DBS0302370	tsuA-	tsuA	increased oscillatory cAMP signaling | abolished establishment of cell polarity | aberrant chemotaxis to folate | aberrant chemotaxis to cAMP | delayed aggregation | decreased mound size | decreased fruiting body size | aberrant pseudopodium formation
DBS0302383	tsuA-/ [unk]: tsuA(1-1774): YFP	tsuA	abolished protein localization to microtubules | abolished protein localization to microtubule organizing center | decreased mound size | decreased fruiting body size
DBS0302385	tsuA-/ [unk]: tsuA(1-260): YFP	tsuA	abolished protein localization to microtubules | abolished protein localization to microtubule organizing center | decreased mound size | decreased fruiting body size
DBS0302384	tsuA-/ [unk]: tsuA(1774-2247): YFP	tsuA	abolished protein localization to microtubules | abolished protein localization to microtubule organizing center | decreased mound size | decreased fruiting body size
DBS0302382	tsuA-/ [unk]: tsuA(K34R): YFP	tsuA	decreased mound size | decreased fruiting body size
DBS0302381	tsuA-/ [unk]: tsuA: YFP	tsuA	wild type
DBS0237024	ubcB-	ubcB	increased number of tip-organizers | development arrests at mound stage
DBS0306165	ube2t-	ube2t	decreased resistance to cisplatin
DBS0237025	ubpA-	ubpA	decreased gene expression | decreased chemotaxis rate | abolished aggregation
DBS0237026	ubpB-	ubpB	aberrant sorus morphology | increased prestalk gene expression | decreased prespore gene expression | precocious development
DBS0351464	uduB-/ AX3	uduB	increased prestalk cell differentiation
DBS0237027	ufc1-	ufc1	wild type
DBS0237028	ugpB-/ DH1	ugpB	abolished sporulation | decreased glycogen level | aberrant cell differentiation | decreased fruiting body size | delayed culmination
DBS0266763	ugpB-/ DH1	ugpB	decreased stalk length
DBS0266764	ugpB-/ HMX	ugpB	abolished cellulose biosynthesis | decreased autophagic vacuole organization | aberrant cell morphology
DBS0350591	uppA-	uppA	decreased catalytic activity
DBS0237031	vacA-	vacA	wild type
DBS0351567	vacA-	vacA	decreased phagocytosis
DBS0351571	vacA-/ vacB-/ vacC-	vacA | vacB | vacC	decreased cell-substrate adhesion | decreased gene expression | decreased phagocytosis | aberrant phagosome maturation | decreased protein localization | aberrant protein localization
DBS0237032	vacB-	vacB	decreased exocytosis | increased defense response to bacterium
DBS0351568	vacB-	vacB	decreased phagocytosis
DBS0351570	vacB-/ vacC-	vacB | vacC	decreased phagocytosis
DBS0351569	vacC-	vacC	decreased phagocytosis
DBS0237034	vasP-	vasP	abolished filopodium formation
DBS0237035	vasP-	vasP	decreased lateral pseudopodium retraction | decreased cell-substrate adhesion | decreased vegetative cell size | decreased cell motility | decreased chemotaxis rate | aberrant hyperosmotic response | aberrant actin filament organization | decreased chemotaxis to cAMP | abolished filopodium formation | decreased filopodium formation
DBS0237033	vasP-/ [act15]: GFP: vasP(1-264/ 285-380)	vasP	abolished filopodium formation
DBS0237836	vasP-/ [act15]: YFP: wipA	vasP | wipA	decreased filopodium formation
DBS0237842	vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG	vasP | wipA	increased filopodium formation
DBS0351313	vasP-/ [act15]: abpB(129-295)	abpB | vasP	aberrant cellular process
DBS0351300	vasP-/ [act15]: eYFP: vasP(S141A)	vasP	decreased protein localization to cell cortex | wild type | decreased lateral pseudopodium retraction | decreased establishment of cell polarity | aberrant actin filament organization
DBS0351301	vasP-/ [act15]: eYFP: vasP(S141D)	vasP	aberrant hyperosmotic response | decreased filopodium formation
DBS0237036	vasP-/ [act15]: myr: vasP	vasP	increased filopodium formation | aberrant cytokinesis | increased actin filament polymerization
DBS0237040	vasP-/ [act15]: vasP	vasP	decreased filopodium formation
DBS0237840	vasP-/ [act15]: vasP	vasP	increased filopodium formation | increased actin filament polymerization
DBS0237037	vasP-/ [act15]: vasP(1-110: 231-380)	vasP	aberrant cytokinesis | increased actin filament polymerization | decreased filopodium formation
DBS0237038	vasP-/ [act15]: vasP(1-228)	vasP	decreased filopodium formation
DBS0237039	vasP-/ [act15]: vasP(111-380)	vasP	increased filopodium formation | increased actin filament polymerization
DBS0350466	vasP-/ [unk]: vasP(1-197: 221-380)	vasP	wild type
DBS0350467	vasP-/ [unk]: vasP(1-261: 285-380)	vasP	decreased cell motility | abolished filopodium formation
DBS0351536	vasP-/ hspc300-	hspc300 | vasP	development arrests at slug stage | aberrant sorocarp development
DBS0351537	vasP-/ pirA-	pirA | vasP	increased number of mound tips
DBS0350602	vilA-	vilA	decreased chemotaxis to cAMP | decreased phototaxis
DBS0236058	vmp1-	vmp1	aberrant aggregation | decreased exocytosis | increased cell death | aberrant autophagy | decreased gene expression | decreased growth rate | aberrant hypotonic response | decreased macropinocytosis | aberrant vacuole organization | aberrant protein localization to autophagosome | aberrant protein localization | aberrant signal transduction
DBS0351250	vmp1-/ [act15]: vmp1(G268L): GFP	vmp1	aberrant aggregation | aberrant protein localization to autophagosome
DBS0350873	vps13F-	vps13F	aberrant defense response to bacterium | decreased growth rate
DG1118	vps46-	vps46	increased sorus size
DBS0237046	vwkA-	vwkA	increased myosin II assembly | decreased growth rate | aberrant cytokinesis | aberrant contractile vacuole morphology | aberrant hypotonic response | delayed development | increased protein level | aberrant fruiting body morphogenesis | decreased contractile vacuole discharge
DBS0350290	vwkA-/ [act15]: GFP: mhcA	mhcA | vwkA	aberrant myosin II filament organization
TL61	wacA-	wacA	wild type
TL99	wacA-	wacA	wild type
DBS0237048	warA-	warA	development arrests at slug stage | increased basal disc size | decreased prespore cell differentiation | increased prestalk O cell differentiation
DBS0237049	warA-	warA	development arrests at slug stage | increased basal disc size | decreased prespore cell differentiation | increased prestalk O cell differentiation
DBS0237050	warA-/ hbx2-	hbx2 | warA	increased basal disc size | development arrests at mound stage | decreased prespore cell differentiation | increased prestalk O cell differentiation
DBS0237051	wasA-	wasA	decreased cell motility | delayed development | aberrant actin filament organization
DBS0351506	wasA-	wasA	aberrant protein localization to trailing edge
DBS0351509	wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A)	scrA | wasA	aberrant pseudopodium formation
DBS0351508	wasA-/ [unk]: GFP: wasA(I173A/ F179A)	wasA	aberrant protein localization to trailing edge | decreased establishment of cell polarity
DBS0237052	wasA1-/ [tet]: YFP: wasA2	wasA	decreased actin filament polymerization | abolished positive chemotaxis | abolished aggregation | aberrant actin filament organization
DBS0237812	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA	wasA	increased actin filament polymerization at leading edge
DBS0237811	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A)	wasA	decreased actin filament polymerization | decreased actin filament polymerization at leading edge
DBS0237820	wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA	wasA | wipA	abolished positive chemotaxis
DBS0350254	wasB-	wasB	abolished protein localization to cytoplasmic vesicle | aberrant chemotaxis to cAMP | increased actin filament polymerization | increased protein level | aberrant pseudopodium formation
DBS0350255	wasB-/ [act15]: YFP: wasB	wasB	wild type
DBS0351525	wasC-	wasC	increased actin filament polymerization | decreased phagocytosis | increased cell-substrate adhesion | decreased chemotaxis rate
DBS0350239	washc5-	washc5	abolished exocytosis | decreased protein level | decreased growth rate | decreased phagocytosis | aberrant endosome morphology | decreased vegetative cell size | abolished phagosome reneutralization | decreased secretion of lysosomal enzymes | abolished actin filament polymerization | aberrant lysosome organization
DBS0351185	washc5-/ [act15]: washc5(N457D): GFP	washc5	abolished exocytosis
DG1053	wimA-	wimA	aberrant fruiting body morphogenesis
DG1064	wimA-	wimA	aberrant fruiting body morphogenesis
DBS0349863	wshA-	wshA	increased protein localization | abolished exocytosis | decreased defense response to Gram-negative bacterium | decreased macroautophagy | abolished endocytic recycling | aberrant vegetative growth | decreased phagocytosis | decreased protein processing in phagocytic vesicle | aberrant phagosome maturation | abolished phagosome reneutralization | decreased secretion of lysosomal enzymes | increased defense response to Gram-positive bacterium | decreased protein localization | aberrant lysosome organization | aberrant protein localization
DBS0350872	wshA-/ [act15]: GFP: wshA/ [act15]: vatB: RFP	vatB | wshA	abolished endocytic recycling
DBS0350451	wshA-/ atg1-	atg1 | wshA	wild type
DBS0350248	wshA-/ fam21-/ [act15]: GFP: fam21	fam21 | wshA	abolished actin filament polymerization
DBS0350247	wshA-/ fam21-/ [act15]: GFP: wshA	fam21 | wshA	aberrant lysosome organization
DBS0350943	xacA-	xacA	decreased hypotonic response | aberrant contractile vacuole morphology | aberrant actin filament organization
DBS0350950	xacA-	xacA	increased lateral pseudopodium formation | decreased chemotaxis to cAMP | aberrant actin filament organization
DBS0350944	xacA-/ [act15]: xacA(1-320)	xacA	decreased growth rate | aberrant cytokinesis
DBS0350945	xacA-/ [act15]: xacA(779-1335)	xacA	decreased hypotonic response | aberrant contractile vacuole morphology
HM1456	xpc-	xpc	wild type | aberrant vegetative growth
HM1403	xpf-	xpf	aberrant vegetative growth | decreased resistance to cisplatin
AK235	yakA-	yakA	abolished aggregation
AK800	yakA-	yakA	decreased protein localization to cell cortex | decreased gene expression | aberrant cell cycle | increased cellular thermotolerance | aberrant gene expression | decreased protein kinase activation | abolished aggregation | aberrant response to oxidative stress | aberrant cellular response to stress | decreased cAMP level
DBS0237087	yakA-/ AX3	yakA	decreased growth rate | abolished aggregation | abolished actin filament polymerization | decreased cGMP biosynthesis
DBS0237091	yakA-/ [crlA]: crlA	crlA | yakA	abolished vegetative growth
DBS0350058	yakA-/ keaA-	keaA | yakA	wild type
DBS0351199	yakA-/ pkaC-	pkaC | yakA	aberrant cellular response to stress
AK804	yakA-/ pufA-	pufA | yakA	increased protein kinase activity | increased protein level | aberrant fruiting body morphogenesis | increased growth rate | precocious development
DBS0350898	yelA-/ AX2	yelA	precocious prestalk gene expression | increased basal disc size
DG1014	yelA-/ AX4	yelA	aberrant spore morphology | precocious sporulation | development arrests at mound stage | aberrant mound color | aberrant sporulation
DBS0349797	zak2-	zak2	decreased prespore gene expression | decreased protein kinase activation | aberrant fruiting body morphogenesis | decreased sporulation
DBS0349883	zak2-/ [act15]: GFP	zak2	decreased sporulation
DBS0349798	zak2-/ [ecmA]: LacZ	zak2	aberrant prestalk gene expression
DBS0349882	zak2-/ [ecmA]: zakA	zak2 | zakA	precocious prestalk gene expression
ARK100-110	zakA-	zakA	abolished stream development | decreased protein kinase activity | increased prestalk gene expression | decreased prespore gene expression | aberrant fruiting body morphogenesis | decreased chemotaxis to cAMP | delayed culmination | decreased sporulation
DBS0238142	zakA-	zakA	development arrests at tipped mound stage
DBS0349803	zakA-/ [ecmB]: LacZ	zakA	aberrant prestalk gene expression
DG1050	zipA-	zipA	decreased fruiting body size
DBS0350068	zizB-	zizB	aberrant fruiting body morphogenesis | delayed development | decreased chemotaxis to cAMP

Last updated July 28, 2024

BACK TO TOP - BACK TO DOWNLOADS INDEX